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Abstract 
Mechanically ventilated (MV) patients are at risk of ventilator-associated pneumonia. During 
mechanical ventilation, it has been proposed that the mouth becomes colonised by 
respiratory pathogens (RP) and the endotracheal tube (ETT) facilitates leakage of 
oropharyngeal secretions to the lower airways, whilst also supporting a biofilm. These are 
likely contributory risk factors for VAP. This research aimed to further establish the 
relationship between oral microorganisms and RP in colonisation of dental plaque and ETT 
biofilms. The study also investigated intervention strategies to limit RP colonisation. 
The microbial composition of dental plaque, ETT biofilms, and non-directed bronchial 
lavages (NBLs) from MV patients was characterised using culture and molecular approaches. 
RPs were frequently present at all these sites, with oral microorganisms also occurring in 
ETTs and NBLs. Isolates from these sites in a single patient also were determined to be the 
same strains based on molecular typing. Additionally, NGS showed no significant difference 
between dental plaque and ETT biofilm microbiomes.  
In vitro biofilms revealed that oral microorganisms increased RP colonisation and associated 
gene expression in biofilms. In in vivo studies, toothbrushes and foam swabs were found to 
be equally efficient at removing dental plaque and improving oral hygiene in MV patients. In 
vitro investigation found Chlorhexidine to be the most effective mouthwash in combatting 
ETT biofilms, despite high tolerance by P. aeruginosa. No difference between ETT 
biomaterials in supporting biofilms was evident.  
The work highlights the importance of dental plaque as a reservoir of RP in MV patients, and 
these RP also colonise ETT biofilms. The synergistic effect of oral microorganisms in 
promoting RP colonisation reinforced the need to adequately manage oral care in MV 
patients. For the first time, equal effectiveness of achieving improved oral care by 
toothbrushes and foam swabs was demonstrated.  
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1. Literature Review 
 2 
 
1.1 Introduction 1 
1.1.1 General commensal microflora 2 
The human microflora is diverse and complex, with hundreds of different species 3 
constituting up to 90% of the cells that inhabit the human body (Ten Cate 2013). In a process 4 
that starts at birth, all body surfaces become colonised by permanent microbial residents 5 
and it is inevitable that microbial and host interactions will follow. In most cases, there is a 6 
mutual benefit to these interactions, however on occasions disruption to the normal balance 7 
of the microflora may lead to human disease. Every exposed body site will offer conditions 8 
that will promote colonisation by certain types of microorganisms, making each microbial 9 
community unique.  10 
The microflora of the skin has been said to protect against colonisation by potential 11 
pathogens, as well as aiding in the processing of skin proteins, free fatty acids, and sebum 12 
(Grice et al. 2008). In the case of microbial residents of the gastrointestinal tract, additional 13 
help with digestion and clearance of pathogens following infection is also known to occur 14 
(Lee and Mazmanian 2010; Stecher and Hardt 2011). It has been proposed that specific 15 
microbial communities like the gut microbiome serve as additional ‘organs’ for the body 16 
(O'Hara and Shanahan 2006). Generally, microbial investigation has involved the study of 17 
individual species using culture-based research. When grown in liquid-based culture media, 18 
such microorganisms are said to be in a free-living or planktonic form. This growth form is 19 
not, however, representative of their natural existence where microorganisms primarily 20 
grow as part of a multispecies community within a biofilm (Johnson 2008).  21 
1.2 Biofilms 22 
Biofilms can be found on any moist surface including submerged substrata, pipes, medical 23 
devices, and body surfaces such as teeth and wounds. The preference for microorganisms 24 
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to grow as a biofilm is highlighted by reports that 90% of microorganisms exist naturally 1 
within biofilms (Flemming and Wingender 2010). A modern definition of a biofilm was 2 
proposed by Donlan and Costerton, describing a biofilm as a microbial-derived sessile 3 
community, characterised by cells that are irreversibly attached to a substratum or to each 4 
other, and are embedded in a matrix of extracellular polymeric substances (EPS) that they 5 
have produced, and these biofilm cells exhibit an altered phenotype with respect to growth 6 
and gene transcription (Donlan and Costerton 2002).  7 
The above definition is greatly developed from the pioneering work of Van Leeuwenhoek in 8 
the 17th century when he first observed the scrapings of his own teeth under the microscope 9 
and described them as his ‘animalcules’, referring to his own dental plaque biofilm 10 
microorganisms. However, it was not until the 1940s that research into biofilms was really 11 
undertaken, this was when it became apparent that bacterial growth increased when 12 
attached to a surface (Heukelekian and Heller 1940). At the same time, it was also postulated 13 
that bacterial adherence to a surface could either be reversible or irreversible (Zobell 1943). 14 
Biofilm research suffered another relatively dormant period until the 1970s, after which, 15 
further biofilm characteristics were described, such as the apparent higher resistance of 16 
biofilm microorganisms to chlorine (Characklis 1973). In 1978, Costerton reported that in 17 
aquatic systems, with appropriate nutrient availability, bacteria adhered to surfaces and 18 
formed ‘glycocalyx–enclosed biofilms’ (Costerton et al. 1978). Costerton also postulated that 19 
chronic infections in patients with indwelling devices were also caused by bacterial biofilms 20 
residing on the device itself.  21 
Table 1.1 shows characteristics of biofilm cells compared to ‘free-living’ or planktonic cells, 22 
biofilm cells are more tolerant of nutrient deprivation, and environmental changes such as 23 
pH fluctuation and exposure to oxygen free radicals (Costerton et al. 1995). Another feature 24 
is that the biofilm microorganisms can express genes that their free planktonic counterparts 25 
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do not (Becker et al. 2001; Shemesh et al. 2007). Interestingly, biofilm cells are described as 1 
having lower growth rates compared with planktonic cells, however, the biofilm 2 
environment would appear to provide a more sustainable form of bacterial growth perhaps 3 
better indicated by biomass and not as individual cells. A key feature of biofilms is their 4 
relatively high tolerance to antimicrobials compared with planktonic cultures, and this 5 
creates a significant challenge when treating biofilm-associated diseases (Costerton et al. 6 
1999; Davey and O'Toole 2000).  7 
Biofilms are complex heterogeneous structures, comprised and developed from multiple 8 
microcolonies. Much, like the human body, biofilms are mainly (85%) comprised of an 9 
extracellular matrix material with a relatively small percentage of cell content (15%). The 10 
biofilm cells are covered by this matrix, forming ‘structures’ of different sizes and shapes. 11 
Open channels occur between the microcolonies that allow fluidic flow to and from the 12 
embedded cells (Donlan and Costerton 2002). 13 
The location of microbial cells within the biofilm also appears to have an impact on their 14 
characteristics. It has been found that since microorganisms towards the biofilm extremities 15 
have greater access to nutrients, gases, and are able to eradicate waste products more 16 
readily, they tend to more metabolically active and therefore larger in size than organisms 17 
more centrally located in the biofilm, making the former more susceptible to antibiotics 18 
(Malic 2008; Stoodley et al. 2002).   19 
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 1 
Table 1.1 Comparison of the characteristics of planktonic and biofilm cells. 2 
Biofilm Planktonic References 
Accounts for 90% of existing 
bacteria 
10% of existing bacteria (Flemming and 
Wingender 2010) 
Attached to a surface 
 
Free floating in an aqueous 
environment 
(Costerton et al. 1978) 
Slow growth 
 
Comparatively rapid growth (Brown et al, 1988) 
Cells are dormant, smaller 
and not actively engaged in 
cell division 
 (Anwar et al. 1992) 
Lower metabolic activity 
 
Metabolic products 
continuously removed 
(Anwar et al. 1992) 
(Costerton et al 1978) 
Greater tolerance to 
antimicrobials 
Greater sensitivity  to 
antimicrobials 
(Luppens et al. 2002) 
 
Unique gene expression 
patterns 
 (Sauer et al. 2002) 
  3 
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1.2.1 Biofilm formation  1 
There are five recognised stages involved in the development of a mature biofilm and 2 
include 1) formation of a conditioning film on the surface for microbial attachment, 2) 3 
movement of microorganisms to the conditioned surface followed by 3) reversible and 4 
irreversible attachment of microorganisms, 4) mature biofilm formation involving 5 
coaggregation/coadhesion and microbial succession, and 5) biofilm cell detachment and 6 
dispersal (Palmer and White 1997, Percival et al., 2011). The stages are illustrated in Figure 7 
1.1. 8 
1.2.1.1 Conditioning film formation  9 
Attachment of microorganisms to a surface is invariably preceded by the formation of a 10 
conditioning film that facilitates adherence of microorganisms. For biomaterials, like silicone 11 
rubber, widely used in the construction of medical devices such as catheters and 12 
endotracheal tubes (ETTs), conditioning film formation involves the adsorption of water, 13 
proteins, lipids, extracellular matrix molecules, complement, fibronectin and inorganic salts 14 
(Busscher et al. 1997; Garrett et al. 2008). This conditioning changes the physicochemical 15 
properties of the surface as well as provides a metabolically favourable environment for 16 
microbial cells with nutritional cues that trigger biofilm formation (Donlan et al. 2002). 17 
Multiple reports support the theory that biofilm formation occurs in response to various 18 
environmental cues (Costerton et al. 1995; O'Toole and Kolter 1998; Pratt and Kolter 1998). 19 
However, how these environmental signals are sensed and transduced by the biofilm-20 
forming bacteria and the molecular mechanism(s) used to initiate the development of a 21 
biofilm are poorly understood. In the case of Pseudomonas aeruginosa, these cues are 22 
integrated by the catabolite repression control (crc) protein, which plays a role in biofilm 23 
formation, possibly by controlling transcription of genes required for type IV pilus 24 
biogenesis. Evidence for this, is from research involving crc mutants which only produce a 25 
 7 
 
dispersed monolayer of cells on surfaces that are devoid of microcolonies, which are typical 1 
of mature biofilms of the wild-type strain (O’Toole et al., 2000). 2 
In dental plaque, the conditioning film is called ‘acquired pellicle’ and starts to form 3 
immediately after a tooth has been cleaned. The acquired pellicle is primarily comprised of 4 
salivary glycoproteins, phosphoproteins, and lipids. Notable components include statherins, 5 
amylase, proline-rich peptides (PRPs) and host defence components. Bacterial-derived 6 
molecules may also contribute, and glucosyltransferases (GTFs) and glucans are important 7 
for mediating microbial attachment within dental plaque (Marsh 2004). 8 
1.2.1.2 Movement of microorganisms to be in proximity to the substratum surface 9 
(Mass transport) 10 
Several mechanism are involved in the movement of microorganisms and nutrients towards 11 
a surface of attachment and include Brownian motion, sedimentation, convective and active 12 
transport, and the Gibbs energy barrier (Palmer et al. 2007a). 13 
Brownian motion is the random movement of microscopic elements in a fluid or gas caused 14 
by collisions of the molecules within the surrounding medium in thermodynamic 15 
equilibrium. The motion is named after the British botanist Robert Brown who, in 1827, first 16 
observed the movement of plant spores floating in water. This movement allows bacteria 17 
with only one flagella to translocate to find food, as otherwise, altering direction would not 18 
be possible (Li et al. 2008). Using total internal reflection fluorescence microscopy, Li et al., 19 
examined the swimming trajectories of the singly flagellated bacterium Caulobacter 20 
crescentus near a glass surface and observed large fluctuations over time in the distance of 21 
the cell from the solid surface. The research implied that Brownian motion, when combined 22 
with hydrodynamic interaction, had a supplementary and even greater influence between a 23 
swimming bacterium and a fluid boundary, significantly changing the direction of the 24 
microorganism closer to the surface (Li et al., 2008). 25 
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Sedimentation occurs due to differences in specific gravity between bacteria and the liquid 1 
media (Palmer et al. 2007a). Li et al., (2011), investigated the contribution of sedimentation 2 
to mass transport in parallel-plate-flow-chamber (PPFC) systems using Staphylococcus 3 
aureus. The research determined the height-dependent bacterial concentration, 4 
sedimentation velocity, and the sedimentation rate by microscopy. They demonstrated a 5 
five-fold difference in the initial staphylococcal deposition rate between the bottom and top 6 
plates of the PPFC, indicating that a different mass transport mechanism was operative for 7 
the bottom and top plates and that sedimentation appeared to be the predominant 8 
contributor to mass transport in the PPFC system (Li et al. 2011).  9 
It has also been proposed that bacteria use the Gibbs energy barrier to aid contact with a 10 
surface. The Gibbs energy barrier is the sum of the Van der Waals interactions- commonly 11 
attractive and electrostatic interactions, usually negative due to both bacteria and the 12 
surface being negatively charged (Palmer et al. 2007a; Vadillo-Rodriguez et al. 2005). 13 
In addition to the above, Convective mass transport refers to bacteria moving towards the 14 
surface by the movement of the liquid media in bulk and active transport explains the role 15 
of bacterial flagella and chemotaxis in bacterial attachment to a surface, although this is still 16 
poorly understood (Palmer et al. 2007a).  17 
  
  
9
 
 
           Figure 1.1 A schematic representation of biofilm formation stages. 
           Reproduced with permission Pirrone et al. (2016).    
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1.2.1.3 Attachment of microorganisms 1 
The initial attachment of microorganisms to a surface is described as being weak, possibly 2 
via a single pole and is easily disrupted by fluid shear forces. It is thought that biofilms 3 
formed in low shear environments exhibit lower tensile strength and disintegrate easily. 4 
Similarly, if formed in high shear conditions biofilms exhibit much stronger mechanical 5 
properties (Donlan and Costerton 2002).  6 
After early reversible attachment of microorganisms to the host surface, EPS substances are 7 
secreted by the microorganisms, which aid adhesion to the surface. Short-term 8 
stereochemical interactions also arise between adhesins on the microbial cells and the 9 
complementary receptors within the conditioning film. In the case of S. aureus, most of 10 
these adhesins are part of the Microbial Surface Components that Recognise Adhesive 11 
Matrix Molecules (MSCRAMMs) which facilitate adhesion to several host cells. Similarly, the 12 
fibronectin adhesins, FnBPA and FnBPB, participate in adhesion to surfaces and create 13 
connections with fibrin, collagen, and heparin in the host (Hall-Stoodley et al., 2004). These 14 
interactions lead to the initial reversible attachment of the microorganisms to the surface to 15 
be replaced by an irreversible one. The process also involves elimination of water films 16 
between the microorganism and the host surface, allowing the surfaces to come closer 17 
together (Donlan and Costerton 2002). Importantly, transition between reversible and 18 
irreversible attachment has been documented as being as short as 5 to 10 min (Meinders et 19 
al. 1995; Schwab et al. 2005). In addition to cell-to-surface adhesion, cell-to-cell adhesion 20 
also occurs during biofilm formation, for example, S. aureus produces a polysaccharide 21 
intercellular adhesion (PIA) that facilitates cell-to-cell adherence (Cafiso et al. 2004). Some 22 
species are more adept than others at creating attachment to the surface which leads to 23 
consider them pioneer colonisers Actinomyces spp, Streptococcus spp, Haemophilus spp, 24 
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Capnocytophaga spp, Veillonella spp, and Neisseria are the main pioneer bacterial genera 1 
attaching to the tooth surface (Huang et al. 2011). 2 
1.2.1.4 Coaggregation/coadhesion and microbial succession 3 
As the biofilm develops, the microbiota becomes more diverse with microorganisms that 4 
were originally unable to attach to the conditioning film, adhering to the pioneer colonisers 5 
by adhesin-receptor interactions (Beachey 1981). In dental plaque, Streptococcus species 6 
exhibit a high degree of coaggregation, and this likely contributes to the high prevalence of 7 
these bacteria as pioneer colonisers. Indeed, the Streptococcus genus accounts for 47-82% 8 
of the microbiota colonising a clean tooth (Socransky and Haffajee 2002).  9 
The metabolism of pioneer microbes in a biofilm can modulate the local environment in a 10 
way that makes it conducive for fastidious or even anaerobic bacteria to persist. For 11 
example, the anaerobic gut bacteria Clostridium perfringens and Bacteriodes fragilis has 12 
been observed to grow in in vitro Candida albicans biofilms , explained by a hypoxic 13 
environment within the biofilm (Fox et al. 2014), some species use oxygen and produce 14 
carbon dioxide and other reduced end products of metabolism, which creates a suitable 15 
environment for strictly anaerobic bacteria to survive, in an oral microbial community 16 
model, strict black pigmented anaerobes survived in an aerated system in the presence of 17 
Fusobacterium nucleatum but failed to do it in its absence. (Bradshaw et al. 1998). The effect 18 
of local metabolic activity by pioneer colonisers also generates nutrients and fermentation 19 
products that other microorganisms can use. It is such environmental changes that 20 
ultimately drive microbial succession within the biofilm (Costerton 1999). 21 
 22 
 23 
 24 
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1.2.1.5 Mature biofilm formation 1 
The biofilm growth rate decreases during maturation to its final 3-dimensional structure. 2 
Bacteria produce extracellular polymers that contribute to the EPS, including soluble and 3 
insoluble glucans, fructans and heteropolymers. Glucans contribute to further acquired 4 
pellicle and microbial adhesion, whereas fructans act as extracellular nutrient storage 5 
compounds (Matsumi et al. 2015; Rozen et al. 2001). Mature biofilms contain channels 6 
within their structure, which enable flow of nutrition and gases into the biofilm and also 7 
facilitate removal of waste products (Stoodley et al. 1999).  8 
In a mature biofilm, differing microenvironments form at distinct locations, microelectrodes 9 
have shown that oxygen does not always reach the ‘deep’ layers of a biofilm, and the result 10 
is the creation of anaerobic niches (de Beer et al. 1994).  11 
The EPS of biofilms not only provides structural support, but also protects embedded cells 12 
from environmental threats such as desiccation, and exposure to antimicrobials and host 13 
immune molecules. The EPS also acts a source of nutrients and enzymes as well as containing 14 
extracellular DNA (eDNA), which can be used in genetic exchange processes (Flemming and 15 
Wingender 2010; Mann et al. 2009; Mulcahy et al. 2008). 16 
1.2.1.6 Dispersal of biofilm cells 17 
External forces such as the physical effects of fluid shear can cause shedding or sloughing of 18 
biofilm cells (Stoodley et al. 2002). Internal biofilm processes, such as endogenous enzymatic 19 
activity leading to the release of EPS and surface-binding proteins can also trigger cell 20 
dispersal (Boyd and Chakrabarty 1994; Lee et al. 1996) creating a risk of distal site infection. 21 
Three types of dispersal (see below) have been described, swarming, clumping and surface 22 
dispersal (Hall-Stoodley et al. 2004). 23 
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In S. aureus biofilms, the accessory gene regulator (agr) quorum-sensing system is required 1 
to form biofilms and its reactivation in established biofilms through autoinducing peptides 2 
(AIPs) addition or glucose depletion triggers cells detachment. Importantly, detachment also 3 
restored sensitivity of the dispersed cells to the antibiotic rifampicin (Boles and Horswill 4 
2008). 5 
1.2.1.6.1 Swarming dispersal 6 
Also known as seeding dispersal, swarming dispersal refers to bacterial cells being locally 7 
released. In some species, gliding or twitching motility allows cells to move individually along 8 
a surface (Bartova et al. 2014). A study using flow cell microscopy showed that in 9-day old 9 
P. aeruginosa biofilms, the inner microcolonies of the biofilm liquefy leading to free 10 
movement of cells and generating empty spaces surrounded by walls of non-motile cell 11 
clusters (Sauer et al. 2002). Aggregatibacter actinomycetemcomitans, Haemophilus 12 
aphrophilus and Streptococcus mitis (Bellissimo-Rodrigues et al. 2009). In the case of non-13 
motile species, it was proposed that bacterial translocation was dependant on convection 14 
currents and temperature gradients in the bulk media (Kaplan and Fine 2002). 15 
1.2.1.6.2 Clumping dispersal 16 
Instead of single cells, aggregates of cells encased in EPS can disperse from biofilms (Stoodley 17 
2001). Biofilm clumps may contain thousands of microorganisms that likely exhibit a similar 18 
phenotype to those retained within the biofilm, including properties such as higher 19 
antibiotic resistance. Such cell clusters can act as ‘metastatic foci’ of infection at distant sites. 20 
This type of dispersal has been reported for non-motile species including S. aureus (Hall-21 
Stoodley et al. 2004). 22 
 23 
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1.2.1.6.3 Surface dispersal 1 
As mentioned previously, environmental conditions such as those facilitated by increased 2 
shear can mediate transport of whole biofilm sections. For example, in vitro studies have 3 
shown that aggregates of endotracheal tube biofilms can travel up to 50 cm away from the 4 
end of the endotracheal tube when exposed to the forces of mechanical ventilation (Inglis 5 
1993). This effect is particularly important in the clinical scenario where developed biofilm 6 
aggregates from the endotracheal tube, potentially with higher tolerance to host immune 7 
mechanisms and antimicrobials, would contaminate the lung. Surface dispersal has also 8 
been reported in vitro for S. aureus biofilms using a glass model of a central venous catheter 9 
model where biofilm was seen to detach, ‘roll’ and then re-attach to a distal point (Hall-10 
Stoodley et al. 2004).  11 
1.2.2 Oral Biofilms: Dental Plaque 12 
Dental plaque was the first discovered ‘biofilm’, first described by Anthony van 13 
Leeuwenhoek in 1684 as “The number of these animalcules in the scurf of a man's teeth are 14 
so many that I believe they exceed the number of men in a kingdom". Dental plaque is the 15 
most studied biofilm, it covers the oral cavity, particularly the teeth and tongue. Dental 16 
plaque is known to harbour over 600 bacterial species (Paster et al. 2001), of which about 17 
350 have been cultivated. The remaining species have been identified by sequencing of 16S 18 
rDNA (Dewhirst et al. 2010; Socransky and Haffajee 2002). Culture analyses estimate that up 19 
to 200 species can be found in one host (Paster et al. 2006), however, next generation 20 
sequencing estimates this number could be close to 500 species per person (Nelson et al. 21 
2010; Zaura et al. 2009). 22 
 23 
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1.2.2.1 Mature dental plaque 1 
In early stages of biofilm development, a condensed layer of only a few bacteria is seen, but 2 
later a thicker layer demonstrating less orientation and higher morphological diversity 3 
occurs. In mature plaque, due to enzymatic activity in the acquired pellicle, plaque 4 
microorganisms can be seen in direct contact with enamel and food particles (Marsh 2004). 5 
Dental plaque deposition continues until it reaches a critical size where surrounding 6 
structures (i.e. lips, tongue, cheeks), mastication and salivary clearance limit its expansion. 7 
Dental plaque is, however, dynamic in both structure and composition and continuously 8 
reorganises (Rosan and Lamont 2000). 9 
1.2.2.2 Microbial composition of dental plaque 10 
Dental plaque microbial communities differ at distinct sites in the mouth. Sites such as the 11 
teeth, tongue and gingival pockets provide different oxygen and nutrient levels as well as 12 
mechanical and temperature challenges to plaque. In addition, there will be different levels 13 
of contact with the host immune system and secretions like saliva and gingival crevicular 14 
fluid (Kolenbrander et al. 2010).  15 
Dental plaque is described as supragingival when above the gingival margin or subgingival 16 
when below. Supragingival plaque is mainly composed of Gram-positive bacteria, including 17 
Streptococcus sanguinis, Streptococcus mutans, Streptococcus mitis, Streptococcus 18 
salivarius and lactobacilli. Less prevalent but are encountered, are facultative anaerobic 19 
Gram-negative species such as Neisseria species and Haemophilus parainfluenza, and 20 
occasionally obligate anaerobes including species of Veillonella and Propionibacterium 21 
(Kroes et al. 1999; Nyvad and Kilian 1987). The differing morphology of the anatomical 22 
structures of the mouth offer distinct microenvironments that will be reflected by the 23 
respective microbial communities. For example, the base of the teeth fissures are commonly 24 
colonised by Streptococcus mutans and Lactobacillus, whereas interproximal plaque, is 25 
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predominantly comprised of Gram-positive bacilli, in particular Actinomyces species 1 
(Kuramitsu et al. 2007; Huang et al. 2011). 2 
Subgingival plaque occurs below the gum line, in a space between the tooth surface and the 3 
gingival epithelium called the gingival crevice or sulcus. In health, subgingival plaque is 4 
composed primarily of Gram-positive facultative anaerobic cocci (40%; e.g. streptococci) and 5 
facultative anaerobic bacilli (35% e.g. Actinomyces). Anaerobic bacteria constitute the 6 
remaining 25% of the subgingival plaque microflora, and spirochetes and anaerobic 7 
streptococci are considered almost exclusive to subgingival plaque (Kroes et al. 1999; Moore 8 
and Moore 1994).  9 
In disease, the gingival crevice can enlarge into a periodontal pocket and the flow of gingival 10 
crevicular fluid increases. In periodontal pockets, plaque presents as a thin compact layer on 11 
the root surface of the tooth with a looser structure towards the epithelial lining of the 12 
pocket. The periodontal pocket is anaerobic, and the most frequent inhabitants are Gram-13 
negative anaerobic bacteria such as Prevotella intermedia, Porphyromonas gingivalis, 14 
Aggregatibacter actinomycetemcomitans, Tannerella forsythia and spirochetes such as 15 
Treponema denticola (Kuramitzu et al. 2007). 16 
Dental appliances may also harbour dental plaque. In the case of the fitting surface of a 17 
denture, plaque tends to be more acidogenic, and the most commonly found bacteria are 18 
streptococci along with yeast of the genus Candida species. Obligate anaerobes like 19 
Actinomyces israelii have been cultured from dentures, whilst molecular techniques have 20 
detected periodontal pathogens such as P. gingivalis, Tannerella forsythia and A. 21 
actinomycetemcomitans (Socransky and Haffajee 2002). 22 
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1.2.2.3 Interspecies interactions in dental plaque 1 
Interestingly, many species encountered in the oral cavity e.g. S. mutans and P. gingivalis, 2 
are not usually found anywhere else in the body. Oral microorganisms need to attach to oral 3 
surfaces (teeth or mucosa) or to existing microorganisms and biofilms, as otherwise they will 4 
be transported to the digestive tract during salivary clearance and swallowing (Kolenbrander 5 
et al. 2010). With such an abundance of microbial species, intercellular interactions play a 6 
key role in dental plaque formation and maintenance. Previous research shows that in the 7 
oral environment, each microbial species has an affinity to another genetically different 8 
microorganism. Fusobacterium nucleatum has partnerships with multiple species including 9 
early and late colonisers as well as aerobic and anaerobic species. For this reason F. 10 
nucleatum has often been described as a ‘bridging’ bacterium (Huang et al. 2011; 11 
Kolenbrander et al. 2010). A well-documented example of multispecies affinity occurs 12 
between Porphyromonas gingivalis and Treponema denticola. P. gingivalis produces 13 
isobutyric acid, and this in turn enhances growth of T. denticola. Meanwhile, T. denticola 14 
produces succinic acid which can be incorporated into the P. gingivalis cell wall (Huang et al. 15 
2011). F. nucleatum and P. intermedia are tolerant of pH levels as low as 5.0 and produce 16 
ammonia and organic acids through fermentation of glutamate and aspartate. These 17 
metabolites increase alkalinity and will make the environment more tolerable for species 18 
like P. gingivalis, which optimally grows at neutral pH (Huang et al. 2011). Similarly, aerobic 19 
species consume oxygen in the environment creating localised anaerobic conditions that 20 
allow the growth of strictly anaerobic bacteria (Kuramitsu et al. 2007). 21 
1.2.3 Gene expression in biofilms 22 
Microorganisms can live as ‘free floating’ (planktonic) cells or as part of a biofilm. Clearly, 23 
different challenges and requirements present themselves when microorganisms grow 24 
within a biofilm. These include the need to adhere to a surface, generate EPS, grow in an 25 
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environment where nutrient availability or oxygen is limited, and the requirement to both 1 
communicate with other cells and to disperse from the biofilm when needed (O'Toole et al. 2 
2000). In order to meet these lifestyle challenges, differential expression of specific biofilm 3 
genes is required (Jefferson, 2004). The first indication that changes in gene expression 4 
occurred in biofilms originated from a gene-fusion study where up to 38% of the Escherichia 5 
coli genome was differentially expressed during biofilm formation (Prigent-Combaret et al. 6 
1999). Later, a study using DNA microarray analysis estimated that only a 1% difference in 7 
terms of gene expression occurred between planktonic and biofilm growth of P. aeruginosa, 8 
with a 50% split between up-regulation and down-regulation of genes. However, these 9 
apparently subtle differences were significant in terms of biofilm formation and also 10 
antibiotic resistance (Whiteley et al. 2001). Furthermore, microarray analyses of E. coli and 11 
Bacillus subtilis growth showed that a change of up to 15% in biofilm gene expression 12 
occurred compared with planktonic cells (Beloin et al. 2004; Ren et al. 2004; Schembri et al. 13 
2003; Stanley et al. 2003). In a study of gene expression patterns in S. aureus biofilms, up-14 
regulation of over 160 genes for biofilm cells compared with planktonic cells was noted. The 15 
up-regulated genes included those involved in the synthesis of binding factors, 16 
peptidoglycan and PIA, as well as those associated with the detoxification of formate, urea, 17 
and reactive oxygen species (Resch et al. 2005). 18 
Use of Affymetrix® GeneChip microarrays has facilitated analyses of almost the entire P. 19 
aeruginosa and E. coli genomes under defined growth conditions. In such studies, 20 
differences of 4-14% in E. coli gene expression has been reported between planktonic and 21 
biofilm cells (Schembri et al. 2003), and for P. aeruginosa the difference in total gene 22 
expression was determined to be approximately 3% when planktonic cells were compared 23 
with those in developing biofilms. Interestingly, this figure increased to 14.3% in more 24 
established biofilms (Waite et al. 2005). More recently, a study using next generation 25 
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sequencing (RNAseq) examined global gene expression of P. aeruginosa biofilms in 96-well 1 
plate microtitre plates and compared these to stationary phase planktonic growth (Dotsch 2 
et al. 2012). In this study, it was reported that some genes were similarly expressed in both 3 
the stationary phase of planktonic cultures and in biofilms, but there was also a group of 4 
genes exclusively expressed in biofilms, most of which were related to adaptation to 5 
microaerophilic growth conditions, repression of type three secretion proteins and 6 
production of extracellular matrix components (Dotsch et al. 2012). 7 
Table 1.2 shows changes in gene expression have also been reported during different stages 8 
of biofilm development, indicating that it is not only biofilm establishment, but also survival 9 
of cells within the biofilm that involves differentially regulated gene expression. 10 
During the early stages of biofilm development, flagella motility may be required for initial 11 
attachment of motile bacteria to a surface. However, once attached, these genes are 12 
subsequently down-regulated (Prigent-Combaret et al. 1999; Sauer and Camper 2001; 13 
Stanley et al. 2003). In the case of P. aeruginosa, type IV pili and cupA fimbriae have been 14 
shown to be involved in the initiation of biofilm formation (D'Argenio et al. 2002; O'Toole 15 
and Kolter 1998; Sauer and Camper 2001; Vallet et al. 2001). Once attached to a surface, 16 
production of EPS is required to provide biofilm support and is also important in self-17 
aggregation of cells. In S. aureus and S. epidermidis biofilms, polysaccharide production is 18 
mediated by the icaABCD operon which encodes for enzymes needed to synthesise the 19 
polymer PIA/PNAG (polysaccharide intercellular adhesion/poly-N-acetylglucosamine) 20 
(Heilmann et al. 1996). In addition to the intercellular adhesion (ica) operon and PIA 21 
production, the AtLE and dltA surface proteins are thought to facilitate adhesion to 22 
polystyrene surfaces (Hall-Stoodley, et al. 2004). 23 
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Table 1.2 Genes required for biofilm formation, adapted from (Jefferson 2004). 2 
Genes Function Species 
Adhesion     
gbpA Polysaccharide formation Streptococcus mutans 
tarC 
Regulator of glucosyltransferase S and glucan 
binding protein Streptococcus mutans 
ica ADBC Intercellular adhesin synthesis Staphylococcus aureus 
clf A Clumping factor A, fibrinogen binding protein Staphylococcus aureus 
bopABCD Biofilm on plastic surface operon Enterococcus faecalis 
Quorum sensing   
com X Competence Streptococcus gordonii 
com ACDE Competence Streptococcus mutans 
LasI Synthesis of 3OC12-HSL quorum sensing signal 
Pseudomonas 
aeruginosa 
Cell Wall     
brpA Possible regulator of autolysis Streptococcus mutans 
glmM Peptidoglycan synthesis Streptococcus gordonii 
bacA Peptidoglycan synthesis Streptococcus gordonii 
Metabolis
m     
ccpA Carbon catabolite control protein Streptococcus mutans 
Crc Global carbon metabolism regulator 
Pseudomonas 
aeruginosa 
Stress response   
Dgk Stress response regulator  Streptococcus mutans 
pur R Regulator of purine synthesis, metabolism 
Staphylococcus 
epidermis 
mut T DNA mismatch repair Streptococcus gordonii 
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For P. aeruginosa, the pel locus (referring to pellicle, a biofilm formed at the air-medium 1 
interface) containing the genes pelA-G, is responsible for synthesis of a glucose-rich 2 
component of the matrix, whereas psl (polysaccharide synthesis locus), containing the pslA-3 
O genes, is responsible for a mannose and galactose rich EPS (Friedman and Kolter 2004; 4 
Khan et al. 2010), and although alginate is often considered a major component of P. 5 
aeruginosa extracellular matrix, this may only be true for mucoid strains commonly isolated 6 
from cystic fibrosis patients. Mucoid strains are proficient alginate producers and non-7 
mucoid strains do not produce significant quantities of alginate, but can still form biofilms 8 
(Friedman and Kolter 2004). 9 
In mature biofilms, embedded cells need to adapt to a new microenvironment and altered 10 
gene expression allows the cells to compete in lower nutrients levels, reduced oxygen 11 
tension and pH changes. For example, anaerobic growth was found to induce expression of 12 
the ica operon and associated PIA production in both S. epidermidis and S. aureus 13 
biofilms (Cramton et al. 2001), whilst in P. aeruginosa biofilms, the stationary phase sigma 14 
factor, rpoS, has been shown to be either repressed by 2-3-fold or slightly activated 15 
(Whiteley et al. 2001; Xu et al. 2001). 16 
1.2.3.1 Differential gene expression as a stress response 17 
Environmental changes may occur in biofilms and are frequently inhibitory to healthy 18 
microbial cell growth and function. Such changes can include nutrient depletion, oxygen 19 
limitation, extreme pH, osmolarity imbalances and temperature shifts, and in turn will 20 
induce stress in the cells. Examples of these environmental changes, include the stress-21 
inducing changes that occur in dental plaque biofilms following the presence of sucrose 22 
immediately after eating and drinking. Fermentation of sucrose by certain bacteria leads to 23 
lactic acid production with a subsequent reduction of local pH in the biofilm from pH 7.5 to 24 
as low as pH 3.5 (Welin-Neilands and Svensäter 2007). Extremes of temperature in S. aureus 25 
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biofilms occur when host core temperature increases as evident in patients with a septic 1 
status. In order to survive these environmental fluctuations, microorganisms need to rapidly 2 
modulate expression of certain genes (de Nadal et al. 2011).  3 
Modulation of gene expression and subsequent differential protein production first requires 4 
the cells to sense the environmental change. In yeast, osmostress is mainly sensed by two 5 
upstream mechanisms that converge on the high osmolarity glycerol (HOG) signal 6 
transduction pathway, which is the central pathway of the yeast osmostress response (de 7 
Nadal et al. 2011). Once the stress is detected, the cell needs to rapidly respond by regulating 8 
expression of proteins that counter the effects of the experienced stress (de Nadal 2004). 9 
For instance, in the example of lowered pH in dental plaque, S. mutans increases specific 10 
activity of the membrane F1 H+/ATPase involved in proton efflux during pH homeostasis 11 
(Belli & Marquis, 1991; Hamilton & Buckley, 1991). In heat shock, in the yeast Saccharomyces 12 
cerevisiae, the main defensive response is protein unfolding as well as the induction of genes 13 
involved in respiration and the use of alternative carbon sources (Causton 2001). 14 
1.2.3.2 Quorum sensing in biofilms 15 
It is widely recognised that microorganisms generate signalling molecules that effectively 16 
allows communication between the cells. The process is termed Quorum Sensing (QS) and 17 
can lead to coordinated gene expression (Socransky and Haffajee 2002). Cells detect the 18 
signalling molecule, which if in sufficient concentration allows the entire microbial 19 
population to harmonically respond to changes in cell density (Binkley et al. 2004). 20 
QS in Gram-positive and Gram negative bacteria can regulate a number of physiological 21 
activities, including competence development, sporulation, antibiotic biosynthesis, and 22 
induction of virulence factors (Miller and Bassler 2001). Additionally, biofilm growth has 23 
been reported to promote cell-cell signalling systems in order to activate genetic 24 
competence and facilitate genetic exchange (Cvitkovitch et al. 2003).  25 
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Several chemical classes of microbially-derived signalling molecule have now been 1 
identified. Broadly, these can be split into two main categories: oligopeptides commonly 2 
utilised by Gram-positive bacteria (Binkley et al. 2004) and fatty acid derivatives like acyl-3 
homoserine lactones (AHLs) frequently utilised by Gram-negative bacteria (Sadikot et al. 4 
2005). 5 
In Gram-positive bacteria, QS systems generally consist of three components, a signal 6 
peptide and a two-component regulatory system (TCRS) or two-component signal 7 
transduction system (TCSTS) that has a membrane-bound histidine kinase sensor and an 8 
intracellular response regulator (Kleerebezem et al. 1997).  9 
In S. aureus, the QS system is encoded by the agr operon, and the communication 10 
molecules are the autoinducing peptides (AIPs). It has been reported that AIPs bind to a 11 
surface histidine kinase receptor, initiating a regulatory cascade that modulates expression 12 
of a multiple genes including virulence factors, such as proteases, haemolysins and toxins 13 
(Boles and Horswill 2008; Novick 2003).  14 
In Pseudomonas aeruginosa, two AHL-based QS systems have been described, namely 15 
the Las and Rhl systems. The Las system comprises of the transcriptional regulator LasR and 16 
its cognate AHL signal, N-(3-oxododecanoyl)-l-homoserine lactone (3-oxo-C12- HSL), which 17 
is synthesised by the AHL synthase LasI. The Rhl system is comprised of RhlR together with 18 
its cognate AHL, N-butyryl-l-homoserine lactone (C4-HSL), synthesised by the RhlI AHL 19 
synthase (Özçaka et al. 2012). Additionally, another signalling molecule called 20 
Pseudomonas Quinolone Signal (PQS) has been reported (Pesci et al. 1999). Structural 21 
genes for PQS production have been identified (pqsABCDH) together with a transcriptional 22 
regulator (pqsR) and the response effector (pqsE) (Özçaka et al. 2012). 23 
 24 
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1.2.4 Antibiotic resistance in biofilms 1 
Biofilm cells exhibit higher resistance to antimicrobial agents compared to their planktonic 2 
counterparts, and this has been documented as being up to 1000-fold higher (Luppens et al. 3 
2002). Multiple factors contribute to this biofilm resistance, including the reduced 4 
metabolism and growth rate of certain biofilm cells, which is thought to be accentuated in 5 
the central regions of the biofilm (Evans et al. 1991; Mah and O'Toole 2001). Furthermore, 6 
the biofilm matrix may provide mechanical protection by impairing diffusion of the antibiotic 7 
molecules into the deeper cell layers, and its concentration decreased below a therapeutic 8 
level due to degradation by enzymes entrapped in the matrix. (Normark and Normark 2002), 9 
in P. aeruginosa sequestration of the antibiotic tobramycin by glucose polymers in the 10 
periplasm has been observed (Mah et al. 2003). Additionally, ionic interactions occur 11 
between antibiotics and the biofilm matrix, recently it was reported that the positively 12 
charged antibiotic tobramycin was sequestered to the biofilm periphery, while the neutral 13 
antibiotic ciprofloxacin readily penetrated (Tseng et al. 2013). 14 
The ability of ciprofloxacin to pass through a P. aeruginosa biofilm revealed that the 15 
antibiotic was able to penetrate some, but not all, of the biofilm, leaving remnant bacteria 16 
(Suci et al. 1994). Furthermore, the trait of the microorganism creates an additional 17 
challenge to the penetration of the antibiotic. Biofilms formed by a β-lactamase negative 18 
Klebsiella pneumonia mutant were readily penetrated by ampicillin, whereas biofilms of the 19 
wild type (β-lactamase positive K. pneumonia) were not (Anwar et al. 1992). Interestingly, 20 
β-lactamase negative K. pneumonia mutants were resistant to ampicillin, and this suggested 21 
that impedance of biofilm penetration was not the mechanisms of resistance (Vrany et al. 22 
1997). Penetration of the biofilm also depends on the antibiotic itself, in a study determining 23 
antibiotic penetration of S. aureus and S. epidermidis biofilms, it was found that the 24 
movement of β-lactams (oxacillin and cefotaxime) and glycopeptide (vancomycin) 25 
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antibiotics was significantly impeded, this contrasted with movement of the aminoglycoside 1 
amikacin and the fluoroquinolone ciprofloxacin, which was unaffected (Singh et al. 2010). 2 
In the case of therapy for infection, if a significant number of planktonic and biofilm bacteria 3 
are killed, then improvement of the clinical condition would be expected. However, as 4 
bacteria in protected biofilm regions often survive, these cells can rapidly re-establish the 5 
biofilm. As a result, mechanical or surgical removal of the biofilm may often be the only 6 
effective treatment options (Davies 2003; Marrie et al. 1982).  7 
Biofilm cell density also contributes to antimicrobial resistance. Interestingly, in experiments 8 
comparing antibiotic sensitivities of planktonic P. gingivalis at similar cell densities to those 9 
encountered in biofilms, higher minimum inhibitory concentrations (MICs) to a range of 10 
antibiotics were observed compared to conventionally determined MICs. However, these 11 
MICs were still 2 to 8-fold lower than those of biofilm populations (Larsen, 2002). 12 
As well as serving as a barrier to antibiotics, biofilms contain microenvironments that exhibit 13 
different gradients in oxygen levels, pH and osmolarity. These can affect the relative 14 
effectiveness of the antibiotic (Costerton and Stewart, 2001). In addition, as biofilm cells 15 
may exhibit reduced metabolic activities and growth rates, antibiotics such as penicillin that 16 
target active cell wall synthesis will have no effect on non-dividing cells (Davies 2003; 17 
Tuomanen et al. 1986).  18 
As described previously, biofilm cells exhibit differential gene expression compared with 19 
planktonic cells and this may enhance resistance against the antimicrobials. For example, 20 
increased expression of efflux pumps in the cell membrane that remove antibiotics from the 21 
cell, has been reported for P. aeruginosa biofilm cells. In this species, the MexAB-OprM 22 
pump has been shown to be able to transport multiple drugs (Davies 2003; Donlan and 23 
Costerton 2002; Sauer and Camper 2001).  24 
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As well as having higher resistance to antimicrobials, biofilms are also more resistant to the 1 
host immune responses. P. aeruginosa has been shown to be resistant to antibodies 2 
produced during cystic fibrosis infection in a rat model (Meluleni et al. 1995). Phagocytosis 3 
may be impaired and the host tissues in vicinity to the biofilm may be affected by neutrophil 4 
and complex system response (Stewart and Costerton, 2002).It has also been reported that 5 
extracellular DNA, a biofilm matrix component, induces antibiotic resistance due to its ability 6 
to bind and sequester cations, including magnesium, from the surrounding environment. 7 
This environmental cue was then detected by P. aeruginosa leading to induction of genes 8 
involved in modification of the cell surface component, lipopolysaccharide, resulting in 9 
physical alterations in the bacterial outer membrane (Mulcahy et al. 2008).  10 
1.2.5 Biofilms in human disease 11 
Biofilms account for at least 80% of infectious diseases in humans and include infection such 12 
as otitis and periodontitis. In addition, biofilms can also cause infection when they colonise 13 
medical devices including contact lenses, venous catheters and endotracheal tubes (Table 14 
1.3). Furthermore, medical equipment including dental unit waterlines and ventilators may 15 
be colonised by biofilms and serve as a sources of infection within hospital environments 16 
(Donlan and Costerton, 2002). 17 
1.2.5.1 Biofilms on medical devices 18 
Microorganisms frequently live in biofilms attached to inert surfaces in the environment, 19 
therefore it is hardly a surprise that biomaterials are not exempt form colonisation. 20 
Implanted medical devices are especially prone to biofilm development, leading to both 21 
infection and/or failure of the device (Høiby et al. 2011; Reid 1999).  22 
The high incidence of infections due to medical devices has led to the term ‘chronic polymer 23 
associated infection’ with involved species often being those not previously thought of as 24 
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pathogens e.g. S. epidermis which is a normal habitant of the skin (Hall-Stoodley et al. 2004). 1 
The primary function of the device may also be compromised by biofilm formation, for 2 
example, biofilm aggregates can block catheter lumens rendering the device unusable and 3 
necessitating replacement (Lindsay and von Holy 2006). 4 
Colonisers of medical devices can be Gram-positive and Gram-negative bacteria as well as 5 
yeast, and the biofilms involved can be single or multispecies (Donlan 2001). These 6 
organisms frequently originate from the patient’s own body (endogenous) or may be of 7 
exogenous origin e.g. from carers or the local environment (Table 1.4) (Hall-Stoodley et al. 8 
2004). 9 
Colonisation of devices can occur within hours of implantation, and the duration the device 10 
is in place influences the risk of biofilm development and patient morbidity (Donlan and 11 
Costerton 2002). 12 
Biofilm prevention strategies include flushing with antimicrobials in venous catheters as well 13 
as impregnation of the biomaterial with antibiotics and antimicrobials such as chlorhexidine 14 
and silver sulfadiazine antiseptics. Unfortunately, such methods often do not reliably 15 
eradicate or prevent biofilm formation. Similarly, a range of materials including silicone, 16 
polyurethane, composites and hydrogel-coated materials have failed to avoid biofilm 17 
formation (Donlan, 2001). 18 
 19 
 20 
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Table 1.3 Biofilm related infections. 
Infection Description Reference 
Native valve endocarditis Streptococcus spp, are the most prevalent bacteria in this infection, but Staphylococcus spp and 
Candida have also been identified. Biofilms can cause valve dysfunction and heart disease as well 
as the production of emboli leading to thromboembolic disease, fungal biofilms have been 
recognized to be larger in size, and larger size biofilms are reported to cause more emboli. 
(Donlan and 
Costerton 2002). 
 
Cystic fibrosis Cystic fibrosis is a heterogeneous genetic disease that affects the lower respiratory tract, where 
the mucocilliary system impaired and the epithelium of the lung becomes covered in viscous mucus 
that has been linked to bacterial lung infections that account for 90% of early deaths. Pseudomonas 
aeruginosa is the most common pathogen  
(Valenza et al. 
2008) 
Chronic bacterial 
prostatitis 
Scanning electron microscopy has shown biofilm growth in the prostate ducts. It has been reported 
that bacteria recovered from prostatitis samples have shown the characteristic slow growth and 
antibiotic resistance of biofilm organisms.  
(Donlan and 
Costerton 2002). 
Otitis media Otitis media is an inflammation of the mucoperiosteal lining of the middle ear. Commonly 
associated with Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, group 
A beta- haemolytic Streptococci, enteric bacteria, Staphylococcus aureus, Staphylococcus epidermis 
and Pseudomonas aeruginosa. A collection of highly viscous fluid occurs and to drain this fluid and 
thus relieve symptoms and prevent hearing loss, tympanostomy tubes are fitted. These tubes 
accumulate biofilms in their inner surfaces and to complicate treatment, the middle ear fluid 
absorbs significantly less antibiotics than plasma therefore middle ear infection are thus difficult to 
treat. 
(Donlan and 
Costerton, 2002) 
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              Table 1.4 Common pathogens in medical devices infection. 
Infection  Microorganisms associated Reference 
Central venous 
catheter 
Staphylococcus epidermis, Staphylococcus aureus, Candida albicans, Pseudomonas 
aeruginosa, Klebsiella peumoniae and Enterococcus faecalis 
(Elliott et al. 1997; Raad 
et al. 1992) 
Prosthetic  valves Streptococcus epidermis, Staphylococcus aureus, Streptococcus spp., Gram negative bacilli, 
diphtheroids, enterococci and Candida species. 
(Donlan 2001) 
Urinary catheters Staphylococcus epidermis, Enterococcus faecalis, Proteus mirabilis, Pseudomonas aeruginosa 
and Klebsiella pneumonia. 
(Donlan 2001) 
Prosthetic Joints Staphylococcus aureus and Staphylococcus epidermidis, other Coagulase Negative 
Staphylococci, Pseudomonas aeruginosa and Enterococcus faecalis. 
(Campoccia et al. 2006) 
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1.3 Ventilator associated pneumonia 1 
Ventilator-associated pneumonia (VAP) is a respiratory infection that develops in patients 2 
after 48 hours of mechanical ventilation (MV). Depending on the number of days of 3 
mechanical ventilation, VAP can be classified as early or late onset (Ibrahim et al. 2000; Kollef 4 
et al. 2012). VAP within the first 4 days after initiation of MV is considered ‘early onset’ and 5 
thought to be caused by possibly endogenous pathogens associated with the community, 6 
namely, Haemophilus influenzae, Escherichia coli or meticillin sensitive Staphylococcus 7 
aureus (MSSA) (Ibrahim et al. 2000; Wiener-Kronish and Dorr 2008). After 5 days mechanical 8 
ventilation, VAP is consider to be ‘late onset’ and is more associated with antibiotic resistant 9 
bacteria typically considered endogenous to healthcare facilities such as Pseudomonas 10 
aeruginosa and meticillin resistant Staphylococcus aureus (MRSA) (Masterton et al. 2008). 11 
1.3.1 Diagnosis of VAP 12 
Diagnosis of VAP is complicated by the absence of a ‘classic sign’ or a gold standard guideline 13 
for diagnosis, and this frequently creates discrepancies in clinical opinion. The most widely 14 
used diagnostic tool is the Clinical Pulmonary Infection Score (CPIS) a clinical score of 0-12 15 
with a score >6 considered indicative of VAP, it is based on the following 6 variables: body 16 
temperature, leukocyte count, volume and character of tracheal secretions, arterial 17 
oxygenation, chest radiograph findings, Gram stain results, and results of culture of tracheal 18 
aspirate specimens (Table 1.5) (Pugin 2002; Pugin et al. 1991). However the CPIS originates 19 
as a secondary outcome from a relatively small sample of 40 blind bronchial lavages from 28 20 
patients and has no evidence of its poor specificity (Zilberberg and Shorr 2010). In view that 21 
potentially hospital acquired pneumonia could be “underdiagnosed” if all of the CPIS criteria 22 
had to be met, in 2008, the British Society of Antimicrobial Chemotherapy (BSAC) 23 
recommended that pneumonia should be considered for patients presenting with the 24 
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presence of purulent tracheal secretions, and new and/or a persistent infiltrate on chest X-1 
ray (CXR), which was otherwise unexplained, increased oxygen requirement, core 2 
temperature above 38.3°C, Blood leucocytosis (>10000/mm³) or leukopenia (<4000 mm³) 3 
(Masterton et al., 2008). The most accurate method for VAP diagnosis would be a lung 4 
biopsy, however such a procedure is clearly highly invasive and therefore a recommendation 5 
against its routine use was made by the BSAC (Masterton et al., 2008).VAP diagnosis can be 6 
facilitated by quantitative microbial culture from bronchoscopic specimens and subsequent 7 
identification of pathogenic microorganisms. Such an approach has been recommended by 8 
the American Thoracic Society (American Thoracic and Infectious Diseases Society of 2005). 9 
There are currently two bronchoscopic methods including use of a protected specimen 10 
brush (PSB) or a bronchoalveolar lavage (BAL). PSB employs a double lumen catheter with a 11 
telescopic cannula and a distal plug, whilst BAL (involving guidance from the bronchoscope), 12 
involves irrigation and subsequent aspiration of the bronchus using approximately 120 ml of 13 
sterile saline (Chastre et al. 2010). A bacterial load of >103 colony forming units (CFU)/ml 14 
from a PSB or 104 CFU/ml from a BAL have been found to positively correlate with histology 15 
reports of VAP (Bonten 1999).An alternative to bronchoscopic techniques is the non-16 
directed bronchial lavage (NBL). In this technique, a catheter is inserted into the 17 
endotracheal tube (ETT) to the point where the operator can feel resistance, and then 18 
approximately 20 ml of sterile saline is introduced and immediately aspirated. As with BAL, 19 
the diagnostic threshold is microbial growth of up to 104 CFU/ml. This technique has been 20 
found to be of similar sensitivity to BALs for VAP diagnosis, but is preferred by some clinicians 21 
as it is deemed to be less invasive, less technically demanding and more cost effective (Felton 22 
et al. 2010; Flanagan et al. 2000).  23 
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Table 1.5 Clinical pulmonary infection score (CPIS). 1 
*ARDS: acute respiratory distress syndrome. 2 
**PaO2:FiO2, radio of partial pressure of arterial oxygen to the fraction of inspired oxygen 3 
Adapted from Zilberberg and Shorr (2010)  4 
Parameter Points 
Temperature,° C  
   36.5 - 38.4 0 
   38.5 – 38.9 1 
   ≥39.0 and ≤36. 2 
Blood leukocyte level, leukocytes/mm-3  
   4000 -11,000 0 
   <4000 or 11,000 1 
   Plus bands forms ≥ 500 2 
Tracheal secretions  
   <14+ 0 
   ≥14+ 1 
   Pus purulence 2 
Oxygenation, Pa:FiO2, mm HgO2 **  
   >240 or ARDS* 0 
   ≤240 and no ARDS 2 
Pulmonary radiograph finding  
   No infiltrate 0 
   Diffuse or patchy infiltrate 1 
   Localised infiltrate 2 
Culture of tracheal aspirate specimen (semi- quantitative: 0-1, -2, or 3+)  
   Pathogenic bacteria cultured ≤1 or no grown 0 
   Pathogenic bacteria cultured  1 
   Plus same pathogenic bacteria on Gram stain >1+ 2 
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1.3.2 Aetiology of VAP 1 
In a healthy individual, the respiratory tract has protective mechanisms against pathogen 2 
colonisation. These mechanisms include the normal function of the glottis, larynx and cough 3 
reflexes, salivary flow over the mucosa, and the action of tracheobronchial secretions and 4 
mucocilliary structures which entrap microorganisms which are later expelled through the 5 
oropharynx or swallowed into the stomach. In the case of patients receiving MV a 6 
predisposition of their respiratory tract to being colonised by pathogenic bacteria arises 7 
because the intubation process can not only lead to mucosal damage, but also impairs the 8 
physiological mucocilliary clearance and cough reflexes (Koeman et al. 2001).  9 
An accumulation of subglottic secretions pools above the ETT cuff in MV patients and despite 10 
nursing efforts to regularly remove these secretions by suction, leakage around the cuff 11 
occurs. Such leakage is thought to arrive through pressure changes occurring in the cuff 12 
creating spaces between the cuff and the trachea. The ETT cuff does not provide an efficient 13 
seal to the lower airways as microchannels form from folding of the cuff biomaterial (Blot et 14 
al. 2014). Unsurprisingly, the most important risk factor for VAP appears to be aspiration of 15 
microorganisms from the oropharynx (Brennan et al. 2004; Rodrigues et al. 2009; Rumbak 16 
2005). Microorganisms originating from the gastrointestinal tract have also been associated 17 
with the infection, although further investigation as to precise involvement is required 18 
(Garrouste-Orgeas et al. 1997).  19 
It has been suggested that microbial laden secretions from the oropharynx leak around the 20 
cuff of the ETT entering the lower respiratory tract. In addition to the lower respiratory tract 21 
becoming colonised, a biofilm also forms within the lumen of the ETT, which is protected 22 
from the normal host defence mechanisms or the action of administered antimicrobials 23 
(Inglis et al. 1989). 24 
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Other factors that may contribute to microbial aspiration include sedation, decreased level 1 
of consciousness, and use of a nasogastric tube and contamination of equipment (Rumbak 2 
2005). Patient dependent factors include age, the presence of chronic lung disease or acute 3 
respiratory distress syndrome, and admission for other medical or neurological reasons 4 
(Vincent 2004). Additional factors are related to the patient’s hospital stay, such as increased 5 
duration of intubation, manipulation of airway, re-intubation, frequent ventilation circuit 6 
changes, low intra-cuff pressure of the ETT, failed subglottic suction, patient transport 7 
between hospitals, supine body position, pH altering agents, enteral feeding and multiple 8 
central venous line insertions (Brennan et al. 2004). Previous use of antibiotics has been 9 
found increase the risk for VAP (Rodrigues et al. 2009). 10 
1.3.3 Epidemiology of VAP 11 
VAP is the most frequent hospital-acquired infection in Intensive Care Units (ICUs) and 12 
defined as a pneumonia that occurs 48 h after commencement of mechanical ventilation 13 
(Ibrahim et al. 2000). A recent prospective surveillance study found that VAP prevalence was 14 
15.6% globally (13.5% in the United States, 19.4% in Europe, 13.8% in Latin America, and 15 
16.0% in Asia Pacific) (Kollef et al. 2014). Previous reports had estimated an incidence 16 
between 8 and 28% (Amin 2009; Chastre and Fagon 2002), with an estimated 17 cases 17 
occurring per 1000 ventilator days (Le Berre et al. 2008). Reports on actual mortality rates 18 
are variable, with a recent meta-analysis estimating an overall attributable mortality of 13% 19 
(Melsen et al. 2013). However, mortality rates will vary with severity of underlying disease, 20 
with studies showing that surgical patients exhibit high VAP mortality (69%), whilst lower 21 
mortality (38%) is reported in patients with moderate grade of illness as determined by an 22 
APACHE (Acute Physiology, Age, Chronic Health Evaluation) score of 20-29 (Melsen et al. 23 
2013; Shen et al. 2011). In contrast, trauma patients have lower mortality compared with 24 
non-trauma patients (odds ratio [OR] = 0.37, 95%CI = 0.21-0.65), (Bonez et al. 2013). For 25 
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patients who are severely ill, it is however difficult to conclusively establish VAP as the 1 
ultimate cause of death. A prolonged ICU stay 5 to 7 days; (Safdar et al. 2005) also increases 2 
patient risk of further morbidities. Additionally, costs attributable to VAP are in the range of 3 
£6000 to £22000 per patient and represent a significant burden to the health care system 4 
(Kollef et al. 2012). 5 
1.3.4 VAP causative microorganisms 6 
In 2002, a review of the microbiology of VAP was undertaken by Chastre and Fagon (2002). 7 
This review examined the findings of 24 previous studies and concluded that that 58% of 8 
VAP causative pathogens were Gram-negative bacteria (GNB) including P. aeruginosa (24%), 9 
Enterobacteriaceae (14%), Haemophilus (10%) and Acinetobacter species (8%). Gram-10 
positive bacteria that were also prevalent included S. aureus (20%) and Streptococcus 11 
species (8%). Over half of the pneumonias caused by S. aureus involved strains that were 12 
meticillin resistant (i.e. MRSA). In a recent Brazilian study, A. baumannii was the most 13 
commonly isolated microorganism from VAP (28% of cases). It was also noted in this study 14 
that 48% of patients had received inappropriate antibiotic therapy (Rodrigues et al. 2009). 15 
In a review comparing Asian and western VAP data, it was found that MRSA occurred more 16 
frequently in western countries (Chawla 2008). It seems apparent that the environment has 17 
an effect on the predominant pathogens for VAP; therefore, antibiotic therapy needs to be 18 
adjusted to local data to avoid inappropriate antibiotic prescribing. 19 
1.3.5 The endotracheal tube (ETT) 20 
The ETT (Figure 1.2) plays an important role in the development of VAP as its presence will 21 
impair the natural patient defence mechanisms of mucocilliary clearance and cough reflexes 22 
(Levine and Niederman 1991) leading to accumulation of tracheobronchial secretions 23 
(Pneumatikos et al. 2009). Furthermore, the insertion of the ETT can lead to traumatic 24 
damage to the tracheal mucosa. The ETT itself can also deliver exogenous microorganisms 25 
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(Rello et al. 1996) to the airway and this could contribute to the view that re-intubation 1 
represents an independent risk factor for development of VAP (de Lassence et al. 2002; 2 
Torres et al. 1995). 3 
1.3.5.1  Leakage around the endotracheal tube cuff  4 
The ETT cuff (Figure 1.3) functions to seal the trachea and prevent oropharyngeal secretions 5 
reaching the lower airways. The cuffs of first generation ETTs were made of rubber and had 6 
a design for low volume and high pressure, and were considered to provide an adequate 7 
seal (Blot et al. 2014). However, this design promoted ischemia and damage to the tracheal 8 
mucosa, and was subsequently modified to one of high volume and low pressure (HVLP), 9 
with the cuff material being made from polyvinyl chloride (PVC) (Blot et al. 2014; Haas et al. 10 
2014).  11 
To achieve an effective seal, the ETT cuff is inflated to a cuff pressure of approximately 25-12 
30 cm of H2O. Since an ETT has to fit a range of different sized tracheas, the inflated cuff can 13 
be 1.5 to 2 times the diameter of an average adult trachea (Pneumatikos et al. 2009). The 14 
result of such differences in the diameter of the inflated cuff and the trachea leads to folding 15 
of the cuff material, and these folds provide microchannels allowing microaspiration of 16 
microbial laden secretions that have pooled above the cuff (Hamilton and Grap 2012; Young 17 
et al. 2006).  18 
Despite different types of ETT cuff are available with distinct designs (including tapered and 19 
cylindrical shapes), and these are often constructed from PVC or polyurethane. There would 20 
however appear to be little impact of these designs on VAP incidence, although two clinical 21 
trials favoured the tapered shape polyurethane cuff to deliver better seals (Dave et al. 2010). 22 
The most recent commercially available ETT is the PneuX ETT (formerly known as LoTrachTM; 23 
Venner Medical, Singapore), which is a straight, wire-reinforced silicone tube that aims to 24 
address multiple factors in VAP prevention, including clearing subglottic secretions and 25 
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minimising tracheal damage thanks to an atraumatic tip. The main purpose of this ETT is to 1 
reduce or even eliminate leakage of tracheal secretions and the tube has recently been used 2 
with a tracheal seal monitor, which in a pilot study produced promising results in VAP 3 
prevention with incidence rates of 1.8% (Doyle et al. 2011). 4 
Recently, Hwang et al., (2013), designed an ETT with two cuffs separated by a 5 mm gap. 5 
Between the cuffs is an outlet port of a line through which water soluble gel can be injected. 6 
The design was tested in vitro using artificial tracheas and compared with 4 commercially 7 
available tubes and the authors found no leakage after a 48 h period only with the double 8 
cuff prototype (Hwang et al. 2013). The design has yet to be clinically evaluated. 9 
In addition to cuff design and materials, strategies to prevent microbial leakage past the cuff 10 
have employed cuff inflators to maintain a constant pressure. Whilst it has been reported 11 
that inflators unreliably estimate cuff pressure (Blanch 2004), a recent randomised 12 
controlled study evaluating a pneumatic device (Nosten®) in 64 patients found this approach 13 
to be effective in controlling cuff pressure. Nevertheless, the impact of this device on 14 
microaspiration was not significant (Jaillette et al. 2013).  15 
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Figure 1.2 Picture of a standard polyvinyl chloride endotracheal tube. 
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 1 
Figure 1.3 VAP pathophysiology: the endotracheal tube -related injury.  2 
(a) Dental plaque becomes colonised by respirator pathogens. (b) A microbial biofilm with 3 
potential pathogens forms in the endotracheal tube (c) oropharyngeal secretions 4 
accumulate in the subglottic space, just above the cuff (d1) These contaminated secretions 5 
leak into the lungs trough the inflated micro-channels that form around the cuff (d2).The 6 
inflated cuff causes mucosal damage because of tracheal wall ischemia, damaging the 7 
integrity of the mucosa and impairing host-defence mechanisms. (e) The functional tracheal 8 
mucociliary apparatus is impaired. Reproduced with permission (Pirrone et al.2016).  9 
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The use of lubricant gel seals has also been proposed to reduce formation or impact of 1 
microchannels. In a clinical trial of lubricating ETT cuffs with a water based lubricating gel 2 
(KY® Jelly), leakage was significantly reduced (11% compared to 83%; p<0.001). However the 3 
effect was relatively limited, as cuff leakage occurred after 48 h and was not therefore 4 
deemed a viable solution for patients requiring longer periods of ventilation (Blunt et al. 5 
2001). There was also no evidence of the effect of these prevention strategies on reducing 6 
incidence of VAP, mortality rates or hospital stay. 7 
1.3.6 VAP prevention 8 
Prevention of VAP has evolved significantly in the recent years as the medical community 9 
realised that a multifactorial approach was required and several recommendations have 10 
been proposed; the lack of structured prevention strategies to implement the 11 
recommendations led to publishing of so-called ‘VAP bundles’. The bundles are an approach 12 
to take evidence-based guidelines to clinical practice, they take a limited number of 13 
prevention strategies (usually 3 to 5) that have independently demonstrated to be effective 14 
and combine them into one guidance that should be applied to every patient providing a 15 
cohesive effect in the improvement of outcomes (Rello et al. 2010b; Wip and Napolitano 16 
2009). 17 
The current components of the Institute for health improvements (IHI) ventilator bundle are 18 
elevation of the head of the bed, daily ‘sedation vacations’ and assessment of readiness to 19 
extubate, peptic ulcer disease prophylaxis, deep venous thrombosis prophylaxis and daily 20 
oral care with chlorhexidine, interestingly, although the bundle was created originally in 21 
2003, oral care was only included in 2010 (Cambridge 2012; Klompas et al. 2014a; Zilberberg 22 
et al. 2009).  23 
 24 
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1.3.6.1 Elevation of the head of the bed 1 
The evidence for head elevation is limited but a recent meta-analysis found that a semi-2 
recumbent position with the head of the bed elevated at 45° as opposed to a supine position 3 
with elevation between 15° and 30° significantly reduced the risk for VAP (Alexiou et al. 4 
2009).  5 
1.3.6.2 Sedation vacations and extubation assessment 6 
Kress et al., (2000) conducted a randomized controlled trial in 128 adult mechanically 7 
ventilated patients. Patients were randomized to receive daily interruption of sedation until 8 
awake versus management at the clinician’s discretion. Daily interruption resulted in a highly 9 
significant reduction in time spent on mechanical ventilation. The duration of mechanical 10 
ventilation decreased from 7.3 days to 4.9 days (p=0.004) (Kress et al. 2000). Similar results 11 
had been reported previously with daily assessment of spontaneous breathing has also 12 
proved to shorten the intubation period for 1 or 2 days (Ely et al. 1996; Esteban et al. 1995). 13 
Importantly, whenever possible, the sedation vacation and trial for spontaneous breathing 14 
should be simultaneous to increase the chances of patients successfully breathing 15 
independently (Strøm et al. 2010). 16 
1.3.6.3 Peptic ulcer disease prophylaxis 17 
Mechanical ventilation creates a significant risk to the onset of stress-related mucosal 18 
disease including gastric bleeding, which in turn dramatically increases mortality in ICU 19 
patients by 5-fold (Cook et al. 1994). This strategy involves the prescription of H2 receptor 20 
inhibitors like ranitidine or proton pump inhibitors which increases the pH of the gastric 21 
contents (Steinberg 2002), this however creates the potential risk of facilitating bacterial 22 
growth in a less hostile environment and the concern lays in that oesophageal reflux and 23 
aspiration of gastric contents along the endotracheal tube may lead to endobronchial 24 
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colonization and pneumonia. Recently a slight risk of VAP has been reported with proton 1 
pump inhibitors compared to a H2 receptor inhibitor (Bateman et al. 2013). 2 
1.3.6.4 Daily oral care 3 
Oral care in conjunction with use of chlorhexidine has been studied in several randomised 4 
controlled clinical trials, which have subsequently been analysed in a minimum of 9 meta-5 
analysis studies including a Cochrane review. Results from these suggest that the use of 6 
chlorhexidine reduces the incidence of VAP from 25% to 19%, with cardiac patients having 7 
the most benefit but there is, however, no evidence that the use of chlorhexidine has an 8 
impact on mortality or length of ICU stay (Chan et al. 2007; Hua et al. 2016; Klompas et al. 9 
2014b; Shi et al. 2013). Unlike use of chlorhexidine, evidence for the effect of toothbrushing 10 
in VAP is limited by the lack of randomised controlled trials and to date impact on VAP 11 
outcomes has not been documented (Alhazzani et al. 2013; Hua et al. 2016; Pobo et al. 12 
2009). Similarly, research including use of other antimicrobial agents is scarce (Shi et al., 13 
2013). Importantly, oral health has been demonstrated to decline in ICU patients (Fourrier 14 
et al. 1998; Munro et al. 2006; Sachdev et al. 2013), but there remain only limited studies 15 
that evaluated the efficacy of oral hygiene in mechanically ventilated patients (Needleman 16 
et al. 2011; Oliveira et al. 2014). There is no clear guidelines on the method and frequency 17 
of the delivery of oral care for mechanically ventilated patients, and wide variation in 18 
practices has been reported (Feider et al. 2010; Rello et al. 2007).  19 
1.3.6.5 Other recommended strategies  20 
Selective gastric decontamination (SDD): This a practice is based on the theory that the 21 
normal anaerobic intestinal flora prevents secondary colonisation with Gram-negative 22 
bacteria like Pseudomonas aeruginosa, which poses a risk for the immunocompromised 23 
patient. The aim of SDD is to eradicate the Gram-negative bacteria and fungi from the 24 
digestive tract whilst maintaining the anaerobic microflora. SDD consists of four steps that 25 
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include (i) oral cavity and gastrointestinal tract decontamination with topical non-1 
absorbable antibiotics (polymyxin E, tobramycin and amphotericin), (ii) systemic 2 
prophylaxis, usually with cefotaxime, (iii) regular monitoring of microbial composition 3 
through culture of throat and faecal specimens, and (iv) good cross-infection practice 4 
(Bonten et al. 2000; de Smet et al. 2009). Selective oropharyngeal decontamination (SOD) is 5 
a variation of SDD which refers to application of topical antibiotics in the oropharynx only 6 
(de Smet et al. 2009). Despite some evidence of that both SOD and SDD reduce ICUs 7 
mortality rates (Roquilly et al. 2015), this practice has seldom been adopted (Bastin and 8 
Ryanna 2009; Oostdijk et al. 2012) and remains controversial due concerns that the use of 9 
antibiotics may promote emergence of resistant bacteria, although no reports have been 10 
made during clinical trials, the long term effect promotion of antibiotic resistant 11 
microorganisms has not been discarded (Price and Cuthbertson 2016).   12 
Subglottic secretion drainage: The reduction of pooling of secretions above the 13 
endotracheal cuff with the use of subglottic secretion drainage endotracheal tubes was 14 
previously reported to reduce VAP incidence, the duration of mechanical ventilation and 15 
reduce antibiotic needs (Bouza et al. 2008; Muscedere et al. 2011). However two recent 16 
meta-analysis that include 17 and 20 randomised clinical trials report that the use of 17 
subglottic drainage reduce VAP incidence but no impact on mortality, length of ICU stay or 18 
use of antibiotics (Caroff et al. 2016; Mao et al. 2016). 19 
Physical activity: Early stimulation of physical activity has reported to speed Increase 20 
extubation and reduces cost. (Klompas et al. 2014a).  21 
Probiotics: preparations of non-pathogenic microorganisms like Lactobacillus rhamnosus 22 
may improve microbial balance, particularly in competing against pathogenic bacteria that 23 
colonises the oropharynx and stomach, lower incidence of VAP has been reported in recent 24 
meta-analysis (Manzanares et al. 2016; Siempos et al. 2010).  25 
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1.3.7 Oral biofilms and Ventilator-Associated Pneumonia 1 
Dental plaque provides a wide variety of microorganisms that may be aspirated into the 2 
respiratory tract. It is thought that oral hygiene can deteriorate in the medically 3 
compromised patient leading to higher plaque levels (Fourrier et al. 1998; Sachdev et al. 4 
2013).  5 
In mechanically ventilated patients, the placement of an endotracheal tube (ETT) is essential 6 
to facilitate gaseous exchange to the lower airway. However, the ETT also impairs the 7 
patient’s ability to clear oral secretions through coughing and mucocilliary activity. There is 8 
also reduced salivary flow in such patients, that combined with broad-spectrum antibiotic 9 
therapy creates a high-risk environment for resistant bacteria to colonise the oropharynx 10 
(Chastre and Fagon 2002; Munro et al. 2006). Hence, an increase in bacterial load in dental 11 
plaque has been shown during intubation (Munro et al. 2006) and multidrug resistant 12 
bacteria like MRSA and P. aeruginosa are commonly associated with VAP (Chastre and 13 
Fagon, 2002). 14 
Lower salivary flow may cause a reduction in the adherence of oral commensal streptococci 15 
to the oral mucosa because of the decreased levels of fibronectin, facilitating overgrowth of 16 
pathogenic bacteria. In vitro studies reported that salivary fibronectin inhibited adherence 17 
of the Gram negative Escherichia coli to saliva-treated buccal cells (Hasty and Simpson 1987), 18 
whereas others have reported that salivary components like mucin and secretory 19 
immunoglobulin A facilitate the adherence of Streptococcus gordonii and Streptococcus 20 
mutans (Ito et al. 2012; Ligtenberg et al. 1992). In critical care patients, it has been 21 
demonstrated that the oropharynx becomes colonised within 48 h post intubation with 22 
Gram negative bacteria and this was a predictor factor on the onset of pneumonia (Ewig et 23 
al. 1999). Indeed, respiratory pathogens including P. aeruginosa, Acinetobacter and 24 
Staphylococcus species have repeatedly been found in plaque and saliva of hospitalised 25 
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patients (Didilescu et al. 2005; Fourrier et al. 1998; Zuanazzi et al. 2010). A link between 1 
periodontal disease and oral colonisation by respiratory pathogens has also been suggested 2 
by different authors who also propose that the inflammatory products of periodontitis may 3 
promote colonisation (Paju and Sannapieco 2007). More research is however needed to fully 4 
understand this relationship. 5 
Poor oral care and difficulties in swallowing were associated with pneumonia in a study 6 
involving 613 elderly patients in a nursing home (Terpenning et al. 2001), whilst dentate 7 
patients have also shown higher incidence of aspiration pneumonia compared with 8 
edentulous patients (Mojon 1997). 9 
Bahrani-Mougeot et al., (2007) took tongue swabs and bronchial lavage fluids (BALs) from 10 
40 patients diagnosed with VAP and analysed these by 16S rRNA gene amplification, cloning 11 
and sequencing. This revealed several novel species at both sites. At least one of the 12 
associated species (H. Influenzae, Escherichia sp., Streptococcus pneumoniae, S. aureus, 13 
Pseudomonas sp., and Proteus mirabilis) were found in BAL and tongue samples of 14 of the 14 
16 patients. Additionally, members of the normal oral microflora were detected in BAL 15 
samples, including Streptococcus, Lactobacillus and Porphyromonas species. These results 16 
support the hypothesis that the oral cavity serves as a reservoir for VAP related 17 
microorganisms (Bahrani-Mougeot et al. 2007).  18 
In collaboration with the critical care unit of the University Hospital of Wales, researchers at 19 
Cardiff Dental School collected 24 ETTs from 20 patients and analysed these using PCR and 20 
molecular profiling. Results revealed the presence of the oral bacteria S. mutans (n=5) and 21 
P. gingivalis (n=5) as well as the yeast Candida albicans (n=6) and supported the hypothesis 22 
that oral microbes participated in ETT biofilms (Cairns et al. 2011). 23 
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There are no studies that have simultaneously analysed ETT biofilms, bronchial lavages and 1 
plaque from the oral cavity. Such data could aid understanding of the pathogenesis of VAP 2 
and promote prevention strategies. 3 
1.4 Methods for the detection microbial species in clinical specimens 4 
1.4.1  Traditional microbiology techniques 5 
Traditional microbiology methods for identification of microbial species in environmental 6 
samples are based on microbial metabolism, for example oxidation-reduction potential, and 7 
gaseous requirements (aerobic, anaerobic, CO2 dependant).  8 
It is imperative that microorganisms are viable and culturable on the selected culture 9 
medium. Bacteria grow as colonies on agar plates, which allows assessment of 10 
morphological characteristics including shape, size, consistency, and opacity, and 11 
subsequent antibiotic resistance testing. Culture media can be one for general purposes 12 
such as blood agar, which supports the growth of many microorganisms, or be tailored for 13 
selective recovery of certain species and suppression of others. Such selective media are 14 
often supplemented with additives such as antibiotics. Differential media are designed to 15 
distinguish between different groups of microorganisms through biochemical reactions that 16 
result in a colour change in the medium to indicate the presence of a particular species.  17 
The culture of bacteria allows a comprehensive characterisation of individual species and 18 
strains’ phenotypic traits, however, for a significant proportion of species this is not yet 19 
possible. In environmental samples it is considered that over 90% of bacteria are 20 
unculturable (Wade 2002). Even though dental plaque is one of the most studied biofilms, it 21 
is estimated that half of the oral microbial community are not yet culturable (Paster et al. 22 
2001) and to screen for a wide range of microorganisms by species specific PCR or cloning 23 
would be formidable expensive and time consuming. Therefore, microbial composition of 24 
 47 
communities such as those in the oral cavity, lower airway and ETT cannot be fully 1 
determined without use of culture-independent molecular techniques.  2 
1.4.2  Polymerase chain reaction (PCR) 3 
PCR relies on the ability of Taq polymerase to repeatedly synthesise new strands of DNA 4 
complementary to template targets following repeated thermal cycles. An oligonucleotide 5 
primer is required for the incorporation of the first nucleotide. On completion of PCR, the 6 
specific target sequence will typically have been amplified 109-fold and these products are 7 
often called amplicons (Van Pelt-Verkuil et al. 2008). 8 
There are multiple applications of PCR in the study of bacteria and yeast, including 9 
genotyping and gene sequencing, both of which will be used in the research presented in 10 
this thesis.  11 
To identify cultured bacteria isolates, amplification and sequencing of the bacterial 16S 12 
ribosomal RNA (rRNA) gene can be undertaken. Sequences are compared to those in a 13 
database and identification made based on similarity. Amplification of 16S rRNA genes 14 
(rDNA) can also identify bacteria in mixed bacterial populations and without prior culture. 15 
Historically, in order to separate different amplicons prior to sequencing from mixed 16 
communities, a cloning step was required, which was both costly and labour intensive. 17 
However, with the advent of next generation sequencing approaches, the need for cloning 18 
has been circumvented. Species-specific PCR can also be used to detect individual species 19 
directly from mixed populations and such methods have successfully been used in the direct 20 
analysis of clinical samples. For example species-specific PCR has been successfully used to 21 
detect bifidobacteria from the gut and respiratory pathogens in children with 22 
parapneumonic empyema (Blaschke et al. 2013; Matsuki et al. 2003). 23 
 24 
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1.4.3 DNA sequencing 1 
DNA sequencing is the process of finding the exact order of nucleotides (adenine, guanine, 2 
cytosine and thymine) in a DNA molecule, the technology to achieve this has advanced 3 
significantly in the last decade allowing the study of whole microbiome populations of an 4 
environment like the gut, oral cavity (Dewhirst et al. 2010; Shreiner et al. 2015). 5 
The characterisation of complex bacterial communities derives from the discovery of the 16S 6 
rRNA gene as a bacterial phylogenic marker (Woese 1987). The 16S rRNA gene is a 7 
housekeeping gene that is considered a “molecular chronometer” and as such a measure 8 
representative of evolution change. (Woese 1987). The 16S rRNA gene includes regions that 9 
are highly conserved and others which are species specific. (Hanage et al. 2006). 10 
1.4.3.1 The Sanger method 11 
The start of genomic sequencing happened in the late 1970s with the introduction of the 12 
Sanger method, which allowed DNA to be sequenced in a reliable and reproducible way 13 
(Sanger et al. 1977). This method uses a single stranded DNA template, a DNA primer that is 14 
complementary to the known sequence, DNA polymerase, deoxynucleosidetriphosphates 15 
(dNTPs) and importantly dideoxynucleotide-triphospate (ddNTPs), this are nucleotide 16 
analogues that lack the 3’-hydroxyl group essential in phosphodiester bond formation thus, 17 
terminating the DNA elongation process. All four ddNTPs are were labelled initially with a 18 
radioactive probe which was later replaced with a fluorescent dye, the label on each ddNTP 19 
corresponds to the nucleotide identity. In the early years products were visualised by gel 20 
based electrophoresis, this later changed to capillary based polymer gel and where products 21 
were separated by size. When a fluorescent dye is used a laser identifies the ddNTP labels 22 
and assigned one of four colours, this provides a chromatogram from which a software 23 
translates the reads into a DNA sequence and generates error probabilities for each base 24 
(Shendure and Ji 2008). 25 
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A variation of the Sanger method is the called shot gun de novo sequencing where DNA is 1 
randomly fragmented and cloned into a high copy number plasmid which is the incorporated 2 
into Escherichia coli, as the bacterium reproduces creates clones of the plasmid inserted that 3 
can be cultured and picked as a single colony from an agar plate, to then be sequenced as 4 
above (Shendure and Ji 2008). 5 
The first automated capillary electrophoresis platform (AB370; Applied Biosystems) was 6 
introduced in 1987. This technology which was used in the Human Genome Project in 2001 7 
increased the output from a maximum of 200 nucleotides per day to approximately 1 8 
megabase.  9 
1.4.3.2 Pyrosequencing  10 
Pyrosequencing was the first generation of Next generation sequencing, introduced in 2004 11 
by Roche with the 454 platform. (Mardis 2008). In pyrosequencing DNA fragments are fixed 12 
on DNA-capture beads in a water-oil emulsion and then amplified by PCR. The beads are 13 
loaded with DNA polymerase on a PicoTiterPlate. The pyrosequencing reaction results in the 14 
release of pyrophosphate, which initiates a series of downstream reactions that produce 15 
light by the firefly enzyme luciferase. The amount of light produced is proportional to the 16 
number of nucleotides and converted into a sequence (Mardis 2008; Oulas et al. 2015). This 17 
technology was widely used in the early years but it has become less popular due to higher 18 
costs and more difficult data analysis (Werner et al. 2012). 19 
1.4.3.3 Next Generation Sequencing (NGS) 20 
NGS, also known as massive parallel sequencing was first commercially introduced in 2005 21 
with the Genome Analyser, where in a single sequencing run produced one gigabase of data 22 
and by 2014 the output increased to 1.8 terabases with the latest platform HiSeqX Ten 23 
(Illumina). The output increase has had an inverse proportional effect on the cost of 24 
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sequencing making it much more accessible for small research projects. The high efficiency 1 
of this technology has changed genomic sequencing as well as opening new opportunities in 2 
other areas like characterisation of ecological diversity (Mardis 2008).  3 
NGS differs from the Sager sequencing in that it is based on spatially separated, clonally 4 
amplified DNA templates or single DNA molecules on a flow cell where the process is 5 
extended across millions of fragments. Similarly to the previous technologies a DNA 6 
polymerase (i.e. Bst ) catalyses fluorescently labelled dNTPs into a DNA template strand 7 
during a series of PCR cycles, at each cycle the nucleotides are identified by fluorophore 8 
excitation (Nakazato et al. 2013). NGS incorporates adapter sequences that allow for 9 
selective amplification by PCR, this eliminates the need for bacterial cloning to achieve 10 
amplification of genomic fragments, for some platforms (Helicos and Pacific Biosystems) the 11 
amplification of DNA fragments is not required before sequencing (Mardis 2008). 12 
1.4.3.4 Metagenomics 13 
One of the fields of study that has benefited greatly by NGS is microbial ecology, which has 14 
led to the rise of metagenomics which has been defined as” the direct genetic analysis of 15 
genomes contained within an environmental sample without the prior need for cultivating 16 
clonal cultures” (Oulas et al. 2015). This aspect of NGS was used initially to characterise the 17 
microbial genomes in an environmental sample, for which is also known as “full shotgun 18 
metagenomics” (Xia et al. 2011). However, metagenomics can also be used for PCR 19 
amplification of selected genes called “meta-genetics” (Handelsman 2009). 20 
Full shotgun metagenomics, uses inventories of 16S rRNA genes to provide a snapshot of the 21 
bacterial diversity and relative abundance within a sample creating a community biodiversity 22 
profile (Gee et al. 2004; Ziesemer et al. 2015). Currently this technology can identify the 23 
species present in a sample as well as what their function and some interspecies interactions 24 
that maintain homeostasis in their ecosystem (Oulas et al. 2015).  25 
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Metagenomics has been used to study a wide range of environmental samples including 1 
those from difficult conditions like extreme temperature, hypoxic environments and 2 
volcanic zones (Benson et al. 2011; Kilias et al. 2013; Stevens and Ulloa 2008).  3 
The study of the human microbiomes has progressed remarkably in the last decade with the 4 
use of metagenomics. In 2007 the National Health institutes launched the Human 5 
Microbiome Project with the intention of achieving a comprehensive characterisation of the 6 
human microbiota and its role in human health and disease, to date there are 564 7 
publications from this project (NHI 2007). From the human body, the gut microbiome has 8 
been the most studied (Qin et al. 2010; Shreiner et al. 2015). Recently, Browne et al. 9 
developed a workflow that combines whole-genome and metagenomic sequencing, with 10 
computational and phenotypic analysis, with this new approach the researchers were able 11 
to culture 90% of the gut bacterial microbiome (Browne et al. 2016) despite the fact it had 12 
previously been considered as predominantly unculturable (Walker et al. 2014). 13 
1.4.4  Molecular fingerprinting of microbial species 14 
1.4.4.1 Random Amplification of Polymorphic DNA (RAPD) 15 
RAPD is a form of PCR used for genotyping of microorganisms and can differentiate between 16 
genetically distinct strains of the same species. The key to this approach is to employ 17 
‘random’ primer sequences whose targets are widely distributed through the bacterial DNA 18 
genome. Multiple amplicons are generated for a given bacterial strain, which when 19 
separated by gel electrophoresis resembles a ‘barcode’ of different sized bands. The number 20 
of bands and their sizes are dependent on the positions of the targets for the original 21 
primers. In RAPD, the primers used are typically arbitrary and short (8 to 10) nucleotide 22 
sequences and importantly it is not necessary to have prior knowledge of the genetic 23 
material for RAPD (Bart et al. 1998). 24 
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1.4.4.2 Pulsed-field gel electrophoresis (PFGE) 1 
PFGE is a genotyping technique that until the development of multilocus sequence typing 2 
was considered the gold standard in epidemiological investigations (Prevost et al. 1991). 3 
PFGE still remains a valuable method as it is relatively inexpensive and is highly 4 
discriminatory with proven benefits in the investigation of nosocomial infections (David et 5 
al. 2013).  6 
PFGE separates chromosome-sized DNA molecules through application of an alternating 7 
electric field between spatially distinct pairs of electrodes. Varying electrical pulses promote 8 
separation of DNA molecules sized between 30 to 2000 Kb. During PFGE, DNA fragments 9 
have to re-orientate themselves within the electrophoresis gel matrix when the direction of 10 
the electric field changes, and the time to do this is dependent on fragment size (Prevost et 11 
al. 1991).  12 
Clamped Homogeneous Electric Field (CHEF)-PFGE is a variation of PFGE. CHEF-PFGE was 13 
developed to improve high resolution, create sharper bands and straight lanes of DNA 14 
profiles. The system uses 24 electrodes along the perimeter of a hexagonal electrophoresis 15 
tray. The electrodes generate two different alternating electric field vectors where each 16 
electrode ‘clamps’ the voltage of its individual region of space as necessary to maintain field 17 
homogeneity (O'Brien et al. 2007).  18 
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1.5 Target species 1 
To study interaction between typical oral microorganisms and respiratory pathogens, this 2 
current research focussed on five microbial species namely, Pseudomonas aeruginosa, 3 
Staphylococcus aureus, Candida albicans, Streptococcus mutans and Porphyromonas 4 
gingivalis. 5 
1.5.1 Pseudomonas aeruginosa 6 
Pseudomonas aeruginosa is a Gram-negative bacillus-shaped bacterium ubiquitously found 7 
in the environment, inhabiting waters, soils and plants (Driscoll et al. 2007). In the hospital 8 
setting, P. aeruginosa has been isolated from the floors, bed rails, sinks of hospitals, as well 9 
as from hands of nurses (Chitkara and Feierabend 1981). P. aeruginosa causes opportunistic 10 
infections in plants, insects and mammals (Battle 2009). In humans, P. aeruginosa is a known 11 
opportunistic pathogen of immunocompromised patients and is the one of most prevalent 12 
microorganisms in nosocomial pneumonia with approximately 24% of cases attributed to it 13 
(Chastre and Fagon 2002; Pearson 1996; Rello et al. 2002). 14 
Pseudomonas aeruginosa is not a frequent member of the normal microbiota of humans, 15 
with colonisation rates ranging between 0 and 3.3% for skin and nasal mucosa, 0 to 6.6% for 16 
the oropharynx and 2.6 to 24% for the gut (Lister et al., 2009, Morrison and Wenzel, 1984). 17 
In contrast, colonisation of up to 50% of hospitalised patients have been reported. Patients 18 
who have skin injuries, catheters, or in receipt of mechanical ventilation or surgery, are most 19 
at risk (Ohara and Itoh 2003; Ozkurt et al. 2005; Thuong et al. 2003; Vallés et al. 2004). In a 20 
3-year prospective study of mechanically ventilated patients, it was found that a 54.2% of 21 
patients were colonised with P. aeruginosa either before or after intubation, and tracheal 22 
colonisation was 30.5% (Vallés et al., 2004), indeed several studies report P. aeruginosa to 23 
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be frequently found in the dental plaque of mechanically ventilated patients (El-Solh et al. 1 
2004; Heo et al. 2008; Sands et al. 2016 (a); Zuanazzi et al. 2010).  2 
Pseudomonas aeruginosa is associated with multiple infections in the body, including those 3 
of the skin, eyes and ears. Chronic lung infection, nosocomial pneumonia, septicaemia, 4 
bacterial keratitis and urinary tract infections are also caused by P. aeruginosa, and these 5 
infections are frequently difficult to treat (Boyle et al., 2013, Valenza et al., 2008). 6 
Additionally, in mechanically ventilated patients, respiratory infections associated with P. 7 
aeruginosa are considered to result in higher mortality than those caused by other 8 
microorganisms (Chastre and Fagon, 2002). 9 
Pseudomonas aeruginosa can maximise available nutrients, produces and releases a wide 10 
range of exoproteins, the majority of which are toxins and hydrolytic enzymes which have 11 
significant impact in its pathogenicity. For example, in environments of low iron 12 
concentrations commonly found in the host, P. aeruginosa secretes the protein HasAp, a 13 
haemophore that generates haem release from haemoglobin, a characteristic considered 14 
important in the onset of infection (Bleves et al. 2010; Wandersman and Delepelaire 2004). 15 
Pseudomonas aeruginosa is naturally resistant to multiple antibiotics and also rapidly adapts 16 
to generate resistance to new drug therapies, a feature which is possible due to its ability to 17 
acquire resistance genes from plasmids or through changes in gene expression (Lister et al. 18 
2009). In patients initially colonised with sensitive P. aeruginosa strains, between 27 to 72% 19 
of those were found to change to exhibit multidrug resistance (Obritsch et al. 2005), which 20 
clearly creates difficulty in eradicating infection. 21 
 22 
 23 
 24 
 55 
1.5.2 Staphylococcus aureus 1 
Staphylococcus aureus is a Gram-positive coccus-shaped bacterium frequently found in the 2 
respiratory tract and skin of humans, it is a permanent coloniser in around 30% of the 3 
population, or a transient coloniser in 30 to 50% (Chambers 2001; Kluytmans et al. 1997). 4 
Although S. aureus is not considered part of the normal oral microbiota, oral carriage occurs 5 
in between 3% to 46% of healthy individuals and a higher occurrence in saliva compared to 6 
dental plaque is evident (Eick et al. 2016; Ohara-Nemoto et al. 2008) (Kluytmans et al., 1997 7 
Chambers, 2001).  8 
Within the Staphylococcus genus, S. aureus is generally regarded the most pathogenic 9 
species and is commonly associated with multiple infections including those of the skin, 10 
respiratory tract and this species is also a cause of food poisoning. On occasions, infections 11 
can be life threatening, as is the case of pneumonia, meningitis, osteomyelitis, endocarditis 12 
and toxic shock syndrome (Lowy 1998). Staphylococci are recognised as the most common 13 
causes of nosocomial infection in intensive care units (Otto 2008) and S. aureus accounts for 14 
approximately 20% of VAP cases (Chastre and Fagon 2002).  15 
Natural defence mechanisms against S. aureus include the relatively low temperature of the 16 
skin surface and its acidic pH, which impeded S. aureus growth as well as its colonising ability 17 
by inhibiting clumping factor B and fibronectin binding protein A (Arciola et al. 2005). 18 
Furthermore, other commensal microorganisms may prevent S. aureus colonisation. For 19 
example, some strains of S. epidermidis produce Esp, a serine protease that prevents S. 20 
aureus biofilm formation and destroys pre-existing biofilms (Iwase et al, 2010). Skin 21 
commensals also promote the innate immune response by inducing expression of 22 
antimicrobial peptides and activation of signalling pathways in keratinocytes, which 23 
facilitate killing of pathogenic bacteria such as S. aureus (Wanke et al. 2011). 24 
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As mentioned earlier, to facilitate adhesion, S. aureus uses microbial surface components 1 
recognising adhesive matrix molecules (MSCRAMMs), which include fibronectin-binding 2 
protein A (Fnbp A) and Fnbp B (Arciola et al. 2005; Patti et al. 1994). Additionally S. aureus 3 
expresses fibrinogen-binding proteins (ClfA and ClfB), iron-regulated surface determinant A 4 
(IsdA) and wall teichoic acid (Weidenmaier et al. 2004). Strains of S. aureus may produce the 5 
toxin, Panton-Valentine Leucocidin (PVL), which enhances virulence by causing leukocyte 6 
lysis or apoptosis via pore formation (Kaneko and Kamio 2004). S. aureus can also 7 
demonstrate resistance to multiple antibiotics including meticillin and vancomycin (Diekema 8 
et al. 2001). 9 
1.5.3 Candida albicans 10 
There are more than 200 species of Candida, several of which are opportunistic pathogens 11 
of humans. Generally, C. albicans is regarded as the most important clinical species and is 12 
commonly found in the oral cavity, eyes, and genitourinary and gastrointestinal tracts of 13 
humans (Spampinato and Leonardi 2013). Other important Candida species found in healthy 14 
individuals but also regarded as opportunistic pathogens include Candida glabrata, Candida 15 
tropicalis, Candida parapsilosis, and Candida krusei (Maccallum 2012). Oral carriage of 16 
Candida has been estimated at 50-75% in healthy individuals depending on the population 17 
group studied (Ariyawardana et al. 2007; Javed et al. 2013).  18 
Candida infection (candidosis) usually occurs in debilitated or immunocompromised 19 
patients, after surgery, during prolonged stay in an intensive care unit, or extended use of 20 
broad-spectrum antibiotic therapy (Azoulay et al. 2006). Infections may be superficial (oral 21 
and vaginal thrush) or systemic and in the case of the latter, are frequently life threatening 22 
(Wisplinghoff et al. 2004). 23 
Candida albicans has several putative virulence factors, the secretion of aspartyl proteinases 24 
(Sap1 to Sap10) facilitates colonization and invasion of host tissues through the disruption 25 
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of host mucosal membranes (Silva et al. 2011) and phospholipases are thought to contribute 1 
to host cell-membrane damage, which could promote cell damage and/or expose receptors 2 
to facilitate adherence of Candida (Ghannoum 2000). Candida albicans can express multiple 3 
adhesins (agglutinin-like sequence, hypha-associated GPI-linked protein) to enable 4 
colonisation of host cells or abiotic surfaces (Mayer et al. 2013; Murciano et al. 2012). The 5 
organism also exhibits polymorphism with regards to its growth and can change from 6 
spherical yeast forms (ovoid-shaped budding) to hyphal or pseudohyphal forms 7 
(filamentous) (Berman and Sudbery 2002). The hyphal form of C. albicans is linked to tissue 8 
invasion, whereas the yeast from is associated with dissemination to distant sites (Cleary et 9 
al. 2011; Malic et al. 2007). 10 
Another virulence factor of C. albicans is its ability to form biofilms on mucosal and 11 
biomaterial surfaces including those of dentures, catheters and endotracheal tubes 12 
(Vandecandelaere et al., 2012, Mayer et al., 2013). Importantly, C. albicans biofilms, are 13 
more resistant than their planktonic counterparts to antifungal therapy due to similar 14 
mechanisms to those previously described for bacterial biofilms. These mechanisms include 15 
increased expression of efflux pumps, higher cell densities, extracellular matrix production 16 
and modified gene expression (Al-Fattani and Douglas 2006; Mukherjee et al. 2003; Taff et 17 
al. 2013). 18 
Airway colonisation by C. albicans in the intensive care setting has been identified as a risk 19 
factor for colonisation by the multidrug resistant bacterium P. aeruginosa pneumonia, as 20 
well as a risk for systemic candidiasis (Azoulay et al. 2006). Additionally, poorer clinical 21 
outcomes have been reported in patients with suspected VAP who have Candida 22 
colonisation of the respiratory tract (Delisle et al. 2011; Williamson et al. 2011). Hamet et 23 
al., (2012) conducted a prospective observational study including 323 suspected VAP 24 
patients a higher mortality rate (44.2% vs 31.5%; p: 0.02) in patients with Candida 25 
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colonisation of the airway, this same study also found Candida airway colonization was one 1 
independent risk factor for multidrug resistant bacteria isolation [odds ratio (OR) = 1.79, 95 2 
% confidence interval 1.05-3.05; p= 0.03 (Hamet et al. 2012). 3 
1.5.4 Streptococcus mutans 4 
The Streptococcus genus currently consists of more than 100 species, which are often 5 
classified into 6 phylogenetic clusters based on their 16S rRNA gene sequences (Nobbs et al. 6 
2009). 7 
Streptococcus mutans is a Gram-positive coccus-shaped bacterium frequently found in 8 
dental plaque. This species was first associated with causing dental caries in 1924 when 9 
Clarke isolated it from a carious lesion. As it is not a microorganism readily present in the 10 
environment, several studies have suggested that the most likely route of colonisation of an 11 
individual is vertical transmission from the mother/carer to the infant (Tanzer et al. 2001). 12 
S. mutans requires a solid, non-shedding surface for colonisation, and as a consequence, it 13 
is not normally found in infants until the first tooth appears. However, insertion of prosthetic 14 
appliances during treatment of edentulous cleft palate in new-borns can lead to earlier 15 
colonisation with S. mutans (de Soet et al. 1998).  16 
S. mutans ferments mannitol and sorbitol to produce organic acids that demineralise tooth 17 
enamel during caries (Decker et al. 2014). The species also produces extracellular 18 
polysaccharides in the form of glucans, which allow it to firmly adhere to the smooth tooth 19 
surface (Kuramitsu 1993; Loesche 1986). The production of glucan-binding proteins (GbpA, 20 
-B, -C and -D) is thought to play an important role in subsequent cell-cell aggregation and 21 
biofilm development (Shah and Russell 2004; Smith and Taubman 1996). Additionally, 22 
antigen I/II surface protein in S. mutans is involved in binding to salivary pellicle, collagen 23 
type I and fibronectin (Petersen et al. 2002). These characteristics promote S. mutans as a 24 
pioneer coloniser of dental plaque and also facilitates co-adherence of other 25 
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microorganisms to the existing biofilm. Indeed it has been suggested that S. mutans 1 
presence will promote lactobacilli colonisation within dental caries lesions (Tanzer et al. 2 
2001). In a similar manner, S. mutans could aid colonisation of teeth by other bacteria 3 
including potential respiratory pathogens, and this clearly has implications with regards to 4 
VAP. S. mutans also has sucrose-independent mechanisms to promote cell to cell 5 
aggregation, in sucrose depleted conditions it produces the wall-associated protein A 6 
(WapA) (Zhu et al. 2006) which could be relevant in the mechanically ventilated patient as 7 
there is no oral intake, is produced  8 
1.5.5 Porphyromonas gingivalis 9 
Porphyromonas gingivalis is a Gram-negative obligate anaerobic bacterium (Benedyk et al. 10 
2016). This bacterium is as non-motile, asaccharolytic, coccobacillus in shape and grows as 11 
smooth, raised colonies on blood supplemented agar media, that are initially white to cream 12 
coloured but within 4 to 8 days start to darken and turn to a deep red to black colour. This 13 
colony colouration correlates with the concentration of protoheme, which derives from the 14 
erythrocytes (Holt et al. 1999; Nakayama 2015). Porphyromonas gingivalis is frequent 15 
member of the oral microbiota and a recognised periodontal pathogen. The prevalence of 16 
P. gingivalis in patients with gingivitis has been reported at 79% compared to 25% in healthy 17 
individuals (Griffen et al. 1998). Porphyromonas gingivalis is able to produce biofilms 18 
independently, but this function is best seen in the presence of other bacterial species like 19 
Tannerella forsythia and Treponema denticola where synergistic relationships have 20 
previously been described (Bao et al. 2014). 21 
The main virulence factors of P. gingivalis are its gingipains, which comprise of three related 22 
cysteine proteases (Bao et al. 2014). Gingipains are thought to contribute to several 23 
functions including biofilm formation through fimbriae assembly, nutrition by digestion of 24 
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host proteins, proteolysis, and alteration of the host immune response (Olsen and Potempa 1 
2014). 2 
Periodontal disease has been proposed to have association with respiratory disease (Paju 3 
and Scannapieco 2007). Lower airway colonisation by anaerobic bacteria in mechanically 4 
ventilated patients has been reported to happen in >50% of mechanically ventilated patients 5 
(Agvald-Ohman et al. 2003; Robert et al. 2003). Species isolated from subglottic and tracheal 6 
secretions include Peptostreptococci and Prevotella spp. (Agvald-Ohman et al. 2003). 7 
Furthermore, P. gingivalis has been detected by molecular methods in endotracheal tube 8 
biofilms (Cairns et al. 2011).  9 
The impact of anaerobic species in respiratory disease may have important clinical 10 
implications, in an experimental mouse model, where a mixed culture of P. gingivalis and T. 11 
denticola was inoculated into the mouse trachea; the resulting infection induced 12 
inflammatory cytokine production and caused pneumonia (Kimizuka et al. 2003). 13 
1.6 Hypothesis  14 
The underlying hypothesis of this present body of work is that oral microorganisms play a 15 
key role in biofilm development and colonisation of respiratory pathogens in the inner 16 
lumen of the ETT and thus the promotion of ventilator-associated pneumonia in intubated 17 
patients.  18 
  19 
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1.7 Aims  1 
The principle aim of this study was to use a combination of cultural and molecular based 2 
methods to characterise in vitro and in vivo biofilms on ETT surfaces and establish 3 
involvement of oral microorganisms in the development of respiratory pathogen biofilms.  4 
Specific aims: 5 
I. Establish the presence of oral microflora and respiratory pathogens in dental 6 
plaque, ETTs, and the lower airways of mechanically ventilated patients and 7 
elucidate genetic similarities between detected species at each site. 8 
II. Characterisation of the bacterial microbiota from dental plaque, ETTs and lower 9 
airways of mechanically ventilated patients using metataxonomics.  10 
III. Characterise the relationship between oral microorganisms and respiratory 11 
pathogens, by investigating potential synergistic effects in gene expression and 12 
growth of respiratory pathogens. 13 
IV. Evaluate oral intervention methods for potential VAP patients. In this research two 14 
oral hygiene methods (brushes vs. swabs) will be compared in a clinical trial and in 15 
vitro experiments will compare different surfaces and designs of ETTs and 16 
susceptibility of respiratory pathogens to antimicrobial mouthwashes. 17 
 18 
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2. Analysis of dental plaque, 
endotracheal tube biofilms and non-
directed bronchoalveolar lavages from 
mechanically-ventilated patients 
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2.1  Introduction 
Mechanical ventilation is required in the majority of critically-ill patients to facilitate 
management of respiratory failure and impaired consciousness. However, this patient group 
is at high risk (15.6%; Kollef et al. 2014) of developing ventilator-associated pneumonia 
(VAP). The overall attributable mortality is estimated at 13%, but can be higher depending 
of the patient group (Melsen et al. 2013). VAP also results in an extended hospital stay of 5 
to 7 days (Safdar et al. 2005) and up to £22000 additional economic cost per patient (Kollef 
et al. 2012; Wagh and Acharya 2009). The pathogenesis of VAP is not yet fully understood 
and multiple variables contribute to its occurrence (Kollef 1999). The endotracheal tube 
(ETT) impairs the natural mucocilliary clearance that occurs in the upper airway and keeps 
the epiglottis open exposing the lower airway to the contents of the pharynx (Bauer et al. 
2002). One important factor in the development of VAP is the aspiration of oropharyngeal 
secretions that accumulate above the inflated cuff; it has been reported that the cuff 
material folds onto itself creating microchannels that allow leakage of the secretions into 
the lower airway (Dave et al. 2010; Haas et al. 2014). If these secretions are loaded with 
potential pathogens an obvious risk for infection is present (Figure 2.1). 
The work outlined in this Chapter focuses on two factors which have been identified as 
contributors of VAP, namely biofilms within the endotracheal tube and the composition of 
the oral microflora. 
     
 
6
4
 
 
Figure 2.1 Schematic diagram showing the leakage of oropharyngeal secretions around 
the endotracheal tube cuff 
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2.1.1 Biofilm development in endotracheal tubes 
Biofilms are communities of microorganisms that are often attached to a surface and 
embedded in extracellular polymeric substances (Hall-Stoodley et al. 2004). It is now thought 
that over 65% of infectious diseases are caused by biofilms and importantly, medical devices 
are prone to colonisation by biofilms (Donlan and Costerton 2002). Biofilms are much more 
than the ‘sum of their parts’, primarily due to altered gene expression. As discussed 
previously, biofilms also exhibit increased antimicrobial resistance (Chapter 1, Section 1.2.4).  
The lumen of the ETT creates an environment that is protected from the patient’s defence 
mechanisms. Unsurprisingly, ETT biofilms have been identified as risk factors for VAP (Adair 
et al. 1999; Danin et al. 2015; De Souza et al. 2014).  
The first study employing imaging techniques for describing ETT biofilms was published in 
the late 1980s and used scanning electron microscopy (SEM) to image biofilms in 25 ETTs 
(Sottile et al. 1986). Results showed that 86% of ETTs were completely covered by biofilm 
and 16% were partially covered (Sottile et al. 1986). In a recent study using atomic force 
microscopy (AFM), full biofilm coverage of the lumen of 6 ETTs was noted (Danin et al. 2015). 
Inglis et al., (1989) analysed ETT biofilm presence and the effect that ventilator gas flow had 
on the biofilm. Using SEM, 30 out of 40 ETTs examined had at least 50 mg (dry weight) of 
biofilm and once connected to a ventilator, fragments of the biofilm detached in 50% of the 
ETTs, and were projected up to 45 cm away from the ETT tip (Inglis et al. 1989). ETT biofilms 
can be detected after only 12 h of intubation and the biofilm will generally accumulate with 
increased duration of ventilation (Inglis et al. 1989; Perkins et al. 2010), but this is not always 
the case (Wilson et al. 2012).  
The importance of ETT biofilms in VAP occurrence has been demonstrated numerous times 
(De Souza et al. 2014; Inglis et al. 1989; Perkins et al. 2010). Importantly, Adair et al., (1999) 
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compared the microbiology of tracheal samples with ETT biofilms and found that 70% of 
patients with VAP had identical pathogens at both sample sites.  
The origin of ETT biofilm microorganisms is an important question, and Feldman et al., 
(1999) were amongst the first researchers to investigate this. This group proposed that 
colonisation progressed from the stomach, the oropharynx, then the lower respiratory tract 
and finally the ETT. At the same time, it was suggested that proteins and other adhesion 
materials interacted with the colonising bacteria facilitating biofilm formation (Feldman et 
al. 1999).  
Perkins et al., (2010) analysed the bacterial content of 8 ETTs from a medical and trauma 
intensive care unit using PCR sequencing of bacterial 16S rDNA. It was evident that over 70% 
of sequences were from typical members of the normal oral microflora. The most prevalent 
species belonged to the Streptococcus genus (7 of the 8 tubes), and many of these were 
normal components of the oropharynx microflora and adept biofilm producers. Species of 
Prevotella and Neisseria were also frequently detected, and 20% of the sequences were 
similar to known VAP pathogens, with only 6% of sequences typical of gastrointestinal 
microflora (Perkins et al. 2010). 
Cairns et al., (2011) assessed the microbial diversity of 20 ETTs using PCR and denaturing gel 
electrophoresis (DGGE). This study showed a significant microbial diversity in ETT biofilm 
samples, with between 3 and 22 bands per sample detected by DGGE. Since each distinct 
DGGE band can represent more than one species (Li et al. 2007), it is clear that the ETT 
biofilms were very complex and diverse in terms of microbial composition. This same study 
used species-specific PCR to detect target key oral microorganisms and respiratory 
pathogens. Interestingly, in these studies Streptococcus mutans (N=5) and Porphyromonas 
gingivalis (N=5) were detected along with Staphylococcus aureus (N=6) and Pseudomonas 
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aeruginosa (N=4) which are primary VAP pathogens. Additionally Candida albicans was 
cultured from 6 of the analysed ETTs (Cairns et al. 2011). 
The findings of Cairns et al., (2011) were later corroborated by Vandecandelaere et al., 
(2012) in a study involving pyrosequencing, sequencing of 16S rRNA gene clone libraries and 
traditional culture techniques targeting ETT biofilms. Once more, a high level of diversity of 
ETT biofilms was evident and potential VAP pathogens were identified using culture and 
pyrosequencing. The study only analysed 4 samples by pyrosequencing, and in all of these, 
the predominant bacteria were members of the oral microflora, namely Prevotella species, 
Peptostreptococcus species and lactic acid bacteria (Vandecandelaere et al. 2012). In 
addition to pathogenic bacteria, it has also recently been demonstrated that the ETT biofilm 
is firmly attached to the surface and rinsing with saline does not effectively remove it (Danin 
et al. 2015). 
Other sources of contamination of the ETT and lower airways could be the ventilator and 
suction equipment, but evidence for this is limited (Sole et al., 2002). Furthermore, the 
presence of a nasogastric tube may facilitate gastroesophageal reflux. Therefore, gastric 
fluid may be aspirated into the lungs, carrying bacteria and provoking local inflammation, 
however colonisation originating from the gastric contents remains a matter of debate 
(Bassis et al. 2015; Bonten and Gaillard 1995).  
2.1.2 The oral microflora 
The oral mucosa and dental plaque has been identified as potential reservoirs of pathogenic 
microorganisms, particularly in hospitalised and critically ill patients (Gilbert et al. 2002; 
Pollitt et al. 2014; Scannapieco et al. 1992). Traditional culture based methods have 
implicated oral microbiota as contributors to infectious respiratory disease (Fourrier et al. 
1998; Johanson et al. 1969; Scannapieco 1999). However, as valuable as culture based 
methods are, there are a number of important limitations. In particular, non culturable or 
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difficult to grow organisms may play an important role in the pathogenesis of disease and 
these may be missed by culture methods. Furthermore, comparing genetic relationships 
between micoorganisms is often preferable to phenotypic approaches when assessing 
similarity of isolates from different origins. Such information may be key in understanding 
the origin of infection, pathogenesis and formulating prevention strategies. 
A pioneering study on the molecular analysis of the diversity and genetic relationship 
between the microbes from the oral cavity and lungs provided the first culture-free evidence 
on the subject. In this study, Bahrani-Mougeot et al., (2007) collected bronchoalveolar 
lavage (BAL) fluid and dorsal tongue swabs from 39 patients. After total bacterial DNA 
extraction and PCR amplification of 16S rRNA gene sequences, the amplicons were cloned 
into Escherichia coli and sequenced. This study found a diversity of bacterial species in both 
samples and confirmed the presence of respiratory pathogens colonising the oral cavity and 
lungs (Bahrani-Mougeot et al. 2007). Later, a separate study compared genetic relationships 
between respiratory pathogens from dental plaque and bronchoalveolar lavages (BALs) 
using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing and found that 
microorganisms from dental plaque and BALs, including S. aureus and P. aeruginosa were 
identical (Heo et al. 2008). 
2.2 Objectives  
Current evidence suggests that oral microorganisms contribute to biofilm formation in ETT 
lumens. These ETT biofilms are also known to contain pathogenic bacteria able to cause VAP. 
However, studies demonstrating a microbiological continum between the oral cavity, the 
ETT and the lung are limited. The principle aims of this Chapter were therefore to: 
 Determine simultaneous presence of representative oral microorganisms (i.e. 
Streptococcus mutans, Porphyromonas gingivalis and Candida albicans) along with 
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potential respiratory pathogens (i.e. Staphylococcus aureus and Pseudomonas 
aeruginosa) in dental plaque, ETT biofilms and NBLs of MV patients. 
 Determine whether strains of isolated and targeted species from different sites in 
individual patients were genetically identical. In cases where identical strains were 
detected, evidence would thus be generated that was supportive of a 
microbiological link between the sampled sites. The methods used to assess strain 
similarities were PCR and PFGE-based genotyping approaches. 
2.3  Materials and Methods 
2.3.1  Ethical approval for patient recruitment 
Ethical approval was obtained from the Research Ethics Committee for Wales (trial 
registration: Clinical Trials.Gov NCT01154257 14th June 2010) for recruitment of 50 patients. 
Informed and written consent was obtained from patients or relatives complying with the 
Mental Capacity Act 2005. 
2.3.2  Patient recruitment 
Patients were recruited soon after admission to the adult intensive care unit at the 
University Hospital of Wales (UHW), Cardiff, UK. The UHW is a major 1000-bed reference 
hospital, with an adult intensive care unit consisting of 33 beds. The unit is involved in the 
treatment of all adult patients with the exception of burns and cardiothoracic cases. 
Patient inclusion criteria were the requirement that patients were aged >18 years, were 
mechanically ventilated with an ETT placed via the oral route, and had >20 teeth of broadly 
symmetric (left and right) distribution. Patients that did not meet the inclusion criteria or 
had thrombocytopenia (platelet count <30) or uncontrolled coagulopathy were not 
included, as risk of bleeding from tooth brushing, facial or oral trauma would be a 
consideration. 
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A total of 28 patients were recruited, of whom 7 withdrew because of death or hospital 
transfer, leaving 21 patients to complete investigations. These 21 patients included 10 males 
and 11 females with a mean age of 48.8 years.  
2.3.3  Collection of clinical samples 
Dental plaque samples were obtained for up to 7 consequitive days. Plaque was recovered 
from the upper and lower first molars, first bicuspid and central incisors on each side of the 
mouth. For patients with missing teeth, the remaining teeth in closest proximity were 
sampled. Plaque was collected using sterile endodontic paper points (size ISO 45; QED, UK), 
with one paper point used per tooth. Sampling commenced at the distal part of the buccal 
aspect of the tooth with 1 mm of the paper point placed into the gingival sulcus, then, with 
a slow and continuous motion the paper point was drawn towards operator to recover the 
plaque. 
In addition to dental plaque, non-directed bronchial lavages (NBLs) were obtained up to 
twice a week (Figure 2.2). The ETT was collected when extubation was clinically indicated for 
biofilm assessment using microbial culture and molecular analysis. 
 
 
Figure 2.2 Chronology of collection of dental plaque and non-directed bronchial lavages 
(NBL).
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2.3.4  Processing of clinical specimens 
Paper points were immediately immersed in 1 ml of microbiological transport medium 
Reduced Transport Fluid (0.045% (w/v) K2HPO4, 0.045% (w/v) KH2PO4, 0.09% (w/v) NaCl, 
0.09% (w/v) (NH4)2SO4, 0.018% (w/v) MgSO4, 0.038% (w/v) EDTA, 0.04% (w/v) NaCO3, 0.02% 
(w/v) dithiothreitol) to protect sample integrity prior to microbial culture (Syed and Loesche 
1972). 
Immediately after extubation, ETTs were wrapped in sterile paper towels previously 
dampened with sterile saline and placed in a sterile bag. ETTs were immediately transferred 
to the microbiology laboratory and stored at 4°C for a maximum of 6 h until processed. A 1 
cm section of from the middle of the ETT was cut and the biofilm in the lumen recovered by 
scraping with a sterile surgical blade. This biofilm was suspended in 1 ml of phosphate saline 
buffer (PBS) and subjected to microbiology and molecular analysis.  
The reduced transport fluid containing plaque, the resuspended biofilm from the ETT and 
the NBL samples, were vortex mixed for 30 s and serially diluted in PBS, prior to a 50-μl 
volume being inoculated on to appropriate agar media using a spiral plating system (Don 
Whitley Scientific, Shipley, UK). All culture media were obtained from Lab M (Heywood, UK) 
unless otherwise stated. The following media were used to culture microorganisms: Blood 
Agar (BA) for aerobic bacteria, Fastidious Anaerobe Agar (FAA) for anaerobic bacteria, 
Sabouraud’s Dextrose Agar (SDA) and CHROMagar® Candida (Chromagar; Paris, France) for 
Candida and yeast species, Mannitol Salt Agar (MSA) for detection of Staphylococcus 
species, Mitis Salivarius Sucrose Bacitracin agar (MSB; Difco, BD; Oxford, UK) (Schaeken et 
al. 1986) for S. mutans and finally, a selective agar for Pseudomonas aeruginosa (PsA). The 
inoculated media were incubated under appropriate gaseous environments at 37°C for 48 h 
with the exception of MSB (5 d) and FAB (7 d). After incubation, colony-forming units (CFU) 
on agars were enumerated. Suspected target species were provisionally identified based on 
  72   
 
colony appearance and selected and distinct colonies stored at -80°C using microbeads (Pro-
Lab Microbank®, Bromborough, UK). 
2.3.5 Phenotypic analysis 
Isolate identification was provisionally based on the conditions of growth, colony 
morphology and colour and a variety of phenotypic tests including catalase and coagulase 
tests. For suspected S. aureus isolates, meticillin resistance was determined. 
2.3.5.1 Catalase test 
The catalase test differentiates staphylococci (catalase positive) from streptococci. A single 
colony was submerged in 2 ml of 3% (v/v) hydrogen peroxide (Fisher Scientific, 
Loughborough, UK) and effervescence was indicative of a positive catalase reaction. 
2.3.5.2 Coagulase test 
The coagulase test is the gold standard to identify S. aureus based on coagulase (clumping 
factor) production. A staphylase test kit (Oxoid, Altrincham, UK) was used according to the 
manufacturer’s instructions. Briefly, two to three colonies were mixed in a drop of distilled 
water and deposited in two demarked regions of the provided test card. Test and control 
reagents were mixed and observed for agglutination, which indicated a positive result for S. 
aureus (Appendix II). 
2.3.5.3 Oxidase test 
The oxidase test reveals the presence of the enzyme cytochrome oxidase, which is 
characteristic of Pseudomonas and Neisseria species (Gaby and Hadley 1957). Oxidase strips 
(Mast group Ltd, Bootle, UK) impregnated with oxidase reagent (N,N-Dimethyl-p-
Phenylenediamine) and ascorbic acid were used. Isolates were cultured overnight on PsA 
agar and the strip placed over the grown colonies; a deep blue colour change within 10 s of 
was considered a positive reaction (Appendix II). 
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2.3.5.4 Testing for meticillin susceptibility 
Meticillin resistance was tested using oxacillin strips and cefoxitin discs (Brown et al. 2005). 
For oxacillin strips, bacterial cultures were grown overnight on BA. Two colonies were 
subsequently streaked onto iso-sensitestTM agar (ISA; Oxoid) in parallel horizontal lines on 
the same plate. Positive MRSA (NCTC 12493) and negative meticillin sensitive S. aureus 
(MSSA; NCIB 9518) control strains were also tested. An oxacillin strip was aseptically placed 
perpendicular to the culture streaks and incubated at 30°C for 24 h (Appendix II). For the 
cefoxitin discs assay, cultures were grown as previously described, and colonies resuspended 
in sterile water to a 0.5 McFarland standard and an iso-sensitive agar (ISA) plate inoculated. 
Agars were dried at room temperature and a cefoxitin disc (Mast group Ltd) was placed in 
the centre of the plate. Up to four isolates were tested simultaneously. Agar containing a 
positive and negative control were concurrently tested. All agars were incubated at 30°C for 
24 h (Appendix II). 
2.3.6 Molecular Analysis 
2.3.6.1  DNA Extraction 
DNA extraction was undertaken for all isolates,ETT and NBL samples, however tipically one 
dental plaque sample (trial day 3 or closest) was subject to molecular analysis. The the 
Gentra Puregene® Yeast/Bacteria kit (Qiagen Manchester, UK) was used. Bacteria and yeast 
isolates were subcultured overnight in Fastidious Anaerobe Broth (FAB) and DNA extracted 
following either the Gram-positive or yeast protocols, as appropriate, and as detailed by the 
manufacturer. Where optional extended incubation times were possible, they were used at 
the maximum recommended time. Clinical samples previously stored at -80°C, were brought 
to room temperature and centrifuged at 10000 g for 10 min and resuspended in PBS prior 
the start of the DNA extraction protocol. 
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For NBLs and ETT biofilms that presented with high viscosity, pre-treatment with Sputasol® 
(Oxoid) was employed to liquidise the specimen. The sample volume was doubled using 
Sputasol® and incubated at 37°C with rotation at 100 rev/min for 2 h (Stuart orbital incubator 
SI500). In addition, portions of samples that remained viscous following Sputasol® 
treatment, were placed in 1.5-ml microcentrifuge tubes with 50 µl of sterile glass beads 
(425–600 μm in diameter, Sigma) and mixed using 30 s pulses in a mini bead beater (Stratech 
Scientific Ltd., Soham, UK). 
2.3.6.2 Species-specific PCR 
All DNA extracts were subjected to PCR using species-specific primer pairs to detect the 
target microorganisms (Table 2.1). All reactions were repeated on two separate occasions. 
The PCR mix (25-μl final reaction volumes) was the same for all PCRs with the exception of 
the primer combinations. PCR mixes contained 0.5 μl of each forward and reverse primer at 
50 μM, 25 μl of PCR mastermix (Promega, Southampton, UK) and DNA template (5 μl), in a 
total reaction volume of 50 μl. The PCR cycling conditions were different for each primer pair 
(targeted species) and were as follows:  
• S. aureus: an initial 5 min at 94°C, then 35 cycles of 94°C for 40 s, 50°C for 40 s and 
72°C for 1 min with a final elongation step of 72°C for 10 min. 
• S. mutans: an initial 2 min at 95°C, then 35 cycles of 95°C for 30 s, 54.5°C for 30 s 
and 72°C for 1 min, and 72°C for 1 min. 
• P. aeruginosa: an initial 5 min at 95°C followed by 35 cycles of 94°C for 45 s, 58.4°C 
for 45 s and 72°C for 1 min, ending with 5 min at 72°C. 
• P. gingivalis: initial denaturation at 94°C for 3 min, then 36 cycles of 94°C for 45 s, 
55°C for 30 s, 72°C for 45 s and a final elongation step of 10 min at 72°C. 
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PCR products were resolved by standard gel electrophoresis in 1.5% (w/v) agarose gels at 
70V/cm2 for 1 h in 0.5 × Tris-Borate-EDTA (TBE; 0.1 M Tris Base; 0.09 M Boric Acid; 0.1 mM 
EDTA) buffer. The resulting amplicons were stained with Safeview® (NBS biologicals; 
Huntingdon, UK) and visualised under UV light using a GelDoc system (Bio-Rad). 
2.3.6.3 PCR identification of isolated microorganisms 
For microbial isolates obtained from clinical samples by culture rDNA was amplified using 
universal bacterial primers targeting the 16S rDNA, and Candida species were identified by 
PCR amplification of the 5.8S rDNA region (Table 2.2). PCR volumes were 50 μl and included 
1 μl of each forward and reverse primers at 50 μM, 12.5 μl of Promega PCR MasterMix® and 
DNA template (5 μl). 
PCR cycling for bacteria comprised of an initial denaturation step at 95°C for 5 min followed 
by 30 cycles each of 95°C for 45 s, 60°C for 60 s, and 72°C for 1 min. The primer extension 
step was extended by 5 s per cycle and employed a final extension cycle of 72°C for 5 min. 
PCR for Candida comprised 30 thermal cycles of 95°C for 1 min, 55°C for 1 min and 72°C for 
2 min, followed by a final extension step at 72°C for 5 min. 
Negative controls of sterile DNA-free water in place of template DNA were included with 
each PCR, and amplicon sizes were confirmed by agarose gel electrophoresis, as described 
previously. 
PCR products (5 μl) were initially ‘cleaned’ using 2 µl of ExoSAP-IT® and this mixture was 
incubated for 15 min at 37°C, and a further 15 min at 80°C. The cleaned products were sent 
with their corresponding forward primer to the Sequencing Core Unit at the School of 
Bioscience (Cardiff University) for automated sequencing using BigDye® Terminator v3.1 
(Life Technologies) and the 3730xl DNA analyser as the platform (Eurofins, Germany). 
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Sequences were identified using the Basic Alignment Search Tool from the National Centre 
for Biotechnology Information (NCIB) for microbes http://blast.ncbi.nlm.nih.gov/Blast.cgi. A 
95% identity match was used as a minimum similarity for identification. 
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                 Table 2.1 Species specifics PCR primers used for identification of isolates and detection of target species in clinical samples. 
Species Target 
Gene 
Primers Product 
size 
Reference 
Staphylococcus  
aureus 
Vick vicK1: 5’-CTA ATA CTG AAA GTG AGA AAC GTA-3’ 
vicK2: 5’-TCC TGC ACA ATC GTA CTA AA-3’ 
289 bp (Liu et al. 2007) 
Streptococcus 
mutans 
Sm479 Sm479F: 5’-TCG CGA AAA AGA TAA ACA AAC A-3’ 
Sm479R: 5’-GCC CCT TCA CAG TTG GTT AG-3’ 
479 bp (Chen et al. 2007) 
Pseudomonas 
aeruginosa 
ecfX Ps.aeru_ECF1: 5’-ATG GAT GAG CGC TTC CGT G -3’ 
Ps.aeru_ECF2: 5’-TCA TCC TTC GCC TCC CTG -3’ 
528 bp (Lavenir et al. 2007) 
Porphyromonas 
gingivalis 
16S rRNA P.ging_16S-1: 5’-AGG CAG CTT GCC ATA CTG CG-3’ 
P.ging_16S-2: 5’-ACT GTT AGC AAC TAC CGA TGT-3’ 
404 bp (Ashimoto et al. 1996) 
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                       Table 2.2 PCR primers used for amplification of microbial rDNA. 
 
 
 
 
 
 
 
 
 
 
Species Target 
Gene 
Primers Product size Reference 
C. albicans 5.8S ITS1: -5’- TCC GTA GGT GAA CCT GCGG 3’ 
ITS2: -5’ – TCC TCC GCT TAT TGA TAT GC 3’ 
540bp (Williams et al. 2001) 
Bacteria 16S D88 : GAGAGTTTGATYMTGGCTCAG 
E94 :  GAAGGAGGTGWTCCARCCGCA 
 
1500bp (Paster et al. 2001) 
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2.3.6.4 Genotyping isolates 
For analysing genetic similarities of the same microbial species from different clinical 
samples of the same patient, RAPD and PFGE were used. Isolates analysed were those that 
were found to be present in dental plaque and at least one other sample (ETT and/or NBL) 
from a given patient. Using this criterion, 36 C. albicans, 15 S. aureus and 5 P. aeruginosa 
isolates were analysed. 
2.3.6.5  RAPD fingerprinting 
Genomic DNA extracts were initially quantified using a Nano-Vue spectrophotometer (GE 
healthcare, Little Chalfont, UK) and the DNA concentration standardised for each species by 
diluting the DNA in nuclease free water. Pseudomonas aeruginosa genomic DNA extracts 
were used at 10 ng/µl, C. albicans at 20 ng/µl and S. aureus between 20 ng/µl and 80 ng/µl 
Samples from the same patient did not have a concentration difference higher than 30 ng/µl. 
RAPD primers with corresponding PCR cycles were selected from published studies and 
validated against isolates from target and other species (Tables 2.3, 2.4). 
For all primers and species, a 50-μl final reaction volume was prepared. All reagents were 
obtained from Promega unless stated otherwise, and PCR was performed in a G-Storm 
(Somertone, UK) thermal cycler. The PCR mix was prepared with 1 μl of primers, 25 μl of PCR 
Mastermix and DNA template (2 μl).  
PCR reactions for S. aureus were prepared using a master mix with a higher concentration 
of Taq polymerase that had previously been successful in obtaining distinctive band patterns 
(Emanuel 2011). Each reaction containing 5 U of Go Taq® Flexi DNA polymerase, 0.2 mM 
dNTPs, 2.5 mM MgCl2, 50 mM primer, 20 μl of 5× colourless GoTaq® reaction buffer, 50 mM 
primer and 10 μl DNA template; 50-μl final volume). 
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Two primers with the best band profiling for each species were chosen, and electrophoresis 
conditions optimised (Table 2.5). All gels were prepared using 2% (w/v) agarose (Sigma, 
Poole, UK) in 0.5 x TBE buffer (Sigma), which was also the running buffer. A 15-μl volume of 
amplicons was loaded in the gel and a commercial DNA ladder was used as reference every 
5 lanes (Table 2.5). RAPD-PCR products were visualised under UV illumination in a GelDoc 
system (Biorad).  
Banding patterns were analysed using GelCompar II software (Applied Maths, Sint-Marterns-
Latem, Belgium). Gels were normalised, and cluster analysis performed using Dice’s 
coefficient and the UPGMA method, thereby calculating a dendrogram of genetic similarity. 
2.3.6.6 Pulsed Field Gel Electrophoresis (PFGE) 
The PFGE instrument (CHEF-DR II®; Biorad) was set up in accordance with the manufacturer’s 
instructions. All reagents were obtained from Sigma unless otherwise stated. Pulse field 
grade agarose (Biorad) was used to prepare the gels at 1% (w/v) with 0.5 x TBE buffer 
(Sigma). To compensate for water evaporation during the melting of the agarose, the TBE 
buffer/agarose mix was weighed before and after melting, and adjusted accordingly. The 
agarose was cooled in a water bath at 60°C for 15 min before use. 
The PFGE casting gel tray and electrophoresis chamber were placed on an even surface 
determined with the provided level marker to avoid curved or slanted lanes. The buffer used 
for conducting electrophoresis was 0.5 × TBE. 
.
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     Table 2.3 Primers for DNA fingerprinting of respiratory pathogens using random amplification of polymorphic DNA (RAPD). 
Species Primer Sequence 
Primer 
per 50 l 
PCR Cycle Reference 
Pseudomonas 
aeruginosa 
272 5'-AGCGGGCCAA-3' 40 pmol 
4 cycles: (5 min 94⁰C,  
5 min 36⁰C,  
(Mahenthiralingam 
et al. 1996) 
    5 min 72⁰C)  
    30 cycles (1 min 94⁰C,  
    1 min 36⁰C,  
    2 min 72⁰C)  
    10 min 72⁰C  
Staphylococcus 
aureus 
MN45 5'-AAGACGCCGT-3' 25 M 5 min 94⁰C 
(Taghi Akhi et al. 
2008) 
    40 cycles (30s 94⁰C  
    40s 35⁰C  
    1 min 72⁰C)  
    7 min 72⁰C  
Staphylococcus 
aureus 
1 5'-GGTTGGGTGAGAATTGCA-3' 50 pmol 4 min 94⁰C 
(van Belkum et al. 
1995) 
 7 5'-GTGGATGCG-3'  35 cycles (1 min 94⁰C,  
 ERIC2 5'-AAGTAAGTGACTGGGGTGAGCG-3'  1 min 25⁰C,  
    2 min 74⁰C)  
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          Table 2.4 Primers for DNA fingerprinting of Candida albicans using random amplification of polymorphic DNA (RAPD). 
Species Primer Sequence 
Primer 
per 50 l 
PCR Cycle Reference 
Candida 
albicans 
1251 5'-TGGGTGTGTGGGTGTGTGGGTGTG-3' 
  
0.5 M 40 cycles   
(1 min 94⁰C 2 min 52⁰C, 3 min 
74⁰C)  
5 min 94⁰C 
(Bartie et al. 
2001) 
Candida 
albicans 
1245 5'-AAG TAA GTG ACT GGG GTG AGC-3' 0.5 M 35 cycles (Bartie et al. 
2001)  
1246 5' ATG TAA GCT CCT GGG GAT TCA C-3'  0.5 M (1 min 94⁰C,1 min 25⁰ C, 2 min 
72⁰C)  
10 min 72⁰C 
Candida 
albicans 
JWFR  5'-GGTCCGTGTTTCAAGACG-3' 1 M 5 cycles  
(30s 94⁰C,2 min 52⁰C,2min 72⁰C) 
(Leung et al. 
2000) 
 
JWFF 5'-GCATATCAATAAGCGGA-3' 1 M 45 cycles(30 s 94⁰C, 2 min 57⁰C,2 
min 72⁰C)   
15 min 72⁰C 
 
Candida 
albicans 
T3B 5'-AGGTCGCGGGTTCGAATCC-3' 25 pmol 5 min 95⁰C 
45 cycles (15s 94⁰C,30 s 52⁰C, 1.2 
min 72⁰C) 
 6 min 72⁰C     
(Thanos et al. 
1996) 
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                      Table 2.5 Random amplification of polymorphic DNA (RAPD) primers and electrophoresis conditions used. 
Species Primer Ladder Volts Time Size of gel 
Candida albicans 1251 Fermentas Ready Run Super Ladder TM 
Low 100 bp (Termo Fisher Scientific) 
50 4 h 40 wells 
Candida albicans 1245 
1246 
O’range RulerTM 100 and 500 bp 
(Termo Fisher Scientific) 
40 9 h 40 wells 
Staphylococcus aureus A1 O’range RulerTM 100 and 500 bp 60 6 h 40 wells 
Staphylococcus aureus A7 O’range RulerTM 100 and 500 bp 50 6 h 20 wells 
Pseudomonas aeruginosa A1 O’range RulerTM 100 and 500 bp 60 6 h 40 wells 
Pseudomonas aeruginosa A7 O’range RulerTM 100 and 500 bp 40 4.5 h 40 wells 
Pseudomonas aeruginosa 1251 100 bp Promega ladder 40 3 h 16 wells 
 
 
 84 
 
2.3.6.7 Staphylococcus aureus PFGE 1 
The PFGE method used for S. aureus was as previously described (O'Brien et al. 2007). 2 
Briefly, isolates were cultured on MSA for 24 h at 37°C and a single colony inoculated into 5 3 
ml of Brain Heart Infusion (BHI; BD Oxford, UK) broth. Inoculated BHI was incubated without 4 
shaking overnight at 37°C. One-ml of broth was centrifuged at 6000×g for 5 min and the cells 5 
washed (×2) by re-suspending in 2 ml of 50 mM EDTA followed by centrifugation. The cells 6 
were then re-suspended in 1 ml of “EC buffer” (6 mM Tris, 1 M sodium chloride, 10 mM 7 
EDTA, 0.5% (w/v) Brij 58, sodium deoxycholate and 0.5% (v/v), pH 7.5). Fifty µl of the cell 8 
suspension was then transferred to a sterile microcentrifuge tube and mixed with 50 µl of 9 
EC buffer containing 500 µg of lysostaphin and 100 µl of melted 2% (w/v) clean cut agarose 10 
(Biorad, Hertfordshire, UK). The preparation was maintained at 56°C, and the cell suspension 11 
was then mixed and transferred to disposable plug moulds (Biorad). Agarose plugs were 12 
allowed to set for a minimum of 10 min before being transferred to 24 well tissue culture 13 
plates (Starsted, Leicester, UK) with 500 µl of EC buffer. The suspended plugs were incubated 14 
at 37°C overnight for cell lysis. After incubation, the EC buffer was removed and 300 µl of 15 
“EST buffer” (5 mM Tris, 0.5 M EDTA and 1% (w/v) sarkosyl pH 7.5) and 20 µl of proteinase 16 
K (20 mg/ml) was added to the wells. This preparation was incubated overnight at 50°C to 17 
promote protein removal. The plugs were washed to remove existing buffer and 1 ml of 50 18 
mM EDTA added. This preparation was incubated at room temperature with gentle shaking 19 
for 30 min, and the step was repeated three times. Plugs were then stored at 4°C until 20 
required. For restriction endonuclease digestion, plugs were bisected and one half of the 21 
plug transferred to a clean 1.5-ml microcentrifuge tube containing 1ml of sterile water and 22 
incubated for 30 min with gentle shaking at room temperature. The plug was then 23 
transferred to a clean 24-well tissue culture plate and 200 µl of sterile water containing 40 24 
U of SmaI restriction enzyme (Promega) added, prior to overnight incubation at 25°C.  25 
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The digested plugs were gently placed into the gel wells, and a 2 mm slice of a molecular 1 
weight standard (PFGE Lambda ladder; New England Biolabs, Hertfordshire, UK) was also 2 
used every 5 to 7 lanes. The plugs and ladder were sealed in the wells using melted agarose 3 
and allowed to set for 10 min. The loaded gel was placed in the PFGE cell, and 2L of TBE 4 
buffer added. The electrophoresis settings employed were 6 V/cm2 for 18 h with pulsing 5 
times of 1-40 s at 14°C. 6 
2.3.6.8 Candida albicans PFGE 7 
The method used was largely as previously described (Wilson et al., 2001) but was slightly 8 
modified in these studies. Candida albicans isolates were cultured on SDA agar (Lab M) at 9 
37°C for 24 h. After incubation, a single colony was inoculated in 5 ml of YNB broth (Difco, 10 
BD, Oxford, UK) supplemented with 500 mM of sucrose (Fisher Scientific, Loughborough, 11 
UK). The inoculated broth was incubated overnight at 37°C. After incubation, cells were 12 
recovered by centrifugation (4000 rev/min; 10 min; Thermoscientific IEC CL10) and the 13 
harvested cells washed twice in 1.5 ml of 50 mM EDTA, pH 8.0. The cell pellet was 14 
resuspended in 100 µl of cell suspension buffer (1250 U/ml lyticase, 10 mM Tris, 20 mM 15 
NaCl, 50 mM EDTA; pH 8.0) and 100 µl of melted 2% (w/v) clean cut agarose (Biorad). This 16 
preparation was maintained at 56°C, and the cell suspension was mixed and transferred to 17 
disposable plug moulds (Biorad). Agarose plugs were allowed to set for a minimum of 10 18 
min prior to transfer into a 24-well tissue culture plate (Starsted) with 500 µl of lyticase 19 
buffer (1250 U/ml lyticase, 10 mM Tris, 50 mM EDTA; pH 8.0). The tissue culture plates were 20 
sealed with Parafilm M® and incubated at 37°C for 72 h for cell lysis. The buffer was then 21 
removed and replaced with 1.5 ml of proteinase K buffer (1 mg/ml proteinase K; Promega), 22 
0 01 M Tris, 50 mM EDTA; pH 8.0) followed by incubation at 50°C for 72 h for protein 23 
removal. Plugs were washed (×4) at 30 min intervals with 1.5 ml of wash buffer (20 mM Tris, 24 
50 mM EDTA; pH 8.0). The plugs were then stored at 4°C until required. Agarose plugs were 25 
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divided in half, with one half being transferred to the wells of a 0.9% (w/v) agarose gel 1 
(Biorad) prepared with 0.5×TBE buffer. Saccharomyces cerevisiae DNA size standards 2 
(Biorad) served as molecular weight markers. The wells of the PFGE gel were sealed with 3 
melted agarose and allowed to set for 10 min. Three switching intervals were assessed (see 4 
below) to optimise resolution of subsequent banding profiles. 5 
1. Initial switch time of 300 s at 4 V/cm2 for 24 h, followed by switching intervals of 6 
1000 s at 2.7 V/cm2 for 42 h, with no final switch time. 7 
2. Initial and final switch time of 300 s at 4 V/cm2 for 24 h followed by an initial and 8 
final switch 1000 s switch time at 2.7 V/cm2 for 42 h. 9 
3. Initial and final switch time 120 s for 24 h followed by initial and final switch time 10 
240 s for 36 h at 3.5 V/cm2. 11 
After electrophoresis, gels were stained using 25 µl/100 ml of Safeview® (NBS Biologicals, 12 
Cambridgeshire, UK) for 2 h. The gels were then de-stained in water for 20 min and imaged 13 
using a GelDoc system (Biorad). Gels were analysed with the GelCompar software as 14 
described in section 2.3.7.1. 15 
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2.4  Results  1 
Dental plaque and NBLs were obtained from all 21 recruited patients. Table 2.6 presents 2 
demographic information, ITU diagnosis, days of hospital stay and days of intubation at the 3 
start of the study. It was not possible to collect ETTs from 3 patients due to hospital transfer, 4 
whilst 2 ETTs were obtained from one patient (Table 2.6) below. 5 
 6 
Table 2.6 Number of samples of dental plaque, non-directed brochial lavages (NBL) and 7 
endotracheal tubes samples collected per patient. 8 
Patient Plaque NBL ETT 
01 5 2 1 
02 5 2 1 
03 5 2 1 
05 2 1 1 
08 4 1 1 
09 5 2 1 
10 6 2 1 
11 5 2 1 
13 4 2 1 
14 3 1 2 
16 4 2 0 
17 3 1 0 
19 3 1 1 
20 5 2 1 
21 6 1 1 
24 3 1 1 
25 7 2 0 
27 6 2 1 
28 3 1 1 
Total 84 30 19 
9 
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              Table 2.7 Characteristics of the 21 patients participating in this study. 
 89 
 
2.4.1  Identification of isolates cultured from clinical samples 1 
Isolate identification targeted 5 microbial species, namely S. mutans, C. albicans, P. 2 
gingivalis, S. aureus and P. aeruginosa. Isolates presumptively identified using differential 3 
and selective agar media were subjected to a range of further phenotypic identification tests 4 
(Appendix II). Definitive identification involved sequencing of rDNA amplicons and 5 
comparison of resulting sequences with those held within the NCIB database. Sequences 6 
with <95% identity to database sequences were not considered reliable and were repeat 7 
sequenced or not identified. 8 
Tables 2.8 and 2.9 present a summary of the identification of cultured isolates based on 9 
phenotypic testing and sequencing. Of the target microorganisms, the most frequently 10 
isolated species was C. albicans with 38 isolates from 19 patients, followed by S. aureus with 11 
17 isolates from 7 patients, and 5 P. aeruginosa was recovered from 2 patients. 12 
Streptococcus mutans was cultured on one occasion, and P. gingivalis was not cultured. Non-13 
target species detected included non-S. aureus Staphylococcus species (N=11), Prevotella 14 
intermedia (N=5), non-S mutans Streptococcus species (N=4), Escherichia coli (N=4) and 15 
Klebsiella pneumoniae (N=2).  16 
Staphylococcus aureus isolates were tested for meticillin resistance. Four of the 17 isolates 17 
were deemed as Meticillin Resistant S. aureus (MRSA), with 3 originating from different 18 
clinical samples from a single patient (Appendix II).  19 
Based on the identification of cultured microorganisms, it was apparent that for 11 patients, 20 
a shared (and targeted) microbial species occurred in the dental plaque and also both the 21 
NBLs and ETTs. For 8 further patients, a shared microbial species was found in dental plaque 22 
and either the NBL or ETT. 23 
 24 
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Table 2.8 Microbial species isolated and confirmed with 16S rRNA sequencing (patients 1 to 
13). 
Patient Site Strain Patient Site Strain 
P01 Plaque 
Staphylococcus 
haemolyticus 
P08 Plaque 
Staphylococcus 
aureus 
  
Candida albicans 
  
Escherichia coli 
  Propionobacterium 
propionicum 
 
NBL 
Staphylococcus 
aureus 
 
NBL Candida albicans 
 
ETT Candida albicans 
  
Staphylococcus epidermis P09 Plaque 
Staphylococcus 
haemolyticus 
 
ETT Candida albicans 
  
Candida albicans 
P02 Plaque Candida albicans 
 
ETT 
Staphylococcus 
haemolyticus 
  
Propionobacterium acnes 
  
Candida albicans 
 
NBL Candida albicans P10 Plaque Candida albicans 
 
ETT Candida albicans 
  
Enterococcus faecalis 
P03 Plaque Pseudomonas aeruginosa 
  
Prevotella intermedia 
 
NBL Pseudomonas aeruginosa 
 
NBL Candida albicans 
 
ETT Pseudomonas aeruginosa 
  Staphylococcus 
aureus 
P05 Plaque Staphylococcus epidermis 
 
ETT 
Staphylococcus 
aureus 
  
Candida albicans P11 Plaque Candida albicans 
  
Escherichia coli 
 
NBL Candida albicans 
 
NBL Escherichia coli 
 
ETT Candida albicans 
P06 Plaque Staphylococcus aureus P13 Plaque Candida albicans 
  
Prevotella intermedia 
 
NBL Candida albicans 
  
Candida albicans 
 
ETT Candida albicans 
 
NBL Staphylococcus aureus       
 
ETT Staphylococcus aureus       
P07 Plaque Prevotella intermedia       
 
NBL Streptococcus intermedius       
 
ETT Candida albicans       
  
Streptococcus intermedius       
  
Streptococcus gordonii       
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Table 2.9 Microbial species isolated and confirmed with 16S rRNA sequencing (patients 14 
to 28). 
Patient Site Strain Patient Site Strain 
P14 Plaque Staphylococcus aureus P24 Plaque 
Pseudomonas 
aeruginosa 
    Candida albicans     Candida albicans 
    
Prevotella intermedia 
  
NBL 
Pseudomonas 
aeruginosa 
  NBL Candida albicans     Candida albicans 
  ETT Candida albicans   ETT Candida albicans 
P16 Plaque 
Staphylococcus 
haemolyticus 
P25 Plaque Prevotella intermedia 
    
Candida albicans 
    
Streptococcus 
intermedius 
  NBL Staphylococcus aureus   NBL Candida albicans 
P17 Plaque Candida albicans P27 Plaque Candida lusitaniae 
P18 Plaque Candida albicans 
    
Staphylococcus 
epidermis 
    Prevotella intermedia     Enterococcus faecium 
    
Shigella sonnei 
  
NBL 
Staphylococcus 
epidermis 
P19 Plaque Candida albicans   ETT Candida albicans 
    
Staphylococcus aureus 
    
Staphylococcus 
epidermis 
  ETT Candida albicans     Enterococcus faecium 
    Escherichia coli P28 Plaque Candida albicans 
P20 Plaque Staphylococcus aureus     Staphylococcus aureus 
    Candida albicans     Klebsiella pneumoniae 
  NBL Candida albicans   NBL Klebsiella pneumoniae 
  ETT Candida albicans     Staphylococcus aureus 
P21 Plaque Streptococcus mutans   ETT Candida albicans 
    Staphylococcus aureus     Staphylococcus aureus 
  
NBL Staphylococcus aureus 
    
Staphylococcus 
lugdunensis 
  ETT Staphylococcus aureus       
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2.4.2 Molecular analysis 
2.4.2.1 DNA Extraction 
Successful extraction of bacterial DNA was confirmed by PCR targeting bacterial 16S rDNA 
genes (D88-E94 primers) and amplicon detection by standard gel electrophoresis. DNA 
extracts positive for PCR amplicons were obtained for all plaque samples, however no PCR 
products were obtained for DNA extracts of 13/21 NBLs (Patient numbers 1, 2, 8, 9, 10, 11, 
13, 14, 16, 17, 19, 20 and 24). Similarly, no PCR products were detected in DNA extracts from 
5 ETTs (Patients 2, 9, 11, 13, and 27). Additionally, 3 ETTs were not recovered from patients 
16, 17, and 25. As a consequence, a total of 13 ETTs DNA extracts were available for species-
specific detection using PCR.  
2.4.2.2 Species-specific PCR 
Bacterial DNA extracted directly from clinical samples was analysed by PCR using species-
specific primers for S. mutans, P. gingivalis, S. aureus and P. aeruginosa (Figure 2.3). The 
identity of cultured clinical isolates was also confirmed using species-specific PCR (Figure 
2.4), and this also served to validate selected primers. 
Porphyromonas gingivalis amplicons were detected in 15 dental plaque samples, 6 ETTs and 
one NBL. Similarly, PCR products from S. mutans were detected in 8 dental plaque samples, 
one NBL and one ETT. Staphylococcus aureus PCR products were found in 13 dental plaque 
samples, 4 NBLs and 8 ETTs. PCR products from P. aeruginosa were not detected in any 
samples (Table 2.9). The summary of target species detected by culture and species-specific 
PCR on clinical samples is shown in Table 2.11.  
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Figure 2.3 1.5% Agarose gel showing species specific PCR for detection of Porphyromonas 
gingivalis. 
 Lane 15: negative marker. Lane 14: Positive marker, Lanes 1 to 13:  DNA extracts from dental 
plaque. Product size: 404 bp. Although P. gingivalis was not recovered by culture it was 
detected by PCR in the plaque, NBLs and ETTs. Target species were identified more often by 
PCR than by culture. 
 
Figure 2.4 1.5% Agarose gel showing species specific PCR for detection of Pseudomonas 
aeruginosa. 
 Lane 18: negative marker, Lane 16 and 17: Positive marker, Lanes 1 to 15: gDNA from clinical 
isolates. Product size: 528 bp.   
L      1   2    3    4     5    6    7     8   9   10   11   12  13   +    -    L 
L    1    2    3    4   5   6    7   8   9  10  11  12  13  14  15   +  +   - 
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Table 2.10 Species Specific PCR detection of target microorganisms. Non-directed 
bronchial lavage (NBL), Endotracheal tube (ETT), S. mutans (SM), P. gingivalis (PG), 
P. aeruginosa (PA) and S. aureus (SA).   
 
  PLAQUE NBL ETT 
Patient SM PG PA SA SM PG PA SA SM PG PA SA 
1   X                     
2 X X                     
3   X                     
5 X X       X       X     
6 X X   X           X     
7 X     X   X   X   X     
8   X   X               X 
9   X                     
10   X   X           X   X 
11 X X                     
13   X   X                 
14   X   X         X X   X 
16 X X             NO ETT 
17       X         NO ETT 
19       X           X   X 
20   X                   X 
21 X X   X       X       X 
24       X               X 
25       X       X NO ETT 
27       X                 
28 X X   X X X   X         
N 7 15  0 13 1 3 0 4 1 6 0 9 
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Table 2.11  Summary results for detection of target species by culture and PCR. 
Candida albicans (CA), Streptococcus mutans (SM), Porphyromonas gingivalis (PG), 
Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) by culture and PCR in plaque, 
NBLs and ETT of each patient (P). 
 Site 
  Plaque   NBL   ETT 
P CA SM PG PA SA   CA SM PG PA SA   CA SM PG PA SA 
1                                   
2                                   
3                                   
5                                   
6                                   
7                                   
8                                   
9                                   
10                                   
11                                   
13                                   
14                                   
16                           NO ETT 
17                           NO ETT 
19                                   
20                                   
21                                   
24                                   
25                          NO ETT 
27                                  
28                                 
N 16 8 15 2 13  9 1 3 2 8  14 1 6 1 9 
                  
      Cultured     PCR detected    Found by culture and PCR  
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2.4.3 Genotyping of target species isolates 
2.4.3.1 Random Amplification of Polymorphic DNA (RAPD) 
Combinations of RAPD primers were selected based on their ability to generate 
discriminatory profiles. All isolates of a target species from dental plaque and at least one of 
the respiratory samples (NBL or ETT) were genotyped using this approach.  
Using primer 1251, RAPD profiles for C. albicans isolates from single patients, resulted in 8 
identical matches between the dental plaque isolate and isolates from either ETTs or/and 
NBLs. Similarly, using the primer pair 1245-1246, 7 identical profiles between the plaque and 
respiratory isolates were evident (Figures 2.4 and 2.5). 
Staphylococcus aureus isolates from 6 patients were analysed using either the A1 or A7 
primer. In the case of primer A1, RAPD profiling revealed identical matches between all the 
isolates for 4 patients. In a further patient (P21), identical profiles for the isolate from the 
dental plaque and NBL was evident, and these differed to the profiles for the ETT isolate. 
The A7 primer did not produce matches for isolates from the same patients (Figure 2.7). 
For genotyping the 5 Pseudomonas aeruginosa isolates from patients 3 and 24, the A1, A7 
and 1251 primers were used. Primers initially tested for P. aeruginosa from the available 
literature failed to provide discriminatory bands for these isolates, therefore the primers 
originally selected for other species were used. Primer 1251 generated 2 different RAPD 
profiles for isolates from 2 patients with 100% identity. Primer A1 also showed identical 
profiles for isolates of patient 24 and for the ETT and NBL isolates of patient 3; the band 
profiling with this primer was less discriminatory than seen with primer 1251. Primer A7 
showed identical profiles for isolates from patient 24 and >90% similarity for isolates from 
patient 3 (Figure 2.8). 
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2.4.3.2 Pulsed-field Gel Electrophoresis (electrophoretic karyotyping) 
Candida albicans band profiles generated by PFGE exhibited a high level of discrimination 
with distinct patterns observed for majority of isolates. Following cluster analysis and 
dendrogram construction, identical profiles between isolates for 5 patients were evident 
(Figure 2.9). 
Staphylococcus aureus PFGE analysis showed distinct band profiling for isolates from 
different patients and identical patterns for isolates obtained from individual patients. 
Isolates from 2 patients (patients 10 and 14) were not viable at the time of the experiments 
and therefore could unfortunately not be analysed (Figure 2.9).  
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Figure 2.5 RAPD dendrogram of Candida albicans isolates using primer 1251. 
Identical profiles from dental plaque isolates and a respiratory sample endotracheal tube 
(ETT) and or non-directed alveolar lavages (NBL) were detected in 8 patients (2, 8, 13, 11, 
14, 19, 20). 
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Figure 2.6 RAPD dendrogram of Candida albicans isolates using primer 1245-1246. 
Identical profiles from dental plaque isolates and a respiratory sample endotracheal tube 
(ETT) and or non-directed alveolar lavages (NBL) were detected in 5 patients (Patients 1, 2, 
8, 11, 14). 
Dice (Opt:0.50%) (Tol 1.0%-1.0%) (H>0.0% S>0.0%) [0.0%-100.0%]
Candida 1245-1246 primers
1
0
0
8
0
6
0
4
0
Candida 1245-1246 primers
10
19
9
19
28
10
10
9
11
11
8
8
14
14
14
14
2
2
2
11
13
13
27
1
1
1
20
20
28
24
20
27
24
24
27
plaque
plaque
ETT
ETT
ETT
NBL
ETT
plaque
plaque
NBL
plaque
ETT
NBL
ETT (B)
ETT
plaque
plaque
NBL
ETT
ETT
NBL
ETT
ETT
plaque
NBL
ETT
NBL
plaque
plaque
plaque
ETT
ETT (B)
NBL
ETT
plaque
 100 
 
 
 
Figure 2.7 Random amplification of polymorphic DNA (RAPD) profiles for Staphylococcus 
aureus isolates RADP profiles. 
Isolates from dental plaque, non-directed bronchial lavages (NBL) and endotracheal tubes 
(ETT). Primers A1 (top) and A7 (bottom). 
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Figure 2.8 Random amplification of polymorphic DNA (RAPD) profiles for Pseudomonas 
aeruginosa isolates. 
Isolates from dental plaque, non-directed bronchial lavages (NBL) and endotracheal tubes 
(ETT). Primers A1 (top), A7 (middle) and 1251 (bottom). 
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Figure 2.9 Dendogram of Candida isolates using pulse field gel electrophoresis.  
Identical patterns from dental plaque, non-directed bronchial lavages (NBL) and/or 
endotracheal tubes (ETT) were evident in samples from 6 patients (2, 8, 11, 14, 20, 28). 
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Figure 2.10 Dendrogram of Staphylococcus aureus isolates using pulse field gel electrophoresis.  
Identical patterns from dental plaque, non-directed bronchial lavages (NBL) and/or endotracheal tubes (ETT) were evident in samples 
from 4 patients (6, 8, 21, 28). 
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2.5  Discussion 1 
VAP is the most common nosocomial infection in the intensive care setting and its 2 
pathogenesis is still not fully understood, although multiple factors are thought to contribute 3 
(Chastre and Fagon 2002). Two of these factors namely oral colonisation and ETT biofilms, 4 
were the subject of this work.  5 
The oropharynx has been identified as a potential source of pathogens that can cause 6 
infection elsewhere, and this is particularly important in the critically ill receiving mechanical 7 
ventilation where an ETT provides an interface between ventilator and lower airways. 8 
Unfortunately the endotracheal cuff does not provide a perfect seal to the lungs and 9 
microorganisms can transit from the oral cavity into the lower airways. Furthermore, the 10 
formation of a biofilm in the lumen of the ETTs creates a second potential reservoir of 11 
pathogens that are protected from the patient’s defence system. However, there remains 12 
insufficient evidence on the route used by microorganisms to infect the lungs.  13 
This study aimed to demonstrate the presence of key target microorganisms representative 14 
of the oral microflora (Streptococcus mutans, Porphyromonas gingivalis and Candida 15 
albicans) and the main respiratory pathogens (Staphylococcus aureus and Pseudomonas 16 
aeruginosa) at three different sites in mechanically ventilated patients (i.e. dental plaque, 17 
ETT and NBL) and establish genetic similarities between isolates recovered. To date, this is 18 
the first time that a single study has simultaneously assessed the microbiology of these three 19 
sites.  20 
The results from culture and PCR analyses showed shared species were present in the dental 21 
plaque and at least one more sample NBL and/or ETT. This finding supports the hypothesis 22 
that there is movement of microorganisms between these sites. In the case of respiratory 23 
pathogens, initial colonisation of the dental plaque is likely prior to translocation to sites in 24 
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the ETT and/or lower airways. It was particularly noticeable that all target species were more 1 
frequently found in dental plaque than the other samples (Table 2.11), which could add 2 
support to this hypothesis. The factors that contribute to microorganisms moving to other 3 
sites and the reasons why plaque colonisation is promoted by respiratory pathogens remain 4 
to be determined. 5 
The most frequently isolated microorganism was C. albicans which was prevalent in 65% 6 
(39/60) of the samples, even though its detection was based solely on culture approaches. 7 
PCR detection was not possible to perform for this microorganism as yeast DNA extraction 8 
protocols differed to those used for bacteria making it difficult to perform both experiments 9 
on the same sample. 10 
Candida albicans is considered part of the normal oral microflora and is found in the mouths 11 
of approximately 50 % to 75% of the healthy population (Ariyawardana et al. 2007; Javed et 12 
al. 2013). This fungal species is a well-recognised opportunistic pathogen in the oropharynx, 13 
vagina and importantly it can cause systemic candidiasis in the severely 14 
immunocompromised (Bassetti et al. 2006; Vincent et al. 1998). However whilst it does not 15 
seem to cause infection in the respiratory tract (el-Ebiary et al. 1997; Rello et al. 1998), in a 16 
multicentre study involving 803 patients bronchial Candida colonisation was identified as an 17 
independent risk factor for pneumonia, particularly involving Pseudomonas (Azoulay et al. 18 
2006). This finding was later supported in a retrospective study that included 639 patients 19 
and reported poorer clinical outcomes including longer hospital stay and higher hospital 20 
mortality when Candida colonisation had occurred (Delisle et al. 2008).  21 
Candida albicans and Pseudomonas aeruginosa are both adept biofilm producers and are 22 
found simultaneously in cystic fibrosis patients and in biofilms formed in medical devices (El-23 
Azizi et al. 2004; McAlester et al. 2008). The interactions between these two microorganisms 24 
are complex. Some studies have found that P. aeruginosa inhibits C. albicans growth in the 25 
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host (Gupta et al. 2005; Kaleli et al. 2007; Kerr 1994) and in vitro studies report that P. 1 
aeruginosa alters the cell wall of C. albicans hyphae by adhering to the hyphae and releasing 2 
the antifungal pyocyanin, resulting in cidal effects (Brand et al. 2008; Kerr et al. 1999). 3 
Infection of C. albicans in vitro biofilms with P.aeruginosa in endotracheal tube sections 4 
resulted in a marked depletion of the C. albicans cells (Chapter 4, section 4.4.1). In contrast, 5 
Ader et al., (2011) showed that short term Candida colonisation of the mouse lung reduced 6 
P. aeruginosa load and also lung injury. Interestingly, antifungal treatment reversed this 7 
effect (Ader et al. 2011). Another murine model based study showed that C. albicans initiates 8 
alveolar innate immunity by the activation of innate lymphoid cells, macrophages, natural 9 
killer cells and dendritic cells. This induces secretion of interleukins 17 and 22 and production 10 
of antimicrobial peptides, protecting the host against subsequent P. aeruginosa infection 11 
(Mear et al. 2014). In contrast, in a burned mice model reported increased mortality when 12 
C. albicans infection was preceded by P. aeruginosa, this was thought to be due to 13 
proteolytic activity generated by the bacteria (Neely et al. 1986). Recently, in an acute lung 14 
injury murine model, it was reported that P. aeruginosa type III secretion system induced IL- 15 
18 secretion causing substantial neutrophil recruitment and host cell damage, and 16 
decreased IL-17 secretion which reduces the clearance of pathogens (Faure et al. 2014). In 17 
this present study, samples containing C. albicans were considerably more often 18 
encountered, compared with P. aeruginosa, but this might reflect the normal commensal 19 
colonisation of the former species.  20 
Interestingly, the oral species P. gingivalis and S. mutans were detected by PCR in both NBL 21 
and ETT samples. Streptococcus mutans was only cultured from one dental plaque sample, 22 
which is lower than expected based on oral carriage rates reported as high as 70% to 93% 23 
(Li et al.,2005, Mortazavi and Akhlaghi 2012). However, it is noted in the literature that its 24 
incidence is closely related to the both the presence of caries and the extent of the carious 25 
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lesions (Hong and Hu 2010; O'Sullivan and Thibodeau 1996), which were not recorded in this 1 
study. It is also likely that the oral microflora of this patient group may differ significantly 2 
from the general population as there is no consumption of foods and patients exhibit a 3 
reduced salivary flow with altered salivary pH (Sands 2016). However, using PCR S. mutans 4 
was detected in the dental plaque of 8 patients as well as one ETTs and one NBL. It is 5 
important to remember that this approach does not distinguish between live and dead 6 
microorganisms and opens the question as to whether this species and other 7 
microorganisms are viable away from the oral cavity in mechanically-ventilated conditions. 8 
The significance of S. mutans colonisation of the ETT was not determined, but it is a 9 
renowned biofilm producer in the presence or absence of sucrose, it produces glucans, 10 
glucan binding proteins, antigen I/II surface proteins and wall-associated protein A which aid 11 
in attachment to the tooth surface, collagen, fibronectin and cell to cell aggregation (Chapter 12 
1 Section 1.5.4). Indeed S. mutans is considered one of the pioneer microorganisms in the 13 
dental plaque biofilm (Krzyściak et al. 2014). It is therefore possible that its presence in the 14 
ETT could generate a ‘biofilm favourable’ surface for attachment of other microorganisms, 15 
including VAP causing agents. 16 
Porphyromonas gingivalis is a particularly fastidious and strictly anaerobic species. The 17 
bacterium is more prevalent in subgingival plaque and likely to be most sensitive of the 18 
targeted species to loss of viability during transport. These reasons might explain why it was 19 
not isolated in this work although its detection was achieved by PCR. Importantly, PCR 20 
revealed the presence of P. gingivalis at all three sites sampled and its incidence in this study 21 
(N=6) in ETTs was similar to that reported previously (N=5) by Cairns et al., (2011). This is the 22 
first time this species has been reported being present within NBL specimens. In a recent 23 
study, Porto et al., (2016) employed qPCR to detect periodontal pathogens in the ETTs of 24 
intensive care patients and found Aggregatibacter actinomycetemcomitans, P. gingivalis 25 
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and Tannerella forsythia. Finding periodontal pathogens in ETTs demonstrates the microbial 1 
complexity and diversity of the biofilms present at these sites. Additionally, although these 2 
organisms are not generally regarded as respiratory pathogens, there has been reported 3 
pneumonia cases caused by A. actinomycetemcomitans and P. gingivalis (Benedyk et al. 4 
2016; Shilo et al. 2015). Furthermore, periodontal disease was identified in a metanalysis as 5 
a significant and independent factor for chronic respiratory disease (Zeng et al. 2012). The 6 
cytokines and enzymes induced from inflamed periodontal tissues may also relocate to the 7 
lungs and trigger local inflammatory processes and lung infections (Paju and Scannapieco 8 
2007).  9 
It has been widely documented that oral hygiene deteriorates during hospitalisation 10 
(Fourrier et al. 1998; Needleman et al. 2012; Sachdev et al. 2013; Scannapieco et al. 1992). 11 
Importantly, the changes in mass and complexity of the dental plaque may be conducive for 12 
colonisation by respiratory pathogens that may later translocate to the lower respiratory 13 
tract (Scannapieco 1999). Multiple culture based studies frequently find respiratory 14 
pathogens in the dental plaque of mechanically ventilated patients (26 to 65%) (Fourrier et 15 
al. 1998; Heo et al. 2008; Sachdev et al. 2013; Sumi et al. 2007). However, culture 16 
independent studies report this to be higher, Sands et al (2016) analysed by next generation 17 
sequencing dental plaque samples from mechanically ventilated patients at the start, during 18 
and after intubation. This study reported that during mechanical ventilation a significant 19 
'microbial shift' occurred, 9/13 patients had >2 respiratory pathogens. Importantly, after 20 
removal of the ETT, the relative abundance of potential respiratory pathogens decreased 21 
and samples returned to a predominantly oral microbiota with a higher relative abundance 22 
of species like Prevotella spp., (Sands et al. 2016). In health, P. aeruginosa incidence has 23 
been estimated as <7% for (Morrison and Wenzel 1984; Rivas Caldas et al. 2015) and 24 
between 3 to 50% for S. aureus, however, when present is often considered to be a transient 25 
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coloniser rather than a permanent resident (Eick et al. 2016; Ohara-Nemoto et al. 2008). 1 
This contrast with the results of this study when the main respiratory pathogens associated 2 
with VAP, namely P. aeruginosa and S. aureus, were found more frequently in the dental 3 
plaque, as well as present in ETTs and NBLs of this studied patient group. To illustrate this, 4 
66% (14/21) of the patients had one of the respiratory pathogens in the dental plaque and 5 
in 47% (10/21) of the NBLs and ETTs.  6 
Porto et al., (2016) found that higher intraoral levels of A. actinomycetemcomitans 7 
correlated with increased levels of this species in the ETTs. This would suggest that improved 8 
dental plaque control may promote lower microbial colonisation of ETTs. Additionally, a 9 
reduced incidence of respiratory disease in hospitalised patients has been shown to occur 10 
after implementation of oral hygiene regimes (Koeman et al. 2006; Mori et al. 2006).  11 
One of the difficulties encountered in this work was obtaining bacterial DNA from NBL and 12 
ETT samples. Some of these samples presented with a high viscosity and were resistant to 13 
the different lysing methods applied. This may have resulted in an underestimation in the 14 
level of colonisation of the studied target species in these samples. A further issue was that 15 
in some cases where a microorganism was isolated, it was not subsequently detected by 16 
PCR. This situation occurred for all 5 P. aeruginosa isolates and one S. aureus isolates, 17 
however 3 of those samples later analysed with next generation sequencing and the species 18 
where detected then (Chapter 3). 19 
One of the aims of this work was to demonstrate the genetic relationship between isolates 20 
found in the dental plaque, ETTs and NBL of the mechanically ventilated patient and it was 21 
found that in the majority of cases the genotype of isolates from the dental plaque was the 22 
same as from isolates from the NBLs and/or ETTs of the same patient. This was evident when 23 
both RAPD and PFGE were employed. RAPD profiles showed identical matches for 8/13 C. 24 
albicans from colonised patients, 4/6 S. aureus from colonised patients and 2/2 P. 25 
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aeruginosa from colonised patients. A limitation of RAPD is that being an enzymatic reaction 1 
results may vary depending on the quality and concentration of template DNA, 2 
concentrations of PCR components, and the PCR cycling conditions, for these reasons its 3 
results are often considered laboratory dependant (Mbwana et al. 2006; Williams et al. 4 
1990). PFGE was been found to have more discriminatory power e and be more reproducible 5 
than RAPD (Werner et al. 2003) and for this reason was chosen to complement the results 6 
found by RAPD. In this study, PFGE showed the same results as encountered for S. aureus, 7 
the matches for C albicans strains were 5/13. No PFGE was performed for P. aeruginosa as 8 
it was considered that with isolates from only 2 patients the resources required were not 9 
justifiable. The results from this study supported the hypothesis that dental plaque served 10 
as reservoir for respiratory pathogens in this patient group. 11 
Previous reports have found similar results using different molecular techniques (Bahrani-12 
Mougeot et al. 2007; El-Solh et al. 2004; Heo et al. 2008; Heo et al. 2011). El-Solh et al., 13 
(2016) used PFGE to analyse isolates from of bronchoalveolar fluid and dental plaque from 14 
49 patients, including S. aureus, enteric Gram- negative bacilli and P. aeruginosa and found 15 
9/13 isolates were identical (El-Solh et al. 2004). Recently, Heo et al., (2008) used PFGE and 16 
MSLT to analyse respiratory pathogens from 100 intensive care patients. Targeted isolates 17 
were S. aureus, P. aeruginosa, E. coli and other Gram-negative bacilli, and in 18 patients the 18 
same strains was isolated from all three clinical sites (oral, tracheal secretions, and 19 
bronchoalveolar lavage). This same study found that not only did the isolates from the same 20 
patient have the same genetic profile, but also the same clone of P. aeruginosa was shared 21 
between 3/6 patients, indicating that its source was a common environmental one (Heo et 22 
al. 2008) in this study this was observed for C. albicans isolates in 2/14 patients (Figure 2.9). 23 
Candida albicans colonisation was also studied for the same cohort of patients and it was 24 
found that over 60% of patients had this fungus at least one site, 14 patients were colonised 25 
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in at least 2 sites and identical genetic profiles were determined for 12 patients (Heo et al. 1 
2011). 2 
All of these results clearly suggest that the route of colonisation to the lower airway follows 3 
mouth-trachea/ETT biofilm-lung, highlighting the importance of oral care in order to 4 
minimize colonisation of the dental plaque by potential pathogens endogenous to critically 5 
ill patients. 6 
2.6 Conclusions 7 
 The most frequent microorganism isolated for this cohort of patients was C. 8 
albicans, the oral bacteria S. mutans and P. gingivalis were found primarily by PCR 9 
in the dental plaque, as well as from ETT biofilms and NBLs 10 
 The respiratory pathogens S. aureus and P. aeruginosa were found in the dental 11 
plaque as well as ETT biofilms and NBLs; it was also noted that these 12 
microorganisms were more frequently found in the dental plaque. 13 
 When isolates of the same species were isolated from dental plaque and at one 14 
other site they were often found to have an identical genetic profiles by RAPD and 15 
PFGE.16 
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3. Biofilm community profiling using 
metataxonomics 
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3.1 Introduction  
The oral cavity has been implicated as a source of respiratory pathogens that can lead to 
pneumonias, including ventilator-associated pneumonia (VAP) (Garrouste-Orgeas et al. 
1997; Scannapieco 1999). As previously mentioned (Chapter 1; Section 1.3.3), VAP is the 
most common nosocomial infection in intensive care settings and it has been linked with 
high patient mortality (up to 69%), extended hospital stay (5 to 7 days) and increased 
economic costs (£22000 per case). As such, in order to help formulate prevention strategies 
it is important to understand the contributory factors associated with VAP. 
A primary contributory factor for VAP is the placement of an endotracheal tube (ETT), which 
is an essential medical device through which gaseous exchange occurs in mechanically 
ventilated patients (Hamilton and Grap 2012). However, the ETT will inadvertently impede 
certain natural host defence processes normally displayed by the respiratory tract, including 
cough reflexes and mucocilliary clearance. The necessity to create a seal between the ETT 
and the trachea using an inflated cuff means that pooling of microbial laden secretions 
invariably occurs above the cuff (Blot et al. 2014; Rello et al. 1996). These secretions may 
subsequently aspirate to the lower airway via microchannels in the cuff material (Figure 2.1), 
and the microorganisms in these secretions may then directly cause VAP or be drawn into 
the ETT lumen were they develop as biofilms (Brennan et al. 2004; Rodrigues et al. 2009; 
Rumbak 2005). Such biofilm formation on ETT surfaces has been known for a number of 
years (Inglis et al. 1989; Lee et al. 2012; Vandecandelaere et al. 2012) and these biofilms 
have been shown to harbour both respiratory pathogens and microorganisms normally 
associated with the oral cavity (Cairns et al. 2011; Perkins et al. 2010; Vandecandelaere et 
al. 2012). The presence of oral microorganisms in the ETT could be an important component 
in facilitating colonisation by respiratory pathogens in the ETT biofilm by providing 
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adherence sites and favourable conditions for attachment. Importantly the ETT biofilms are 
protected from the host immune system and administered antibiotic therapy. 
Dental plaque itself is naturally diverse and dynamic in terms of its microbial constituents, 
and typically contains between 500 and 700 bacterial species (Dewhirst et al. 2010). An 
estimated 96% of these species belong to the phyla Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria, Spirochaetes, and Fusobacteria. The remaining 4% of taxa 
are formed by Euryarchaeota, Chlamydia, Chloroflexi, SR1, Synergistetes, Tenericutes, and 
TM7 (Dewhirst et al. 2010). Streptococcus species are the most abundant in the mouth, 
followed by Lactobacillus. Dynamic changes in the microbial ecology of dental plaque arises 
following receipt of various medications, an altered diet, or due to the presence of an 
underlying systemic condition (Adler et al. 2013; Marsh 2006; Szymanska et al. 2014). 
Respiratory pathogens are not normally present in the oral cavity, although they have been 
found in the plaque of some healthy adults (S. aureus 3% to 30%, P. aeruginosa 6%) (Eick et 
al. 2016; Lister et al. 2009), where they are likely to be transient rather than endogenous 
colonisers. Importantly, however, a number of studies into the dental plaque of hospitalised 
and institutionalised patients have suggested that during mechanical ventilation, dental 
plaque can rapidly become colonised by respiratory pathogens (Fourrier et al. 1998; Sachdev 
et al. 2013; Scannapieco et al. 1992). Sands et al. (2016) collected dental plaque at the start, 
during and after mechanical ventilation with an endotracheal tube. The authors described a 
microbial “shift” that occurred during mechanical ventilation towards a plaque that 
contained respiratory pathogens including P. aeruginosa and S. aureus. Importantly after 
extubation the dental plaque of the majority of patients returned to one that was dominated 
by traditionally accepted oral species, and the respiratory pathogens were reduced in 
prevalence and abundance (Sands et al. 2016). The reasons why mechanical ventilation may 
induce such microbial changes remain unclear, but could relate to difficulties in maintaining 
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adequate oral hygiene in these patients, a reduced salivary flow, or be a feature of 
underlying disease and associated treatments. Regardless, the colonisation of the mouth by 
respiratory pathogens would likely represent a significant risk factor for subsequent VAP. 
Most evidence to date for oral microbial involvement in VAP has been based on culture 
methods, which have also been used to analyse bronchial lavages, protected brush 
specimens or non-directed bronchial lavages (NBLs) in VAP diagnosis. In a suspected VAP 
patient, culture analysis tends to initially focus on microorganisms most frequently 
associated with VAP including Staphylococcus aureus, certain Streptococcus species, 
Pseudomonas aeruginosa, Enterobacteriaceae, Haemophilus and Acinetobacter species 
(Chastre and Fagon 2002). Whilst microbial culture permits characterisation of phenotypic 
traits for individual isolates (including antibiotic susceptibility), a significant proportion of 
bacteria remain unculturable using standard microbiological methods. For example, in 
environmental samples, it has been estimated that over 90% of bacteria cannot be grown in 
vitro (Wade 2002) and even though dental plaque is one of the most studied biofilms, it is 
estimated that over half of its microbial community is unculturable (Paster et al. 2001). 
Therefore, the microbial composition of such communities cannot be fully determined 
without use of culture-independent molecular techniques.  
Given the increased accessibility of culture-independent methods, including next generation 
sequencing (NGS), a more comprehensive characterisation of dental plaque and clinical 
samples is now possible (Xie et al. 2010). NGS was introduced commercially in 2005 with the 
Genome Analyser, where a single sequencing run produced one gigabase of data (Mardis 
2008). By 2014, the output of NGS increased to 1.8 terabases using the latest platform 
HiSeqX Ten (Illumina). The output increase has also had an inverse proportional effect on 
the cost of sequencing, making it much more accessible for small research projects. The high 
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efficiency of this technology has transformed our ability to determine the microbial diversity 
of complex microbial communities including those of biofilms (Oulas et al. 2015).  
In recent years, molecular approaches have been developed that combine the sensitivity of 
polymerase chain reaction (PCR) with the specificity of sequencing to gain detailed 
information and understanding of the interactions between microbial species in particular 
communities. Microbiomics is a collective term, which encompasses the molecular tools 
available to achieve profiling of microbial communities, including uncultivable components 
(Culligan et al. 2013). One aspect of this toolkit uses inventories of 16S rRNA genes to provide 
a “snapshot” of bacterial diversity and relative abundance within a sample (Gee et al. 2004; 
Ziesemer et al. 2015). NGS differs from traditional Sanger sequencing as it is based on 
spatially separated, clonally amplified DNA templates or single DNA molecules on a flow cell 
where the process is extended across millions of fragments. Similar to previous technologies, 
a DNA polymerase (i.e. Bst) catalyses fluorescently labelled dNTPs into a DNA template 
strand during a series of PCR cycles and in each cycle, the incorporated nucleotides are 
identified by fluorophore excitation (Nakazato et al. 2013). NGS employs adapter sequences 
that allow for selective amplification by PCR, and this eliminates the need for bacterial 
cloning to achieve amplification of genomic fragments, in fact for some platforms (Helicos 
and Pacific Biosystems) the amplification of DNA fragments is not required before 
sequencing (Mardis 2008). Figure 3.1 explains the Illumina platform used in this work. 
This research has been partially published in: 
Marino P J, Wise M P, Smith A, Marchesi J R, Riggio M P Lewis M A O, Williams D W. 
Community analysis of dental plaque and endotracheal tube biofilms from mechanically 
ventilated patients. Journal of Critical Care. 2017 (in press).  
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Figure 3.1. The Illumina sequencing-by-synthesis approach. Reproduced with permission 
from Mardis (2008). 
 
 118  
 
3.2 Objectives 
In this experimental chapter, for the first time the microbiota of dental plaque, ETT biofilms 
and NBLs from mechanically ventilated patients is characterised using metataxonomics. 
These sites could potentially be related, similarities in the microbiomes of these three sites 
could demonstrate that dental plaque plays an important role in the colonisation of the 
lower airways by respiratory pathogens and in the development of biofilm in the lumen of 
ETTs 
3.3 Materials and Methods 
3.3.1 Collection and processing of clinical specimens 
Ethical approval for collection of clinical samples was obtained from the Research Ethics 
Committee for Wales (Reference # 08044240; Appendix I). A total of 21 patients were 
recruited (Trial registration: Clinical Trials.Gov NCT01154257 14th June 2010) for a trial that 
compared toothbrushes and foam swabs as methods of delivering oral care for mechanically 
ventilated patients (Chapter 5) and following receipt of informed and written consent from 
patients or relatives complying with the Mental Capacity Act 2005, these patients provided 
dental plaque, NBLs and ETT samples for analyses. 
Inclusion criteria were that patients had to be aged >18 years, had >20 teeth, and had an 
expectation of mechanical ventilation with an ETT for >24 h. Samples from 12 patients (7 
male and 5 female, aged 23 to 70 years old; Table 3.1) were selected for NGS. Patients were 
recruited for the study for a minimum of 2 days and a maximum of 7 days. At the time of 
recruitment, the typically prescribed antibiotics were tazocin or meropenem to cover both 
Gram-positive and Gram-negative bacteria. 
Dental plaque was obtained from the upper and lower first molars, first bicuspid and central 
incisors on each side of the mouth using sterile endodontic paper points (size ISO45). 
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Sampling was initiated at the distal part of the buccal aspect of the tooth with 1 mm of paper 
point placed into the gingival sulcus. Using a slow and continuous motion, the paper point 
collected dental plaque by being drawn towards the operator. Paper points were placed in 
1 ml of microbiological transport medium (Reduced Transport Fluid) (Loesche et al. 1972) 
prior to processing for DNA extraction.  
NBL specimens were obtained twice weekly from patients as part of routine screening at the 
time of the study. This involved insertion of a suction catheter with a 20-mL syringe of saline 
attached into the lung via the ETT until resistance was met. Saline was instilled and slowly 
withdrawn immediately. The ETT itself was recovered for analysis after extubation. The ETT 
was wrapped in a sterile paper towel damped with sterile saline solution and sealed; all the 
samples were processed within 4 h. The central part of the ETT was cut to provide a 1 cm 
section from which the biofilm was recovered by scraping with a sterile surgical blade. 
Recovered biofilm was resuspended in 1 ml of phosphate saline buffer (PBS). All samples 
were stored at -80°C prior to DNA extraction. 
 
. 
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  Table 3.1 Demographics of the 12 patients participating in this study 
Patient Sex Age Diagnosis Days between 
hospital stay and 
ITU admission 
Days of intubation 
at time of 
recruitment 
Antibiotic therapy 
at start of study 
P01 M 53 Sepsis 2 2 Y 
P03 M 70 Pneumonia/ Pneumocystis 
Pneumonia (PCP) 
4 2 Y 
P05 M 43 Substance overdose/ 
Aspiration pneumonia 
0 2 N 
P08 F 26 Ventricular fibrillation arrest 
postpartum 
0 9 Y 
P10 F 68 Head injury 0 0 N 
P14 M 29 Head injury 0 0 N 
P20 F 23 Alcoholic liver disease and 
pneumonia 
10 0 Y 
P21 M 32 Cardiac arrest 0 4 N 
P24 F 44 Sepsis 3 1 Y 
P25 F 49 Cardiogenic shock 0 3 Y 
P27 M 39 Type 1 respiratory 
failure/Pneumonia 
1 5 Y 
P28 M 52 Septic shock 13 0 Y 
The initial reason for mechanical ventilation in 7 patients (5, 8, 10, 14, 21, 24, 25) was for a reduced conscious level, and in the other 5 patients, it was for 
respiratory failure as a result of pneumonia (3, 20, 27) or extrapulmonary sepsis (1, 28). F indicates female; M, male; Y, yes; N, no 
 121  
 
3.3.2 DNA extraction 
DNA was extracted from the samples using the Gentra Puregene® Yeast/Bacteria kit 
employing the Gram-positive bacterial protocol as described by the manufacturer (Qiagen, 
Manchester, UK). Pre-treatment of highly viscous NBLs and ETT biofilms involved addition of 
an equal volume of Sputasol® (Oxoid, Altrincham, UK) to the specimen, which was incubated 
at 37°C whilst being rotated at 100 rev/min for 2 h (Stuart orbital incubator SI500). Samples 
that remained viscous following Sputasol® treatment had 50 μl sterile glass beads (425–600 
μm in diameter, Sigma) added and were homogenised for 30 s in a mini bead beater 
(Stratech Scientific, Newmarket, UK) before proceeding with the DNA extraction protocol. 
Purified DNA was stabilised in a DNA eluting solution (Qiagen). 
DNA extraction was confirmed by PCR of the bacterial 16S rRNA gene using the bacterial 
primers pair of D88 GAGAGTTTGATYMTGGCTCAG and E94 GAAGGAGGTGWTCCARCCGCA 
(Paster et al. 2001). For 25 μl reactions, the PCR mix contained 12.5 μl of PCR master mix 
(Promega), 1 μl of DNA template, and 0.5 μl of each forward and reverse primers at 50 μM.  
PCR thermal cycling parameters were an initial denaturation step of 95°C for 1 min, followed 
by 26 cycles of 94°C for 45 s, 50°C for 45 s and 72°C for 90 s (Thermocycler G-Storm, 
Somertone, UK). Amplicons were visualised by standard gel electrophoresis as described 
earlier (Chapter 2 section 2.3.6.2). 
3.3.3 MiSeq sequencing 
Sequencing of targeted bacterial 16S rRNA gene regions, was undertaken by Research and 
Testing Laboratory (Austin, USA) using the Illumina MiSeq. Bacterial primers (28F; 
GAGTTTGATCNTGGCTCAG and 388R; TGCTGCCTCCCGTAGGAGT). Sequences of 
approximately 250 base pairs, overlapping at the V4 region of the 16S rRNA gene were 
generated. 
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3.3.4 Phylogenetic identification and data analysis 
The 16S rRNA gene sequences were analysed using the bioinformatics software package 
Mothur (Kozich, 2013) and the MiSeq SOP Pipeline. 16S rRNA gene sequence reads were 
quality checked and normalised to the lowest number of reads in Mothur. To maintain 
normalisation and minimise artefacts, singletons and any Operational Taxonomic Units 
(OTUs), which were not found on more than 10 occasions in any sample were collated as 
OTU singletons and OTU_rare phylotypes. Using the Vegan package of the R statistical 
package (R Development Core Team, 2008), analysis was performed on the datasets 
contained within the files generated by Mothur (all OTUs were defined using a cut off value 
of 97%). The Unifrac weighted distance matrix was analysed in R using non-metric 
multidimensional scaling (NMDS) ordination and the shared OTU file was used to determine 
the number of times that an OTU was observed in multiple samples, and was used for 
multivariate analysis in R. OTU taxonomies (from phylum to genus) were determined using 
the RDP MultiClassifier script to generate the RDP taxonomy (Wang et al. 2007). Alpha and 
beta indices were calculated from these datasets with Mothur and R using the Vegan 
package. 
3.4 Results 
From the 12 participating patients, 34 samples were obtained (Table 3.2) with one dental 
plaque sample from each patient, 12 ETTs from 10 patients and 10 NBLs from 7 patients. 
There were samples from all three sites for 5 patients (P05, P10, P14, P20 and P21). The raw 
number of sequence reads was 2248956 and this was subsampled down to 9385 per sample.  
The number of OTUs was 127 for plaque, 125 for ETTs, and 83 for NBLs 
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3.4.1 Evaluation of diversity microbiome diversity between samples sites 
Chao, Shannon, and analysis of variance (ANOVA) were used to measure similarities in 
diversity of the whole microbiome of dental plaque, NBLs and ETTs. Analyses revealed no 
significant differences in the microbiomes at the three different sites (Shannon P=0.306, 
Chao P=0.685; (Figure 3.2). Although pairwise comparisons (P values adjusted using the 
Bonferroni correction) did show a statistical difference between the microbial communities 
of NBL samples compared with dental plaque (P=0.003) and ETTs (P=0.027). No significant 
difference was evident between ETT and dental plaque biofilm communities. NMDS was 
used to visualise the position of each sample’s community in a multidimensional space and 
showed overlaps between the microbial communities of dental plaque, NBLs and ETTs 
(Figure 3.3).  
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Table 3.2 Number of samples and number of days of mechanical ventilation at time of 
collection. 
  Number of samples 
Patient 
code 
Plaque NBL ETT 
P01 1 (6) 0 1 (10) 
P03 1 (7) 2 (3,6) 0  
P05 1 (4) 1 (3) 1 (5) 
P08 1 (12) 0 2 (13) 
P10 1 (4) 1 (3) 1 (11) 
P14 1 (3) 1 (1) 2 (2,4) 
P20 1 (3) 2 (1) 1 (8) 
P21 1 (6) 1(6) 1 (12) 
P24 1 (4) 0 1 (6) 
P25 1 (6) 0 1 (12) 
P27 1(8) 2 (7) 0 
P28 1 (2) 0 1 (3) 
    
 
Number in parenthesis indicates days of mechanical ventilation at time of sample collection, 
NBL indicates non directed bronchial lavage, ETT indicates endotracheal tube. 
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Figure 3.2 Diversity analysis for non-directed bronchial lavages (NBL), dental plaque and endotracheal tubes (ETT) using Chao and 
Shannon analyses. 
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 1 
Figure 3.3 Nonmetric multidimensional scaling analysis illustrating the position of microbial 2 
communities of dental plaque, non-directed bronchial lavages (NBL) and endotracheal tube 3 
biofilms (ETT). 4 
 5 
  6 
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3.4.3 Similarities between samples 1 
Similarities between samples were analysed using the Bray-Curtis index. A constructed 2 
dendrogram (Figure 3.4) showed identification of four major sample clusters, and each 3 
cluster contained dental plaque, ETT and/or NBL samples. There were eight sub-clusters of 4 
four pairs, where the microbial composition of dental plaque and either NBL or ETT from the 5 
same patient was indistinguishable (P28, P03, P24, P27). Moreover, the same level of 6 
similarity was observed for samples from different patients on 7 occasions, forming pairs 7 
between dental plaque and NBLs (N=2), dental plaque and ETT (N=1), ETT and NBL (N=1), 8 
and grouping same site samples from different patients NBLs (N=2) and ETT (N=1). One 9 
cluster of three ‘identical’ dental plaque samples (P10, P14, P20) and a further 4 pairs of 10 
closely related samples from the same patient were apparent. Interestingly, samples from 11 
all three sites for patients 21, 10 and 14 appeared distantly related. 12 
3.4.4 Bacterial composition  13 
Analysis of the most representative species was based on the 100 most abundant species, 14 
with 58.5% of species identified at a cut off value of 97%. Analyses of the first 20 species 15 
showed that overall, the most commonly detected species was S. aureus, followed by P. 16 
aeruginosa, S. pneumoniae and H. influenzae. Importantly all these species are potential 17 
respiratory pathogens. This group was followed with species normally associated with the 18 
urinary (Enterococcus hirae) and gastrointestinal (Shigella dysenteriae) tracts. The remaining 19 
13 species were typical oral microorganisms. 20 
 21 
 22 
 23 
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Figure 3.4 Bray Curtis dissimilarity dendrogram of sequences from dental plaque (P), non-directed bronchial lavage (N) and 
endotracheal tubes (T) 
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The top 100 species were further analysed per sample site. In dental plaque (Figure 3.5), S. 
pneumoniae was the most abundant species followed by E. hirae, (although most OTUs for 
this species originated from only one patient; P27) and Fusobacterium nucleatum, an oral 
microorganism recognised for its role in bacterial coaggregation. Importantly, the 
respiratory pathogens S. aureus and P. aeruginosa were also abundant in dental plaque 
samples. For ETTs, S. aureus, H. influenzae and S. pneumoniae were the three most abundant 
species, but the presence of oral microorganisms in these biofilms was also evident (Figure 
3. 6). Finally, in NBLs, and similar to the ETTs, typical oral species such as F. nucleatum, S. 
oralis and P. melaninogenica were detected (Figure 3.7). 
The top 20 species per individual patient was analysed by heat maps, and revealed that most 
microorganisms were simultaneously present in all available samples. Interestingly, in some 
cases (S aureus in P14, P20 and P21) the OTUs were higher in the NBL and/or the ETTs than 
in dental plaque (Figures 3.8 -3.10).  
An attempt was made to evaluate if antibiotic therapy at the start of the intubation period 
had an impact on the microbiome but no differences were found. Similarly dental plaque 
and gingival scores available from the toothbrushes/foam swabs trial (Chapter 5) had no 
impact on the colonisation of respiratory pathogens. 
From this cohort of patients three were admitted to the ICU with pneumonia (P03, P20 and 
P27) and two were diagnosed with VAP during the study (P21, 25) in accordance with the 
clinical pulmonary infection score (>6 points; Table 1.5) (Pugin 2002). The most abundant 
species found in ETT and/or NBLs are listed in table 3.3, all species were also found in dental 
plaque with lower OTU reads. 
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Figure 3.5 The 20 most abundant species in dental plaque 
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Figure 3.6 The 20 most abundant species in endotracheal tube biofilms (ETT). 
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Figure 3.7 The 20 most abundant species in non-directed bronchial lavages (NBLs).  
Not visible values start from 702 to 209 OTUs 
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Figure 3.8 Heat map for patient 14 shows shared species in the dental plaque, non-directed 
bronchial lavage (NBL) and endotracheal tube (ETT). Numbers indicate operational 
taxonomic unit reads. 
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Figure 3.9 Heat map for patient 20 shows shared species in the dental plaque, non-directed 
bronchial lavage (NBL) and endotracheal tube (ETTb). Numbers indicate operational 
taxonomic unit reads. 
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Figure 3.10 Heat map for patient 21 shows shared species in the dental plaque, non- directed 
bronchial lavage (NBL) and endotracheal tube (ETT). Numbers indicate operational 
taxonomic unit reads. 
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Table 3.3 Most abundant species in patients with diagnosed pneumonia. 
Patient Organism OTUs per site 
  
Plaque ETT NBL 
3 Pseudomonas aeruginosa 5 N/A 183678 
20 Staphylococcus aureus 62 4163 8437 
21* Staphylococcus aureus 357 3473 84145 
25* Haemophilus influenzae 176 94809 N/A 
27 Staphylococcus aureus 665 N/A 25114 
                 
Operational taxonomic unit (OTU) reads of the most abundant species found in endotracheal 
tubes (ETT) and /or, non- directed bronchial lavage (NBL). *Patients were diagnosed with 
ventilator-associated pneumonia during the course of the study. N/A: not applicable as no 
sample was analysed.  
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3.5 Discussion 1 
The colonisation of dental plaque and ETT biofilms by respiratory pathogens has been 2 
identified as risk factors for VAP in mechanically-ventilated patients (Fourrier et al. 1998; 3 
Sachdev et al. 2013; Scannapieco et al. 1992). VAP is an important nosocomial disease that 4 
prolongs hospital stay for up to 7 days, increases mortality rates and carries significant cost 5 
to the health care systems (Kollef et al. 2012; Melsen et al. 2013). 6 
Culture-dependant and independent approaches have shown the presence of respiratory 7 
pathogens in dental plaque and similarly, microbial species normally associated with the oral 8 
cavity have been detected in lower airways specimens and ETT biofilms (Cairns et al. 2011; 9 
Perkins et al. 2010; Vandecandelaere et al. 2012).  10 
The underlying hypothesis proposed for microbial aspiration to the lower airway is that 11 
subglottic secretions pool above the ETT cuff and subsequently leak past the cuff via 12 
microchannels created by folding of the cuff material. These secretions contain microbial 13 
components from the oropharynx and due to the forces of mechanical ventilation some of 14 
these will be drawn into the ETT lumen and form biofilms. If the secretions contain 15 
respiratory pathogens then this presents an imminent risk for the development of VAP. 16 
In these studies, next generation sequencing (NGS) has been used for the first time, to 17 
characterise the microbiota from three separate, but potentially associated sites within 18 
mechanically ventilated patients. The sites were the oral cavity (dental plaque samples), the 19 
lumen of the ETT and the lower airway (NBL samples). Samples were studied simultaneously 20 
to establish whether high levels of similarities existed in terms of microbiome in the samples.   21 
Metataxonomics is an NGS technique that allows characterisation of a microbial community 22 
through analysis of conserved and variable sequences of the bacterial 16S rRNA gene 23 
(Culligan et al. 2014; Marchesi and Ravel 2015). This culture-independent technique 24 
 138  
 
overcomes the shortcomings of culture, which relate to the failure to detect many 1 
microorganisms that are unculturable in vitro. Indeed, currently an estimated 50% of oral 2 
microorganisms are thought to be unculturable (Paster et al. 2001). Metataxonomics also 3 
avoids the need for a cloning step which was a necessity when analysing mixed species 4 
populations using the Sanger sequencing method (Didelot et al. 2012). 5 
The lower airways were previously deemed to be sterile until the development of molecular 6 
approaches. Now, multiple studies have reported that the lower airways microbiota is 7 
similar to that of the oropharynx and upper respiratory tract (Beck et al. 2015; Cui et al. 8 
2014). Prevotella and Veillonella species have also been reported amongst the most 9 
prevalent detected species accounting for >20% of OTUs (Hilty et al. 2010). 10 
Clearly, it is not possible to fully appreciate complex microbial communities without the use 11 
of culture independent methods, of which, metataxonomics offers the most advantages in 12 
terms of output, cost and effort. 13 
In these studies, samples (n=34) of dental plaque, NBLs and or ETTs were obtained from 12 14 
mechanically ventilated patients for analysis. It was not possible to obtain all samples 15 
simultaneously for a single patient, but given that biofilms develop over time, we did not 16 
consider this to be detrimental in our comparison of dental plaque and ETT biofilm 17 
communities. It could be argued that NBL samples might be more variable with temporal 18 
change, which could be regarded as a potential limitation to the study. Whilst 19 
metataxonomics have previously been used to characterise the microbiology in ETT biofilms 20 
(Vandecandelaere et al. 2012), dental plaque (Sands et al. 2016) and lavage samples (Yang 21 
et al. 2015), this represents the first study to simultaneously compare the microbiome from 22 
all three sites within a given patient.  23 
In the normal oral microbiome the Streptococcus genus, which comprises several key species 24 
(e.g. S. mitis, S. oralis, S. salivarius, S. sanguinis) is the most abundant (Dewhirst et al. 2010). 25 
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Interestingly, in the studied patient group, the most common OTU (153,665; Figure 3.5) in 1 
dental plaque belonged to S. pneumoniae which is the most common causative organisms 2 
for community acquired pneumonia (CAP) (AlonsoDeVelasco et al. 1995). High prevalence 3 
of S. pneumoniae in dental plaque is compatible with health, as was shown by a study 4 
comparing the dental plaque of healthy young, healthy elderly and elderly requiring nursing 5 
care (N=97), all groups had high prevalence of S. pneumoniae (60 to 77%) (Abe et al. 2001). 6 
This contrasts with another study on healthy independent elderly including 265 individuals 7 
in which the organism was not detected (Ogawa et al. 2012). Importantly, this organism is 8 
opportunistic by nature (Siegel and Weiser 2015) therefore it presents a risk for vulnerable 9 
groups as is the case for most patients in ICU. The species S. sanguis was the second most 10 
prevalent streptococcal OTU but this was noticeably lower than for S. pneumonia (5,322). Of 11 
particular note, was the detection of other respiratory pathogens in dental plaque including 12 
H. influenzae, S. aureus and P. aeruginosa. Not only were these species found in dental 13 
plaque, but they were also amongst the top 20 of the most abundant species and all patients 14 
had at least one of these species. These findings are similar to those previously reported by 15 
Sands et al. (2016), where NGS showed that 9/13 mechanically ventilated patients had >2 16 
respiratory pathogens in their dental plaque.  17 
Previous studies analysing the dental plaque of elderly institutionalised and critically ill 18 
patients using microbiological culture have also reported colonisation with respiratory 19 
pathogens (Abe et al. 2001; El-Solh et al. 2004; Sachdev et al. 2013). Even though these 20 
respiratory pathogens are frequently recovered from dental plaque by culture, reported 21 
incidence in mechanically ventilated patients varies from 26% to 60% when culture is used 22 
(Heo et al. 2008; Sachdev et al. 2013). These levels are much lower that the results from this 23 
work (100%), and emphasises the sensitivity of the NGS approach employed. A key outcome 24 
from these analyses was that dental plaque was confirmed to be a reservoir of respiratory 25 
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pathogens in these patients at risk of acquiring VAP. From this group of patients two patients 1 
were diagnosed with VAP, likely caused by S. aureus and H. influenzae, both of which were 2 
present in dental plaque as well as the ETT and NBL.  3 
In terms of species abundance, the NBLs from the studied patients were dominated by P. 4 
aeruginosa and S. aureus with 360,581 and 145,915 OTUs, respectively.  This result is 5 
comparable to a recent study where bronchial lavages and ETT aspirates from 120 suspected 6 
VAP patients were analysed by culture and real time PCR, the most common isolates were 7 
S. aureus, P. aeruginosa and H. influenzae (Clavel et al. 2016).   8 
The presence of oral species in the lower respiratory tract, whether they are normal 9 
inhabitants or transient colonisers could be significant as they may promote biofilm 10 
formation, in Chapter 4 of this thesis it was found that in the presence of S. mutans, S. aureus 11 
produced a more abundant biofilm and exhibited  enhanced expression of biofilm genes. In 12 
NBLs, amongst the top 20 species was Fusobacterium nucleatum, which is renowned as a 13 
large ‘bridging’ bacterium that co-aggregates with numerous other species of bacteria there 14 
by playing a role in biofilm stability (Shen et al. 2005). The presence of this species in the 15 
NBLs may promote respiratory pathogens to thrive in associated biofilms, further in vitro 16 
studies may demonstrate synergistic effects between F. nucleatum and respiratory 17 
pathogens. In a recent study involving 83 cases of CAP and 94 cases of healthcare-associated 18 
pneumonia (HCAP) , bacterial 16S rRNA genes in bronchial lavage samples were analysed 19 
using PCR, cloning and sequencing (Akata et al 2016). It was found that a higher percentage 20 
of oral streptococci were present in patients with aspiration risk, comorbidities or a previous 21 
history of pneumonia (Akata et al. 2016). 22 
Interestingly, E. hirae was amongst the top 5 species found overall, however this bacterium 23 
was only found in two patients, one of whom had very high OTU reads in their dental plaque 24 
(71730) and NBL (9808). This bacterium is mainly associated with disease in mammals and 25 
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birds and is considered a rare pathogen of humans (Larsson et al. 2014). However, there 1 
have been recent reports of urinary tract infections and severe bacteraemia caused by this 2 
species (Bourafa et al. 2015; Dicpinigaitis et al. 2015).  3 
Biofilms have been shown to develop in 80% of ETTs independently of the duration of 4 
mechanical ventilation (Feldman et al. 1999; Wilson et al. 2012). Such biofilms have been 5 
shown to possess complex structures that incorporate a fibrin network, blood cells, bacteria 6 
and yeast (De Souza et al. 2014). Importantly, ETT biofilms are an identified risk factor for 7 
VAP (Adair et al. 1999; Gil-Perotin et al. 2012).  8 
In this present study, the biofilms from 11 ETTs from 10 patients were analysed, and found 9 
to have a microbial diversity that generally correlated with dental plaque and NBLs. Of the 10 
top 20 species found in ETT biofilms, 10 and 12 species were also present in the top 20 of 11 
NBLs and dental plaque, respectively. Five of these species were amongst the top 20 species 12 
for all samples and these were S. aureus, S. pneumoniae, Prevotella melaninogenica, 13 
Mycoplasma salivarium and P. aeruginosa. The results support those previously reported by 14 
Cairns et al. (2011) which showed that of 24 ETTs analysed by Denaturating Gradiant Gel 15 
Electrophoresis (DGGE), a high microbial diversity was evident with an average of 6 bands 16 
present per ETT biofilm. Of note is that in DGGE, each band can represent more than one 17 
bacterial species (Zijnge et al. 2006). Additionally, with species-specific PCR, the key 18 
respiratory pathogens of S. aureus and P. aeruginosa, along with the oral microorganisms. 19 
S. mutans and P. gingivalis were detected in this study (Cairns et al. 2011). Similarly, Perkins 20 
et al. (2010) studied biofilms from 8 ETTs using both quantitative PCR and surveys of the 16s 21 
rRNA gene and reported that 70% of sequences belonged to genera commonly associated 22 
with the oral cavity. This study also highlighted that Streptococcus and Actinomyces species 23 
were found in 7 samples even though some ETTs had been in place for <24 h. Species of 24 
these two genera are primary colonisers in dental plaque and have proven co-aggregation 25 
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interactions (Palmer et al. 2003). In the group of patients presented in this chapter, members 1 
of the Actinomyces genus were detected in 10/12 plaque samples, 9/11 ETTs and one NBL. 2 
In neonatal ETT biofilms, Klebsiella, Streptococcus, and Pseudomonas are reported as being 3 
the most frequent bacterial genera (Li et al. 2015). In these investigations, it was proposed 4 
that the quorum-sensing AI-2 molecule, produced by K. pneumoniae and Streptococcus 5 
species could facilitate P. aeruginosa aggregation in ETT biofilms (Li et al. 2015). 6 
In this study, the microbial diversity between samples was similar.  It was evident, 7 
that when all community profiles were compared for 4 patients (P03, P24, P28, P27), the 8 
microbiome of either the ETT or the NBL had highest similarity to the dental plaque from the 9 
same patient. This would suggest that any inter-patient variation between dental plaque 10 
communities was on occasion, greater than the variation between different sample types 11 
from the same patient, demonstrating that the microorganisms were likely to have a 12 
common origin. Since the most microbiologically ‘diverse’ sample was dental plaque, it 13 
would not be unreasonable to suggest that that dental plaque represents the main reservoir 14 
of bacteria present in the other sample types. Also, the oropharynx is in constant exposure 15 
to the environment, and in hospitalised patients this may contribute to oral colonisation by 16 
pathogenic bacteria.  17 
Since the microbiome of the lower airways and ETTs was similar to that of dental plaque, 18 
there may be scope for VAP surveillance by sampling the mouth, instead of the lower 19 
airways. This would certainly be a less invasive procedure for patients in cases where VAP is 20 
not suspected.  21 
The oral health status of patients admitted into intensive care is generally poorer 22 
than that of the general population (Chapter 5; Table 5.7). For mechanically-23 
ventilated patients, oral hygiene tends to deteriorate with time (Fourrier et al. 24 
1998; Jones et al. 2011; Sachdev et al. 2013; Scannapieco 2006). Despite a greater 25 
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recognition that improving oral care can be a means of preventing infection as 1 
opposed to merely improving comfort (Dale et al. 2013), there remains a need to 2 
improve attitudes and protocols of oral care in mechanically-ventilated patients. 3 
As is evident in Table 3.2 the samples analysed in this study were not obtained on 4 
the same day. Simultaneous sample taking was not always possible; ETTs could only 5 
be obtained after extubation was clinically indicated. Similarly, NBLs were only 6 
obtained up to twice a week for non VAP suspected patients, therefore it was 7 
decided that whenever possible a “mid trial” plaque sample was to be analysed. 8 
Although it is possible this may present potential for error in inte rpretation, it was 9 
not considered detrimental for the investigation as similarities in the microbiome 10 
of the different sites were observed. However the timing of colonisation of dental 11 
plaque by respiratory pathogens was not an aim of this investigation an d cannot be 12 
concluded from its results.  13 
A limitation of this study is that in a small number of subjects there was great 14 
variability in age, clinical diagnosis, underlying medical conditions and exposure to 15 
antimicrobial agents. These variables are likely  to have an impact in the oral 16 
microbiome but could not be analysed independently ,a great higher number of 17 
patients would be required to factor these confounging factors.  18 
Another limitation of this present work was that the metagenomic analysis only 19 
involved bacteria, but of course viruses and yeast are also likely to co -exist in these 20 
samples. Also, although NGS offers high sensitivity, the method is not able to 21 
determine whether the bacteria are viable, which is of course determined by 22 
traditional culture, which also offers the advantage of being able to test isolates 23 
for their antibiotic sensitivity. 24 
 25 
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3.6 Conclusions 1 
 The microbiomes of dental plaque, NBL and ETT biofilms were similar in terms of 2 
their microbial diversity. It was noted that the similarities between samples from a 3 
given patient were higher than between the sample type of different patients.  4 
 Microorganisms traditionally regarded as members of the oral microbiome were 5 
frequently found in all sample types.  6 
 A high abundance of respiratory pathogens was evident in dental plaque, ETT and 7 
NBL. 8 
 These findings support the role of dental plaque as a reservoir for pathogens that 9 
disseminate to the lower airways and ETT biofilms. 10 
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4. Characterisation of in vitro 
endotracheal tubes biofilms 
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4.1 Introduction 
It is widely recognised that microorganisms primarily exist within biofilms, which are 
typically multi-species communities adhered to a surface and encased in extracellular 
polymeric substances (EPS) (O'Toole et al. 2000). Biofilm microorganisms are notably distinct 
from their equivalent free-living or planktonic counterparts. In these different growth types, 
differential gene expression has been reported (Jefferson 2004) with biofilm cells also 
frequently exhibiting higher (up to 1000 fold greater)  resistance to antimicrobials and host 
defences (Luppens et al. 2002). Cells within complex mixed species biofilms are effectively 
shielded against host defence mechanisms, whilst EPS is often attributed with impeding 
antimicrobial penetration by diffusion limitation and sequestration (Mah et al. 2003). 
Biofilms are known to instigate numerous human diseases, and are currently thought to be 
responsible for over 60% of human infections. Examples of such biofilm infections include 
chronic middle ear infections, chronic sinusitis, chronic otitis, and respiratory infections 
including ventilator-associated pneumonia (VAP), (Donlan and Costerton 2002).  
VAP is the most common nosocomial infection in patients receiving intensive care, and in 
terms of hospital acquired infections (HAIs) is second only to urinary tract infections in its 
prevalence. VAP has been proposed to account for more than half of the antibiotics 
prescribed in the intensive care unit (ICU) (Zilberberg and Shorr 2010). The high incidence of 
VAP combined with an attributable increased hospital stay and mortality (Melsen et al. 2013; 
Safdar et al. 2005) justify efforts aimed at increasing our understanding of the pathogenesis 
of this infection and the development of prevention strategies.  
The most common causative microorganisms for VAP are Pseudomonas aeruginosa (24%), 
Staphylococcus aureus (20%) Enterobacteriaceae (14%), Haemophilus species (10%), 
Acinetobacter species (8%) and Streptococcus species (8%) (Chastre and Fagon 2002). 
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One commonly attributed aetiological factor for the development of VAP is aspiration of 
oropharyngeal secretions into the lungs. In mechanically-ventilated patients, the 
endotracheal tube (ETT) facilitates gas exchange, however its presence impairs natural 
barrier defence mechanisms including the cough reflex and mucociliary clearance. Once the 
ETT is inserted, a polyvinyl chloride (PVC) balloon referred to as a cuff (Figure 1.2), is inflated 
to 1.5 to 2 times the diameter of the trachea in an attempt to seal the lower airways 
(Pneumatikos et al. 2009). However, as the cuff inflates the material folds, creating 
microchannels that allow passage of pooled oropharyngeal secretions above the cuff 
(Hamilton and Grap 2012). If these secretions contain respiratory pathogens, then there is a 
clear risk for subsequent infection. 
In institutionalised and hospitalised patients, a deterioration in oral hygiene occurs (Fourrier 
et al. 1998; Jones et al. 2011; Sousa et al. 2014) and it has been shown that the dental plaque 
can become colonised by respiratory pathogens (Binkley et al. 2009; Ewan et al. 2010). This 
phenomenon has also been reported in mechanically-ventilated patients, with P. 
aeruginosa, Acinetobacter species and S. aureus repeatedly being recovered from dental 
plaque and saliva in these patients (Sachdev et al. 2013; Sands et al. 2016b; Zuanazzi et al. 
2010). Indeed, this finding was also reported in Chapters 2 and 3 of this thesis. 
The presence of an ETT is an identified risk factor for VAP and a recent study reported an 
increased risk of VAP (RR 7.41, P < 0.001) for intubation periods exceeding 8 days (De Souza 
et al. 2014). The ETT also supports the growth of biofilms in its lumen and these biofilms 
have been observed in ETTs after as little as 12 h intubation (Adair et al. 1999). As the ETT 
biofilm is not exposed to the patient’s immune system or administered antibiotics, this 
biofilm provides a protected reservoir of pathogens (Bauer et al. 2002). In an observational 
study of 75 patients where ETTs and endotracheal aspirates were collected, respiratory 
pathogens were detected in both sample types (Gil-Perotin et al. 2012). Importantly, the 
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study reported that higher treatment failure and relapse (100% vs 29%, P = 0.021; 57% vs 
14%, P = 0.133) occurred when the causative organism was present in the ETT as well as the 
ETT aspirate (Gil-Perotin et al. 2012).  
Molecular studies of ETT biofilms have identified respiratory pathogens as well as oral 
microbes including species of Streptococcus, Lactobacillus, Candida and Porphyromonas 
(Cairns et al. 2011; Perkins et al. 2010). Perkins et al. (2010) showed that the most common 
bacterial genus found in ETT biofilms was Streptococcus and that 70% of the sequences 
found in biofilms were typical of the oral microflora. Similarly, a study using pyrosequencing 
to characterise 4 ETT biofilms showed a high diversity and prevalence of oral bacteria 
including Prevotella and Peptostreptococcus species (Vandecandelaere et al. 2012). 
Importantly, bacteria recovered from ETTs have also shown increased antibiotic resistance 
(Sands et al. 2016b). 
Oral microbes are known to be adept biofilm producers. This feature is illustrated by 
Streptococcus mutans which produces extracellular polysaccharides in the form of glucans, 
which allow it to firmly adhere to the smooth tooth surface (Kuramitsu et al. 2007). 
Streptococcus mutans also produces glucan binding proteins (i.e. GbpA, -B, -C and –D) that 
are thought to play important roles in subsequent cell-cell aggregation and biofilm 
development (Lynch et al. 2013). Therefore it is plausible that oral microorganisms could 
‘precondition’ the ETT with a biofilm that is conducive to colonisation by respiratory 
pathogens.  
 
4.1.1 Microbial interaction 
In polymicrobial biofilms, the intimate relationship in which microorganisms are spatially 
distributed means that interactions will inevitably occur. This may be through sharing of 
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metabolic end products between species, where the donor of the metabolite exhibits 
accelerated growth along with the recipient (Kouzuma et al. 2015). Additionally, microbial 
cells can display multiple phenotypes within a biofilm, and are able to interact with each 
other through quorum sensing (Burmølle et al. 2006). It is inevitable that interactions 
between respiratory pathogens and oral microorganisms will arise when both are present in 
the same biofilm.  
Multiple synergistic effects can occur from interactions in multispecies biofilms. One of these 
is the coaggregation of cells, an effect that has been studied frequently in dental plaque. In 
terms of shared metabolic products, the oral bacterial species Treponema denticola 
produces succinate and this facilitates growth Porphyromonas gingivalis in biofilms (Grenier 
1992). P. gingivalis is a primary coloniser of the subgingival tooth surface and confocal laser 
scanning microscopy (CLSM) of dental plaque has shown close proximity of T. denticola to P. 
gingivalis, rather than to the enamel, suggesting the later might facilitate T. denticola 
colonisation (Yamada et al. 2005). Similar relationships have been described between 
Streptococcus and Actinomyces species (Palmer Jr et al. 2003), and between Tannerella 
forsythia and Fusobacterium nucleatum (Sharma et al. 2005). Similarly, an increased biofilm 
streptococcal biomass has been shown to occur in an in vitro open flow cell system mucosal 
model in the presence of C. albicans. The underlying mechanism for this was deemed to be 
enhanced coaggregation, rather than growth stimulation (Diaz et al. 2012). 
In the case of respiratory pathogens, there is also evidence of bacterial interactions. An in 
vitro experiment showed a 26 and 106-fold increase in numbers of Acinetobacter baumannii 
and Pseudomonas aeruginosa, respectively, when cultured with Stenotrophomonas 
maltophilia. S. maltophilia is an opportunistic Gram-negative bacterium that colonises 
humid indwelling medical devices such as ETTs and urinary catheters (Chang et al. 2015) and 
unsurprisingly, is frequently linked to medical device infections (Varposhti et al. 2014).  
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Another phenomenon in mixed biofilms is conjugation, where physical contact between 
bacterial cells allows exchange of genetic material (also known as horizontal gene transfer) 
occurs, and it is thought to be facilitated by plasmid expressed factors that promote biofilm 
formation by planktonic bacteria (Ghigo 2001). 
Bacterial interaction can also result in antagonistic effects in biofilm growth due to the 
production of bacterial toxins (Leriche et al. 2003). In dual species in vitro biofilms of P. 
aeruginosa and C. albicans, P. aeruginosa can degrade the hyphal cell wall of C. albicans by 
release of phenazines, namely pyocyanin and 1-hydroxyphenazine, which are toxic to C. 
albicans (Harriott and Noverr 2011; Kerr et al. 1999). Hogan et al., (2004) demonstrated that 
P. aeruginosa was also able to kill C. albicans hyphae, through a process involving the 
homoserine lactone quorum-sensing molecule, 3-oxo-C12.  
4.1.2 Gene expression in biofilms 
Multiple in vitro studies reveal that microorganisms exhibit different gene expression when 
growing in a biofilm, compared to planktonic growth (Cvitkovitch et al. 2003; Jefferson 
2004). Such changes in gene expression allow bacteria to attach to surfaces, produce 
extracellular polymeric matrices and survive under limited nutrient content and suboptimal 
oxygen levels (Dotsch et al. 2012). Changes in gene expression also alter the virulence of 
microorganisms, for example, hyphal growth by C. albicans facilitates host tissue invasion 
and protects it from phagocytosis (Gow et al. 2012). The presence of certain microorganisms 
may influence both biofilm formation and virulence of other microbes. There are multiple in 
vitro and in vivo studies showing that oral streptococcal species including S. gordonii, S. oralis 
and S. mutans enhance the virulence of C. albicans (Bamford et al. 2009; Cavalcanti et al. 
2015; Diaz et al. 2012; Falsetta et al. 2014). It has also been proposed that excretion of 
lactate by streptococci provides a carbon source that promotes hyphal growth by C. albicans 
(Holmes et al. 1996; Jenkinson et al. 1990). Streptococcus sanguinis and Actinomyces species 
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can also influence virulence of C. albicans, through up regulation of genes encoding for 
secreted aspartyl proteinases (SAPs) and hyphal wall protein in in vitro biofilms (Cavalcanti 
et al. 2015). 
Staphylococcus aureus and C. albicans often co-exist in other biofilm infections including 
chronic wounds, intraperitoneal and lung infections. Interestingly, studies of 24 h in vitro 
biofilms comprising of both C. albicans and S. aureus on catheter discs, have demonstrated 
increased pathogenicity of S. aureus (Peters et al. 2010). Peters et al. (2010) found that 27 
proteins were up regulated in these dual species biofilms and these were mainly involved in 
growth, metabolism, or stress responses. Another study from the same group, used high 
resolution scanning electron microscopy (SEM) and fluorescence in situ hybridisation using 
peptide nucleic acid probes (PNA FISH) to show S. aureus attachment to C. albicans hyphae. 
This interaction appeared to relate to the C. albicans Als3 protein, as S aureus attachment 
was reduced in C. albicans mutants lacking this protein. Importantly hyphal attachment by 
S. aureus also aided invasion of epithelial cells by the bacterium (Peters et al. 2012b). 
As previously mentioned, P. aeruginosa and S. aureus are frequently involved in the 
development of VAP (Section 4.1 and Chapter 1 Section 1.3.4) and as such are a focus of this 
research. A selection of genes required for different stages of biofilm formation by P. 
aeruginosa and S. aureus are presented in tables 4.1 and 4.2. 
4.1.2.1 Gene expression in Pseudomonas aeruginosa biofilms 
Pseudomonas aeruginosa is a Gram-negative bacterium that is recognised as a major human 
pathogen and is frequently linked to nosocomial infections including VAP. Pseudomonas 
aeruginosa can adhere to abiotic surfaces, host tissues, and to each other and is considered 
an adept biofilm producer. Infections caused by P. aeruginosa are often difficult to treat due 
to increased antibiotic resistance (Obritsch et al. 2005; Vallet et al. 2001). 
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One important P. aeruginosa virulence factor is the production of alginate. Alginate is a 
viscous exopolysaccharide comprising of linked D-mannuronic and L-guluronic acid. Alginate 
production is associated with biofilm formation by P. aeruginosa, bacterial adherence, 
protection of cells against phagocytosis and the neutralisation of oxygen free radicals 
(Matsukawa and Greenberg 2004; Ramsey and Wozniak 2005). 
Alginate production is regulated by environmental factors through a response regulator 
involved in a signal transduction system, and by a gene cluster containing the sigma factor 
algU (Edwards and Saunders 2001). The algU gene is auto-regulated by the negative 
regulators mucA and mucB and inactivation of these regulators results in enhanced algU 
expression and alginate production (Edwards and Saunders 2001).  
Although alginate is the most important factor in P. aeruginosa biofilm formation, alginate-
independent biofilm formation occurs and is mediated by genes that increase levels of the 
non-alginate exopolysaccharide, Psl (Huse et al. 2013). 
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            Table .5.1 Selected Pseudomonas aeruginosa genes involved in different stages of biofilm formation. 
 
         
Biofilm stage Gene Function Reference 
Initial adhesion Type IV Pili 
Chaperone usher pathway (cup A, B, C) 
Twitching motility 
Assembly of fimbria 
(O'Toole and Kolter 1998) 
(Vallet et al. 2001) 
Attachment  cupA Adhesion to inert surfaces (Vallet et al. 2001) 
Coaggregation  Psl Cell to cell attachment (Jackson et al. 2004) 
EPS and maintenance of 
biofilm 
algA-algD operon 
Muc A, MucB 
Pel 
 
Alginate synthesis 
Regulates the algA-D operon 
Production of glucose matrix 
(Ramsey and Wozniak 2005) 
 
(Pulcrano et al. 2012) 
(Friedman and Kolter 2004) 
Maturation Rpo 
2070, 5033 
Adapt to environmental stresses 
Biofilm formation and antibiotic 
resistance 
(Schuster et al. 2004) 
(Zhang et al. 2013) 
Dispersal nirS 
bdlA 
Sensing of environmental clues and 
detachment 
Nitric oxide signalling  
(Morgan et al. 2006) 
(Barraud et al. 2009) 
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 Table 4.2 Selected Staphylococcus aureus genes involved in different stages of biofilm formation. 
             
Biofilm stage Genes Function Reference 
Initial 
adhesion   
MSCRAMMs 
(Microbial surface 
components recognizing 
adhesive matrix molecules) 
Bap 
Bind to fibrinogen or fibronectin 
 
 
 
Induce biofilm formation 
(Patti et al. 1994) 
 
 
 
(Cucarella 2001) 
Attachment  fnbA, fnbB 
 
AtLE, dltA, Bap 
 
Fibronectin binding proteins 
 
adhesion to polystyrene surfaces 
(Arciola et al. 2005) 
 
(Cucarella 2001; Hall-Stoodley 
et al. 2004) 
Coaggregation  
 
Agr 
Aap 
Quorum sensing 
Cell to cell adhesion 
(Yarwood and Schlievert 2003) 
(Conrady et al. 2013) 
EPS; biofilm 
maintenance 
IcaABCD 
icaR 
Polysaccharide intercellular adhesins (PIA) 
Environmental regulation, regulation of ica operon 
(Heilmann et al. 1996) 
(Conlon et al. 2002) 
Maturation Beta toxin Hlb Production of nucleoprotein matrix (Huseby et al. 2010) 
Dispersal luxS Reduces cell to cell adhesion (Mirani et al. 2013) 
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4.1.2.2 Gene expression in Staphylococcus aureus biofilms 
Staphylococcus aureus is a Gram-positive, coccus-shaped bacterium that is frequently 
associated with a wide variety of human infections including chronic wounds, respiratory 
tract infections (including VAP), bacteraemia, endocarditis and food poisoning (Lowy, 1998). 
In terms of gene expression, the agr system of S. aureus regulates production of several 
virulence factors that enable adaption to different stages of cell life e.g. the upregulation of 
cell-wall associated proteins during early stages of biofilm development (Pollitt et al. 2014). 
Based on autoinducing peptide specificity for the signal receptor agrC, strains can be 
classified into four specific agr groups (I-IV). Within a given group, each strain produces a 
peptide that can activate the agr response in the other member strains, whereas the 
autoinducing peptides produced by the different groups are usually mutually inhibitory 
(Shopsin et al. 2003). It appears that strains of a particular agr type would be related to a 
particular disease, e.g. group III to toxic shock syndrome, Group IV to exfoliative syndromes 
like staphylococcal scalded-skin syndrome, and group I to meticillin resistance and 
suppurative infections (Jarraud et al. 2002).  
Another important component of S. aureus biofilm development is expression of 
polysaccharide intercellular adhesin (PIA), which facilitates adhesion to a substrate and cell 
to cell adhesion (Heilmann et al. 1996; O'Gara 2007). PIA is a linear polysaccharide of β-1, 6-
linked glucosaminolglycans and its production is regulated by the ica locus. The locus is 
comprised of 4 intercellular adhesion genes (icaA, icaB, icaC and icaD) and one regulator 
gene, icaR (Figure 4.1) (Cafiso et al. 2004; O'Gara 2007). IcaA produces an N-
acetylglucosamine transferase, icaB encodes a signal peptide that is secreted into the 
medium, and icaC and D encode membrane proteins (O'Gara 2007).  
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4.2 Objectives 
Although co-occurrence of respiratory pathogens and oral bacterial species in biofilms has 
been reported in multiple clinical studies, including those of the oral cavity and respiratory 
tract, the effect that the two microbial types exert on each other has not been characterised. 
The research in this chapter will address this for specific aspects relating to virulence and 
biofilm development. Specifically the research aims to: 
 Assess synergistic/antagonistic effects of oral microorganisms on respiratory 
pathogens in in vitro biofilms. 
 Ascertain the spatial location and interaction between oral microorganisms and 
respiratory pathogens in mixed species biofilms. 
 Determine the effects of oral microorganisms on the expression of respiratory 
pathogen virulence factors.
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Figure 4.4.1 Schematic despiectionof the ica dependant biofilm mechanism in Staphylococcus aureus.  
The green arrows indicate a positive regulatory pathway and the white arrow is the negative regulatory effect of ica R locus. Production 
of the polysaccharide intercellular adhesion (PIA) and polymeric N-acetyl-glucosamine (PNAG) are mediated by the ica operon. Adapted 
from (O'Gara 2007). 
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4.3 Materials and Methods 
4.3.1 Microorganisms and culture conditions 
Reference strains of target microorganisms that were representative members of the oral 
microflora (S. mutans, P. gingivalis and C. albicans) and known VAP pathogens (S. aureus and 
P. aeruginosa) (Table 4.3) were used in these experiments. The identity of the reference 
strains was confirmed through PCR-mediated 16S rDNA sequencing. Sequences were 
identified using the Basic Alignment Search Tool (BLAST) from the National Centre for 
Biotechnology Information (NCIB) as previously described in Chapter 2 (Section 2.3.6.3). 
Culture media was obtained from Lab M (Burry, UK) unless otherwise stated. Bacterial 
species were initially grown on blood agar (BA) for 48 h, except for the anaerobic oral 
bacterium P. gingivalis, which was cultured for a minimum of 4 days anaerobically on 
Fastidious Anaerobe Agar (FAA), and the yeast C. albicans, which was grown on Sabouraud 
dextrose agar (SDA).  
4.3.2 Growth of in vitro biofilms in ETT sections 
A 20-ml volume of fastidious anaerobe broth (FAB) was inoculated with a loop-full of each 
microorganism for 18 h at 37°C. Porphyromonas gingivalis cultures were incubated 
anaerobically for 48 h. A standardised (McFarland 0.5 turbidity) inoculum was generated 
from which serial decimal dilutions were prepared in Phosphate Buffered Saline (PBS). The 
diluted preparations were spiral-plated on BA, FAA or SDA using a Whitley Automated Spiral 
Plater (WASP) system (Don Whitley Scientific, Shipley, UK) as described above. This enabled 
determination of the numbers of viable cells in the inoculum. 
Three sterile cylindrical (1 cm x 8 mm) lengths of ETT were placed in a universal container 
with 1 ml of the prepared inoculum and 9 ml of FAB.  
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                                Table 4.3 Test microorganisms used for in vitro ETT biofilm formation. 
Species Source Strain 16S sequence identity 
Candida albicans American Type Culture Collection 90028 99% 
Streptococcus mutans Deutsche Sammlung von Mikroorganismen 
(DSM; German collection of microorganisms 
and cultures) 
20523t 97% 
Porphyromonas 
gingivalis 
National Collection of Type Cultures 11834 99% 
Staphylococcus aureus National Collection of Industrial Bacteria 9518 96% 
Pseudomonas 
aeruginosa 
American Type Culture Collection 15682 98% 
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Three separate experimental conditions were used: 
1. Mixed biofilms comprising of all test strains and incubation for 5 d. 
2. Dual species biofilms, where single species biofilms of S. mutans, C. albicans or P. 
gingivalis were first generated by incubation for 5 d, followed by addition of a VAP 
pathogen and further incubation for 5 d.  
3. Single species biofilms, served as controls for mixed and dual species biofilms and 
were incubated for 5 days. 
Culture medium was replenished every 24 h to ensure constant nutrient availability and 
waste removal. After incubation, the broth was discarded and the three ETT sections were 
rinsed (×3) in sterile PBS and processed for culture analysis, fluorescent in situ hybridisation 
(FISH), Gram staining, and scanning electron microscopy (SEM). 
4.3.2.1 Culture analysis 
Using a dry sterile cotton swab, the biofilm was scraped from the lumen of the ETT and 
placed in 10 ml of PBS. The cotton swab was then agitated by vortex mixing in PBS for 5 s 
and 10-fold serial dilutions of the recovered biofilm cells prepared. From these dilutions, 50 
µl was spiral-plated on to selective culture media for the species of interest i.e. FAA for P. 
gingivalis, SDA or CHROMagar® Candida (CHROMagar, Paris, France) for C. albicans, Mitis 
Salivarius Bacitracin agar (MSB; Difco, BD, Oxford, UK) for S. mutans, mannitol salt agar 
(MSA) for S. aureus, and Pseudomonas aeruginosa agar (PsA) for P. aeruginosa. Agars were 
incubated under appropriate gaseous conditions for up to 7d. Enumeration and colony 
identification of isolates from the plates was performed after 24 h for P. aeruginosa, 48 h 
for C. albicans, S. aureus and S. mutans and 7 d for P. gingivalis. 
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4.3.2.2 Preparation of ETT sections for light microscopy 
ETT sections were placed in 35 mm tissue culture dishes (Lennox, Dublin, Ireland) and 
covered with 2% (w/v) agarose (Sigma, Poole, UK) to stabilise the biofilm. Once the agar had 
solidified, excess agarose was trimmed and the ETT sections immersed in 2% (v/v) 
paraformaldehyde for at least 24 h prior to embedding in paraffin wax and processing using 
standard histological techniques. Sections (20 µm thickness) were prepared from these ETT 
by Ms Kath Allsopp (Oral pathology, School of Dentistry, Cardiff University). 
4.3.2.3 Fluorescent in situ hybridisation (FISH) 
Biofilm cells on sections were stained using peptide nucleic acid (PNA) probes (Table 4.4) 
and analysed using confocal laser scanning microscopy (CLSM). Validation of PNA probe 
specificity was initially undertaken using planktonic cells of the reference strains. The 
method was as previously described by O’Keefe et al. (2001) and included some 
modifications (Malic 2008). Porphyromonas gingivalis was cultured in FAB, whilst S. mutans, 
S. aureus and P. aeruginosa were grown in Brain Heart Infusion (BHI; Oxoid, Hampshire, UK) 
and C. albicans in Sabouraud dextrose broth (SDB). All these species were incubated 
overnight at 37°C. Porphyromonas gingivalis was cultured anaerobically for 48 h. 
A 1-ml volume of broth was pelleted by centrifugation (9,600 x g, 5 min) and re-suspended 
in PBS. Cell suspensions were re-centrifuged and suspended in PBS with 4% (w/v) 
paraformaldehyde (Sigma) and fixed for 1 h. The fixed cells were rinsed in PBS and re-
suspended in 50% (v/v) ethanol and incubated for at least 30 min at -20°C.  
A 100-µl volume of fixed cells was pelleted by centrifugation and the pellet was rinsed with 
PBS. The cells were then suspended in 100 µl of hybridisation buffer (25 mM Tris-HCL, pH 
9.0; 100 mM NaCl; 0.5% (w/v) SDS) containing 150 to 500 nM of PNA probe. For S. aureus 
and S. mutans, incubation in 10 mg/ml of lysozyme (Grade VI from chicken egg white, Sigma) 
was performed prior to incubation with the probe. Additionally, formamide (Sigma) 30% 
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(w/v) was added to the hybridisation buffer containing the PNA probe specific for S. aureus 
and S. mutans. 
The re-suspended cells in hybridisation buffer were incubated for 15 to 90 min at 55°C 
depending on the species. Cells were then centrifuged (13,000 x g) for 5 min and re-
suspended in 500 µl of wash solution (10 mM Tris pH 9.0, 1 mM EDTA), incubated for 10 min 
and pelleted by centrifugation. This was procedure was repeated on a further two occasions. 
After the last wash, cells were re-suspended in 100 µl of wash solution and 5 µl of the cell 
suspension spread on a clean HistoBond®-coated microscope slide (Raymond A Lamb, UK) 
and allowed to dry. Vectashield® (Vector ltd, Orton Southgate, UK) mounting medium (2 µl) 
was applied to the specimen and the preparation was overlaid with a coverslip. The coverslip 
was sealed using nail varnish. 
For in vitro biofilms, the paraffin embedded sections were de-waxed by gentle washing with 
xylene for 5 min, followed with absolute ethanol for 2 min and distilled water for 2 min; this 
process was performed twice. Sections were treated with 100 µl of lysozyme (10 mg/ml) and 
incubated for 30 min at 37°C, followed by a brief rinse with wash solution, which had been 
pre-warmed at 55°C. Then, a 150-µl volume of hybridisation buffer containing PNA probes 
was added and the sections placed in a dark humidified chamber and incubated for 90 min 
at 55°C. Sections were then suspended in wash solution with a magnetic stirrer for 30 min 
at room temperature, after which they were air dried prior to 2 µl of Vectashield® (Vector 
Laboratories, Peterborough, UK) being added and overlaid with a coverslip as described 
above. 
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Table 4.4 Peptide nucleic acid (PNA) probes used for fluorescent in situ hybridisation (FISH). 
Probes Target Nucleotide sequence 
(5’→3’) 
Fluorescent 
label 
nM * References 
Bac-Uni1 Bacterial 
Universal  
OO-CTGCCTCCCGTAGGA CY3 150 (Perry-O'Keefe et al. 2001) 
Psaer P. aeruginosa OO-AACTTGCTGAACCAC FITC 300 (Coull and Hylding-Nielsen, 2003) 
Sta 16S03 S. aureus OO-GCTTCTCGTCCGTTC CY5 500 (Perry-O'Keefe et al. 2001) 
Mut590 S. mutans OO-ACT-CCA-GAC-TTT-CCT-
GAC 
Alexa 405 300 (Thurnheer, Gmür et al. 2001) 
Candida C. albicans  ACAGCAGAAGCCGTG FITC 300 (Oliveira et al. 2001) 
* Working concentration (nM)  
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4.3.2.4 Confocal Laser Scanning Microscopy (CLSM) 
CLSM was accomplished with the assistance of Dr Anthony Hayes (School of Bioscience, 
Cardiff University). The stained sections were viewed using a Leica TCS SP2 AOBS spectral 
confocal microscope (Leica; Wetzalar, Germany) and scanning with the appropriate 
excitation laser lines for the fluorescent labels of each probe. 
Single and mixed cultures of planktonic microorganisms were analysed with multiplex probe 
staining. For multichannel recordings, fluorochromes were scanned sequentially to 
eliminate spectral overlap.  
4.3.2.5 Gram staining 
ETT sections were de-waxed as described above and the microscope slides were flooded 
with 1% (v/v) crystal violet for 2 min. Followed by brief washing with distilled water, slides 
were flooded with 3% (v/v) Lugol’s iodine for 2 min sections decolourised with 100% acetone 
for 2s, rinsed with distilled water and flooded with 1%(v/v) carbol-fushin as counterstain for 
2 min, washed with distilled water and air dried. Sections were viewed using light microscopy 
(Cark Zeiss Ltd, UK). 
4.3.2.6 Scanning electron microscopy  
Sections were left in 9 ml of FAB, and for fixation of the biofilms 1 ml of 25% glutaraldehyde 
(to give final concentration of 2.5% v/v) was added and incubated at room temperature for 
24 h. Samples were then transferred for microscopy in the medical microscopy unit of the 
School of Medicine (Cardiff University) and imaging was achieved with the assistance of Dr 
Jan Hobot. 
Sections were washed in increasing concentrations of ethanol (50%, 70%, 90% and 100%) 
for 5 min each, then washed (3) with hexamethyldisilazane and air dried overnight. Self-
adhesive carbon tabs (25 mm diameter, G3348N, Agar Scientific) were placed onto an 
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aluminium stub and the ETT sections were then placed onto the tabs and sputter coated 
with gold for 8 min. The sections were viewed using a JEOL 840A SEM operated at 5 kV and 
a working distance of 12 mm. Digital images captured using SIS software at screen 
magnifications of x100. 
4.3.3 Preparation of in vitro biofilms for gene expression analysis 
4.3.3.1 Formation of biofilms in ETT sections 
Biofilms were initially grown on ETT sections with media and culture conditions identical to 
those previously described (section 4.3.2). To optimise biofilm quantities and subsequent 
RNA yields, different ETT section lengths (1, 3, 6 and 12 cm of an 8 mm diameter ETT; 
Portex®, Smiths Medical, Kent, UK) were used.  
4.3.3.1.1 Biofilms grown in 6-well plates  
In vitro biofilms were also developed in 6-well plates with shorter incubation times in an 
attempt to increase RNA yields. The principle of the biofilms grown on ETT sections were 
maintained, however P. gingivalis was not included in these experiments. Bacteria were 
initially cultured aerobically at 37°C for 24 h on BA, and SDA was used for C. albicans. 
One to 3 colonies of each microorganism were used to separately inoculate 10 ml of BHI, 
which was incubated aerobically and statically overnight at 37°C. Turbidity of the broth 
containing each microorganism was then standardised between 0.8 to 1.0 OD at 600 nm 
(Implen, Geneflow) and then diluted 10-fold in BHI to give approximately 107 CFU/ml. A 3-
ml volume of this inoculum was added to the wells of tissue culture plates (9.5 cm2 area per 
well; Starsted, Leicester, UK), which were incubated without agitation at 37°C for 24 h.  
Single species biofilms incubated for 24 h were used as controls for mixed and dual species 
biofilms. Mixed biofilms, included all test strains incubated for 24 h. Dual species biofilms, 
involved initial development of a 24 h single species biofilm (S. mutans or C. albicans) and to 
   
166 
  
this, a VAP pathogen was added and incubated for a further 24 h Figure 4.2 illustrates the 
protocol followed for these biofilms 
For mixed species biofilms, all microorganisms were prepared in BHI as above and then 
added together in equal volumes prior to inoculation of the tissue culture wells and 24 h 
incubation at 37°C. For dual species biofilms, the first 24 h of biofilm growth was either with 
single species of S. mutans or C. albicans. After this time, the broth was removed and a 3-ml 
volume of BHI with either S. aureus or P. aeruginosa was introduced gently to avoid 
disruption of the existing biofilm. This preparation was then incubated for a further 24 h. 
4.3.3.2 Recovery of biofilms on ETT sections 
Biofilm recovery was initially performed as described earlier for culture analysis (section 
4.3.2.1). The method was later modified to replace the cotton swab with a sterile 25 cm cell 
scraper (Starsted, Newton, USA) to recover the biofilm from the ETTs whilst immersed in 3 
ml of PBS in 35-mm tissue culture dishes (Iwaki® Sterling, Billingham, UK). Resuspended 
biofilms were transferred to a universal container and centrifuged at 4000 rev/min for 13 
min (IEC CL 10, Thermo scientific), the supernatant was discarded and the biofilm cells 
resuspended in 2 ml of RNA Bacteria Protect® (Qiagen, Manchester, UK), vortex mixed for 
10 s and incubated at room temperature for 5 min. After this treatment, the preparation 
was centrifuged (10,000 rev/min for 5 min; IEC CL 10, Thermo scientific), the supernatant 
discarded and the biofilm pellets were either frozen at -80°C or immediately processed for 
RNA extraction.  
 
   
 
  
1
6
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Figure 4.4.2 Schematic of in vitro biofilm protocol for gene expression analysis. 
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4.3.3.3 Recovery of biofilms from 6-well tissue plates 1 
After incubation, broth was removed from the wells which were then gently washed with 3 2 
ml of ice cold PBS. One-ml of RNA Bacteria Protect® (Qiagen) was placed in each well and a 3 
sterile cell scraper (Starsted) was used to disrupt the biofilm. Biofilm was resuspended by 4 
pipetting, vortex mixed and incubated for 5 min at room temperature followed by 5 
centrifugation at 6000 rev/min for 5 min (Heraeus PICO 27, Thermoscientific). The 6 
supernatant was discarded and the biofilm pellets stored at -80°C. 7 
4.3.4 RNA extraction from in vitro biofilms 8 
4.3.4.1 Cell lysis 9 
For all protocols, an initial enzymatic disruption was performed. Frozen bacterial cells were 10 
thawed at room temperature prior to being suspended and vortex mixed in either 100 µl or 11 
200 µl of Lysing buffer (LTE) (10 mM Tris-HCL; 1 mM EDTA; 10 mg/ml lysozyme, pH 8.0). For 12 
samples containing S. aureus, LTE buffer was supplemented with 200 µg/ml of lysostaphin 13 
(Sigma, Dorset, UK). Samples were then incubated with shaking (250 to 300 rev/min, RT, 90 14 
min, Stuart, SI500). RNA extraction protocols were then performed as described below.  15 
4.3.4.2 Qiagen RNA extraction protocol 16 
The manufacturer’s (Qiagen) recommended protocol for total bacterial RNA extraction was 17 
followed using the RNeasy®mini kit. In brief, to the initial lysate, 350 µl of RTL buffer 18 
(containing 10µl/ml of β-mercaptoethanol) was added and vortex mixed for 5 s before 19 
transferring into a Pathogen Lysis Tube® (Qiagen) with small glass beads. Biofilm cells were 20 
homogenised twice for 30 s using a Mini-Bead Beater (Stratech Scientific Ltd., Soham, 21 
UK).After cell disruption, the lysate was transferred to a clean 1.5 ml tube containing 350 µl 22 
of absolute ethanol (molecular grade; Sigma). The ethanol/lysate mix was then transferred 23 
to an RNAeasy column and centrifuged (10000 rev/min, 1 min; Heraeus PICO 27, 24 
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Thermoscientific). The flow-through was discarded and 350 µl of buffer RW1 added followed 1 
by centrifugation (10.000 rev/min, 1 min). The flow-through was again discarded and 80 µl 2 
of DNase 1 incubation mix (10 µl of DNase stock solution; 70µl of buffer RDD; Qiagen) was 3 
applied to the column membrane for DNA digestion and incubated (RT, 15 min). A 350-µl 4 
volume of RW1 buffer was added and incubated at room temperature for 5 min. After 5 
incubation, the column was centrifuged (10.000 rev/min, 1 min) and the flow through 6 
discarded. The membrane was washed twice by adding 500 µl of RPE buffer followed by 7 
centrifugation (10.000 rev/min, 1 min). The column was dried by centrifugation (10.000 8 
rev/min, 1 min) before adding 30 µl of RNase free water to elute the RNA. The column was 9 
then placed in a clean collection tube and centrifuged (10.000 rev/min, 1 min) and this step 10 
was repeated using the RNA eluate to increase yield. Modifications of this method included 11 
addition of 100 µl of Proteinase K (Qiagen) to 1 ml of the LTE buffer; changing the enzymatic 12 
lysis incubation from 90 min RT to 30 min at 37°C in parallel samples; and the exclusion of 13 
glass beads. 14 
4.3.4.3 Trizol RNA extraction protocol 15 
To the initial lysate, 500 µl of TRIsolate reagent (NBS Biologicals, Cambridgeshire, UK) was 16 
added and mixed. The mix was homogenised using a tissue homogeniser (T 8 ULTRA-17 
TURRAX® IKA®-WERKE, Staufen, Germany) for 10 s and incubated for 5 min at room 18 
temperature. The preparations were then centrifuged (12.000 × g for 10 min at 4°C) to 19 
remove any insoluble material like extracellular membranes, polysaccharides, and high 20 
molecular mass DNA. The clear supernatant was transferred to a clean 1.5 ml 21 
microcentrifuge tube, and a 100-µl volume of chloroform (>99%; Sigma) added. The 22 
preparation was vortex mixed for 15 s and incubated (15 min, room temperature). A phase 23 
lock gel microfuge tube (5 Prime, Hilden, Germany) was initially centrifuged (12.000 x g, 24 
room temperature, 30 s) to remove the gel, and the above preparation added and 25 
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centrifuged (12.000 x g, 4°C, 15 min). The upper aqueous phase containing RNA was 1 
transferred to a clean tube to which a 250-µL volume of 2-propanol (Fisher Scientific, 2 
Loughborough, UK) was added and vortex mixed. The preparation was then incubated for 3 
10 min at room temperature and centrifuged (12.000 × g, 4°C, 10 min). The supernatant was 4 
discarded and the RNA pellet washed with 1 ml of 75% (v/v) ice cold ethanol prepared with 5 
nuclease free water and centrifuged (7.500 × g, 4°C, 5 min). The supernatant was discarded 6 
and the RNA pellet air dried for 15 min. To re-suspend the RNA, 30 µl of RNAse free water 7 
was added and the suspension incubated in a water bath (Grant, Shepreth, UK; 60°C, 15 8 
min). 9 
4.3.4.4 Combined Phenol/Qiagen RNA Protocol. 10 
To the initial lysate, 350 µl of RLT buffer (containing 10µl/ml of β-mercaptoethanol) was 11 
added and this was vortex mixed for 15 s. To the mixture, 500 µl of 12 
phenol:chloroform:isoamyl alcohol (25:24:1 saturated with 10 mM Tris pH 8.0, 1 mM EDTA; 13 
Sigma) was added, mixed and transferred to a Pathogen Lysis Tube®(Qiagen) which 14 
contained small glass beads. The preparation was then disrupted in a Mini-Bead Beater 15 
(Stratech Scientific Ltd) for 1 min at maximum speed. Preparations were centrifuged (11.000 16 
x g, room temperature, 5 min) and the upper aqueous transparent phase transferred to a 17 
1.5 ml tube containing 700 µl of absolute ethanol, mixed and incubated (-20C, 15 min) to 18 
precipitate RNA. The lysate was transferred to an RNAeasy column and centrifuged (11.000 19 
x g, 1 min). The flow-through was discarded, and any residual DNA removed by addition of 20 
80 µl of DNase 1 incubation mix (10 µl of DNase stock solution; 70µl of buffer RDD; Qiagen) 21 
to the column membrane and incubation (room temperature, 30 min). After this step, 350 22 
µl of RW1 buffer was added for 5 min and then centrifuged (11.000 x g, 1 min). Wash steps 23 
with RPE buffer and RNA elution were performed as described earlier (Qiagen protocol) and 24 
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the RNA then resuspended in a 25-µl volume of nuclease free water. This method was also 1 
undertaken without the use of glass beads. 2 
4.3.4.5 Quality, quantification and storage of RNA 3 
The quantity of RNA in the eluates was measured using a spectrophotometer (Nano-VueTM, 4 
GE healthcare) and the A260/A280 ratio confirmed to be of ≥1.7. To check integrity of RNA 5 
extracts, visualisation of RNA following electrophoresis was also performed. Using this 6 
approach, intact RNA would show as two clear rRNA (28S and 18S) bands. For 7 
electrophoresis, an aliquot of approximate 500 ng of RNA was loaded into 1.5% (w/v) 8 
agarose gels prepared in 0.5  Tris-Borate-EDTA (TBE; 0.1 M Tris Base; 0.09 M Boric Acid; 0.1 9 
mM EDTA) buffer and stained with Safeview® (NBS biologicals; Huntingdon, UK). Gels were 10 
run at 70 V/cm2 for 1 h and visualised under UV light using a GelDoc system (Bio-Rad). 11 
Extracted RNA was stored at -80°C. 12 
4.3.4.6 Removal of DNA from RNA extracts 13 
Elimination of genomic DNA from RNA extracts was necessary to avoid interference with 14 
expression analysis. To remove DNA, the RQ1 RNase-Free DNase (Promega) protocol was 15 
followed using the manufacturer’s instructions. Reactions included 1 µg of RNA, 7 µl of 16 
water, 1 µl of RQ1 DNase and 1 µl of buffer (×10) within a PCR tube. Reactions were 17 
incubated at 37°C for 30 min, after which 1 µl of the provided ‘Stop solution’ was added. The 18 
mixture was then incubated in a water bath for 10 min at 65°C to deactivate the DNase 19 
activity. Treated samples were then immediately subjected to reverse transcription. 20 
4.3.5 Preparation of cDNA libraries  21 
All reagents used to prepare cDNA were obtained from Promega. A total of 1 µg of RNA was 22 
used for reverse transcription and this involved a two-stage process. Firstly, to 1 µg of RNA, 23 
50 ng of random primers were added along with RNase free water to make a final volume of 24 
  
172 
 
15 µl. The mixture was briefly centrifuged and incubated at 70°C for 30 min. Preparations 1 
were then rapidly cooled on ice. The mixture was then incorporated to a ‘master mix’ 2 
containing 10 mM of dNTPs, 25 U of RNAsin, 1 µl of M-MLV enzyme, 5 µl of M-MLV reaction 3 
buffer (×5) and 2 µl of water, to generate a total volume of 25 µl. The mixture was incubated 4 
at 37°C for 1 h, and then cooled to 4°C, prior to storage at -20°C. Before use cDNA was diluted 5 
1:5 in nuclease free water.  6 
4.3.6 PCR on cDNA libraries 7 
PCR targeted six virulence genes for P. aeruginosa, these included genes involved in 8 
adhesion (cupA) alginate synthesis (algD, mucA, mucB ) and biofilm formation and 9 
antimicrobial resistance (2070, 5033) (Edwards and Saunders 2001; Mah et al. 2003; Zhang 10 
et al. 2013). The constitutively expressed gene encoding the 50S ribosomal protein L21 (rplU) 11 
was used as housekeeping control (Mah et al. 2003) (Table 4.5). Similarly for S. aureus genes 12 
related to adhesion (fnbA), polysaccharide intercellular adhesins (PIA) production (icaC, icaR, 13 
icaB, icaA), quorum sensing (AgrI) (Atshan et al. 2013; Cafiso et al. 2004; Malic 2008; Shopsin 14 
et al. 2003) and the 16S gene was used as control (Table 4.6). 15 
PCR volumes were 20 μl and included 2 μl of each forward and reverse primers at 3 μM, 10 16 
μl of Primer design MasterMix® and 5 μl of the diluted cDNA template. 17 
PCRs were performed in a real-time PCR instrument (ABI 7000 prism or QuantStudio ®6 Flex; 18 
Applied Biosystems). Cycling conditions included an initial denaturation step (95°C ;2 min) 19 
followed by 40 cycles of denaturation (95°C ;15 s), annealing (55°C ;30 s) and extension 20 
(72°C; 30 s). All reactions were undertaken in triplicate for three biofilms prepared on 21 
separate occasions resulting in a total of 9 biofilms being analysed.   22 
  
173 
 
Table 4.5 Primers used to amplify virulence factors and control gene for Pseudomonas 1 
aeruginosa. 2 
Gene Primer sequence Reference 
rplU 
(housekeeping) 
F: 5'-CGCAGTGATTGTTACCGGTG-3' 
R: 5'-AGGCCTGAATGCCGGTGATC-3' 
(Mah et al. 2003; 
Palmer et al. 
2007b) 
cupA1 F: 5'-CATGCGCAGTGGTATTGGCCTTTG-3' 
R: 5'-GAACAGGGTGGTGAAATGCTCGTC-3' 
(Mah et al. 2003) 
algD F: 5'-GCGACCTGGACCTGGGCT-3' 
R: 5'-TCCTCGATCACGGGGATC-3' 
(Edwards and 
Saunders 2001) 
mucA F: 5'-GGAAACTCTGTCCGCTGTGATGGA-3' 
R: 5'-GGCTCGCGGTGCATGACG-3' 
(Edwards and 
Saunders 2001) 
mucB F: 5’GCTGCCGACGCTTCCGACTGGCT-3' 
R: 5'-CGCTGTCCACGCGATGCC-3' 
(Edwards and 
Saunders 2001) 
5033 F: 5’GGCGTTCTGGTAGGAACCTG-3’ 
R: 5’AGACCACGTTGCCGAAGCTG-3’ 
(Zhang et al. 2013) 
2070 F: 5’CTCCGCGGTGGATCTCAACA-3’ 
R: 5’GTCGAAGCGGCCTTCGTTCA-3’ 
(Zhang et al. 2013) 
 3 
   4 
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Table 4.6 Primers used to amplify virulence factors and control genes for Staphylococcus 1 
aureus. 2 
 3 
  4 
Gene Primer sequence Reference 
16S 
(housekeeping) 
F 5'-GGGACCCGCACAAGCGGTGG-3' 
R: 5'-GGGTTGCGCTCGTTGCGGGA-3' 
(Atshan et al. 2013) 
agrI F: 5'-ATGCACATGGTGCACATGC-3' 
R: 5'-GTCACAAGTACTATAAGCTGCGAT-3' 
(Shopsin et al. 2003) 
icaB F: 5'-CACATACCCACGATTTGCAT-3' 
R: 5'-TCGGAGTGACTGCTTTTTCC-3' 
(Malic 2008) 
icaAb F: 5'-CGCACTCAATCAAGGCATTA-3' 
R: 5'-CCAGCAAGTGTCTGACTTCG-3' 
(Malic 2008) 
icaRa F: 5'-CCAAATTTTTGCGAAAAGGA-3'  
R: 5'-TACGCCTGAGGAATTTTCTG-3' 
(Malic 2008) 
IcaC F: 5'-CTTGGGTATTTGCACGCATT-3' 
R: 5'-GCAATATCATGCCGACACCT-3' 
(Cafiso et al. 2004) 
fnbA F: 5'-AAATTGGGAGCAGCATCAGT-3 
R: 5'-GCAGCTGAATTCCCATTTTC-3' 
(Atshan et al. 2013) 
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4.3.7 gDNA contamination assessment 1 
To further confirm total elimination of gDNA, in addition to a cDNA preparation, a ‘non-RT’ 2 
cDNA control was prepared by following all the c-DNA library preparation steps but replacing 3 
the M-MLV enzyme with water. A PCR cycle was completed as above targeting the 4 
housekeeping gene for non-RT controls and samples. The PCR products were then visualised 5 
by gel electrophoresis 6 
4.3.8 Statistical analysis 7 
For statistical analysis the Graph Pad Prism ® statistical software was used. Culture analysis 8 
and qPCR results of mixed and dual biofilms were analysed with Wilcoxon matched pair 9 
signed ranks test with single biofilms of identical conditions used as controls. 10 
4.4 Results 11 
4.4.1 Biofilm culture 12 
In vitro biofilms were created using different combinations of five microbial species as 13 
examples of typical oral commensal microorganisms (S. mutans, P. gingivalis and C. albicans) 14 
and key respiratory pathogens for VAP (S. aureus and P. aeruginosa). To assess biofilm 15 
formation, cells were recovered from the lumen of ETT sections and enumerated to estimate 16 
microbial growth. Single species biofilms were used as comparative controls and the average 17 
inoculum levels of each species used is presented in Table 4.7. The single/mixed biofilms 18 
were prepared and tested on multiple occasions (10 to 20 times). 19 
In single species biofilm preparations, all tested microorganisms were found to generate ETT 20 
biofilms (Figure 4.3). In terms of cell numbers, the most extensive single species biofilms 21 
were produced by P. gingivalis (1.9 x 105 CFU/ml; SD 6.1 x 105 CFU/ml) and P. aeruginosa 22 
(1.7 x 105 CFU/ml; SD 1.9 x 105 CFU/ml). For all bacterial species, when comparing single 23 
species to mixed species biofilms, higher cell counts were encountered in the latter. The 24 
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most notable increase was evident for mixed species biofilms of S. aureus and S. mutans (p= 1 
<0.05). In the respective single species biofilms the cell counts were of the order of 1104 2 
CFU/ml. However, in mixed species biofilms, the counts were 100-fold higher (Figure 4.3). In 3 
contrast, in the case of C. albicans, lower counts occurred in mixed species biofilms 4 
compared with single species biofilms (1101 CFU/ml compared to 1102 CFU/ml; p<0.005). 5 
Interestingly, the strict anaerobic bacterium P. gingivalis was recovered from aerobic mixed 6 
species biofilm preparations in these studies.  7 
In dual species biofilms, pre-existing biofilms formed by an oral microorganism were later 8 
infected with a respiratory pathogen. In these experiments, initial biofilms formed by S. 9 
mutans, P. gingivalis and C. albicans did not subsequently lead to significant differences in 10 
P. aeruginosa biofilm growth in ETT sections (p= >0.5; Figure 4.4). 11 
Figure 4.5 shows dual species biofilms of S. aureus with oral species. It was evident that a 12 
significantly higher number of S. aureus CFU/ml was obtained when cultured with S. mutans, 13 
2.2 x 105 CFU/ml compared to 3.8 x 104 CFU/ml (p= < 0.05). No significant changes in cell 14 
counts were seen in dual biofilms of S. aureus with C. albicans or P. gingivalis (p= >0.5). 15 
To estimate the impact on biofilm formation by oral species in the presence of respiratory 16 
pathogens the number S. mutans, C. albicans and P. gingivalis recovered from ETT biofilm 17 
sections were also recorded in dual preparations with S. aureus and P. aeruginosa. Figure 18 
4.6 shows no significant difference (p= >0.05) in S. mutans cell counts from the single species 19 
biofilms occurred when this species was cultured in dual biofilms with either P. aeruginosa 20 
or S. aureus. Of note was that numbers of C. albicans were significantly reduced when 21 
combination with P. aeruginosa (2.3 x 103 CFU/ml compared to 1.0 x 101 CFU/ml; p= 0.005; 22 
Figure 4.7). No statistical difference was seen in the counts of C. albicans in the presence or 23 
absence of S. aureus (p= >0.05). For P. gingivalis cultured in aerobic biofilms (Figure 4.8), the 24 
mean number of cells recovered from dual species biofilms (both P. aeruginosa and S. 25 
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aureus) was lower than in single biofilms. However, this finding was inconsistent and a 1 
statistical difference (p= >0.5) was not evident.  2 
 3 
 4 
 5 
Table 4.7 Standardised inoculum used for development of endotracheal tube biofilms. 6 
 7 
 8 
 9 
 10 
 11 
 12 
  13 
Microorganims Inoculum 
Streptococcus mutans 2.0 x 108 
Porphyromonas gingivalis 1.7 x 107 
Candida albicans 7.8 x 106 
Staphylococcus aureus 4.3 x 108 
Pseudomonas aeruginosa 8.0 x 107 
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 4 
Figure 4.3 Microbial cells recovered from single and mixed species biofilms.  5 
Average results shown for estimated number of recovered cells per cm2 of biofilm grown in 6 
endotracheal tube sections. Bars represent standard deviation. 7 
  8 
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Figure 4.4 Recovery of Pseudomonas aeruginosa from dual species in vitro biofilms with oral 5 
microbial species 6 
Mean results shown for estimated number of recovered viable cells per cm2 of biofilm grown 7 
in endotracheal tube sections. Bars represent standard deviation.  8 
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Figure 4.5 Recovery of Staphylococcus aureus from dual species in vitro biofilms with oral 5 
microbial species. 6 
Mean results shown for estimated number of recovered viable cells per cm2 of biofilm grown 7 
in endotracheal tube sections. Bars represent standard deviation.  8 
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Figure 4.6 Recovery of Streptococcus mutans from dual species in vitro biofilms with 5 
Staphylococcus aureus or Pseudomonas aeruginosa. 6 
Mean results shown for estimated number of recovered viable cells per cm2 of biofilm grown 7 
in endotracheal tube sections. Bars represent standard deviation. 8 
  9 
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Figure 4.7 Recovery of Candida albicans from dual species in vitro biofilms with 5 
Staphylococcus aureus or Pseudomonas aeruginosa. 6 
Mean results shown for estimated number of recovered viable cells per cm2 of biofilm grown 7 
in endotracheal tube sections. Bars represent standard deviation. 8 
  9 
  
183 
 
 1 
 2 
 3 
 4 
Figure 4. 8 Recovery of Porphyromonas gingivalis from dual species in vitro biofilms with 5 
Staphylococcus aureus or Pseudomonas aeruginosa. 6 
Mean results shown for estimated number of recovered viable cells per cm2 of biofilm grown 7 
in endotracheal tube sections. Bars represent standard deviation.  8 
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4.4.2 FISH, Gram staining and SEM imaging of biofilms  1 
All PNA probes were validated using planktonic cultures of the target species (Figure 4.9). 2 
Mixed planktonic cultures were used to validate probe specificity and each probe served as 3 
a negative control to each other to discard autofluorescence or background fluorescence. 4 
Using CLSM, up to 3 probes could be exited simultaneously and an overlay with all probes 5 
subsequently generated (Figure 4.10). 6 
FISH using PNA probes applied to ETT sections, and these in vitro biofilms showed multiple 7 
cell layers and channels appropriate of mature biofilms (Figure 4.11). However, it was not 8 
possible to obtain multiplex images involving all the different probes. Gram staining also 9 
showed a multiple cell layered biofilm (Figure 4.12), whilst SEM showed high density biofilms 10 
embedded in a matrix with multiple cell layers and possibly water/nutrition channels (Figure 11 
4.13). 12 
4.4.3 RNA Extraction 13 
RNA extraction from biofilms created in ETT sections failed to yield adequate RNA quantities 14 
with all protocols. Successful RNA extractions were only achieved from biofilms developed 15 
in 6-well plates using the combined phenol/Qiagen method with satisfactory A260/A280 16 
ratios evident between 1.8–2.2. RNA gels confirmed the presence of the 16S and 23S bands 17 
(Figure 4.14). 18 
Elimination of gDNA using DNase I treatment during column RNA recovery (as per 19 
manufacturer’s instructions) was insufficient, as gDNA band was evident prior to cDNA 20 
preparation using gel electrophoresis. Longer incubation periods for the DNase I treatment, 21 
or repeating the treatment still did not eliminate gDNA. The additional step of treating RNA 22 
extracts with RQ1 RNase-Free DNase (Promega) was however successful in completely 23 
removing gDNA remnants, as evident by the absence of visible products from non-RT 24 
controls (Figure 4.14). 25 
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4.4.4 Gene expression  1 
Figure 4.15 shows relative gene expression results for P. aeruginosa biofilms. Biofilms 2 
combining P. aeruginosa with S. mutans did not lead to different gene expression for any of 3 
the studied genes (p= >0.05), whereas dual preparations involving C. albicans showed 4 
upregulation of the algD and cupA genes (p= <0.05). Mixed species biofilms increased 5 
expression of the alg D, mucA, muc B, cupA and 5033 (p= <0.05) In the case of the P. 6 
aeruginosa 2070 gene, no difference in expression for single and dual/mixed species biofilms 7 
were encountered (p= >0.05). 8 
Figure 4.16 shows relative S. aureus gene expression in different species combination 9 
biofilms. The combination of S. aureus with S. mutans upregulated expression of the S. 10 
aureus genes agrI, icaC, icaAb, icaBa, icaRa (p= <0.05).  However, these genes were not 11 
altered when S. aureus was cultured in biofilms with C. albicans (p= >0.05). Mixed species 12 
biofilms also exhibited upregulation of agrI, icaC, icaAb, icaRa. Expression of the S. aureus 13 
fnbA gene did not significantly alter between single, dual or mixed biofilm combinations.  14 
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Figure 4.4.9 PNA-FISH targeting single species of planktonic bacteria. A: P. aeruginosa 
specific PNA probe, B: P. aeruginosa with the universal bacterial PNA probe. C: S. aureus 
specific PNA probe, D: S. aureus universal bacterial PNA probe, E: S. mutans specific PNA 
probe, F: S. mutans with universal PNA probe, G: C. albicans specific PNA probe, H: P. 
gingivalis with the universal bacterial PNA probe. 
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 1 
 2 
            Figure 4.10 Multiplex PNA-FISH targeting mixed species of planktonic bacteria. 3 
. 4 
 5 
 6 
 7 
 8 
Top left: P. aeruginosa specific PNA probe. Top right: Bacteria stained with a 
universal bacterial PNA probe. Bottom left: S. aureus specific PNA probe. Bottom 
right: overlay of the three different channels, S. aureus depicted as purple as 
hybridises with both the universal (red) and specific probe (blue), similarly, 
P.aeruginosa depicted as light green/yellow showing hybridisation of both 
specific and universal PNA probes. 
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Figure 4.11 Confocal laser scanning microscopy of a Streptococcus mutans biofilm grown on an endotracheal tube section and stained with 
a universal bacterial PNA probe. 
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                Figure.4.12 Gram staining of a mixed species in vitro biofilm. 
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Figure 4.13 : Scanning electron microscopy of in vitro biofilms grown on endotracheal tube sections.  
Top left and right are S mutans and P. aeruginosa dual species biofilms. Bottom left: Mixed species biofilm. Bottom 
right: image from a C. albicans single species biofilm illustrating hyphal formation by adherent Candida. Bar marker 
is 10 μm. 
  
 191  
 
 
 
Figure  4.14 Agarose gels showing RNA extracts and qPCR products from in vitro biofilms. 
Top: 1% agarose gel showing RNA extracts from in vitro biofilms P. aeruginosa single, 2. P. 
aeruginosa + S. mutans, 3. P. aeruginosa + C. albicans, 4, 5, 6 mixed species, 7. S. aureus 
single, 8, 9. S. aureus +S. mutans, 10, 11. S. aureus + C. albicans, 12. 100bp ladder. 
Bottom: 1.5% agarose gel showing qPCR products using primer pair for the housekeeping 
gene (rplU) of P. aeruginosa. Lanes 2, 4, 6, 8 and 10 are PCRs derived from P. aeruginosa 
single dual and mixed biofilms. Lanes 3, 5, 7, 9 are negative controls (no reverse 
transcriptase). Lanes 11 and 12 are water controls. The absence of bands in controls 
demonstrated complete removal of gDNA in the RNA template. 
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Figure 4.15 Relative expression of P. aeruginosa biofilm production genes. 
 Comparisons were made between P. aeruginosa only and dual species biofilms with S. mutans and C. albicans, as well as mixed biofilms (**) containing 
P. aeruginosa, S. mutans, C. albicans and S. aureus. Analysis of quantitative RT-PCR was made by the ∆∆Ct method. P. aeruginosa single biofilms were used 
as reference biofilms for relative expression of other groups. * p= <0.05 
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Figure 4.16 Relative expression of S. aureus biofilm production genes.  
Comparisons were made between S. aureus only and dual species biofilms with S. mutans and C. albicans, as well as mixed biofilms (**) which contained 
P. aeruginosa, S. mutans, C. albicans and S. aureus. Analysis of quantitative RT-PCR was made by the ∆∆Ct method. Staphylococcus aureus single biofilms 
were used as reference biofilms for relative expression of other groups. * p= <0.05 
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4.5 Discussion 1 
Respiratory pathogens frequently colonise the dental plaque of mechanically ventilated 2 
patients (Munro et al. 2006) who are at a high risk of developing VAP, a difficult to treat 3 
nosocomial infection that increases both mortality and hospital stay (Kollef et al. 2012). 4 
Currently there is very limited evidence of the effects that oral microorganisms may exert 5 
on the behaviour respiratory pathogens. The aim for this work was therefore to characterise 6 
in vitro biofilms formed by oral and respiratory pathogens and to assess the possible 7 
synergistic or antagonistic effects that could occur between the two groups of 8 
microorganisms in terms of biofilm formation and gene expression as well as visualise the 9 
spatial location of each microorganism within a mixed species biofilm.  10 
For clarity, interpretation and reproducibility these experiments utilised simple 11 
combinations of microorganisms rather than trying to generate complex in vitro oral 12 
biofilms. Selected key target microorganisms were included. For the respiratory pathogen 13 
group, the two main VAP pathogens P. aeruginosa and S. aureus (Chastre and Fagon 2002) 14 
were used. For the oral microorganisms group, S. mutans, P. gingivalis respectively 15 
represented supra and sub gingival plaque bacteria. Both of these oral species are well-16 
recognised for their biofilm production and capacity to attach to the tooth surface 17 
(Kuramitsu et al. 2007; Yamada et al. 2005) and have both previously been detected in ETT 18 
biofilms (Cairns et al. 2011). Additionally, the yeast C. albicans was also included as an ‘oral’ 19 
microorganism since carriage in the oral mucosa is frequently encountered and it is also an 20 
organism adept at biofilm formation (Chapter 1, section 1.5.3).  21 
Importantly, all selected species formed single species biofilms in ETT sections, with P. 22 
aeruginosa and P. gingivalis creating the most abundant biofilms (Figure 4.3). It was clear 23 
that the PVC material surface of ETT sections provided a suitable substrata for biofilms 24 
development. In vivo, indwelling medical devices including ETTs are colonised in a matter of 25 
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hours after insertion into a patient (Adair et al. 1999; Donlan 2001) and the microbial 1 
biofilms that form on these devices have been identified as the cause of serious infections 2 
like VAP, urinary tract infections, infective endocarditis and sepsis (Donlan 2001; Vaudaux et 3 
al. 1994). 4 
One important observation from the results of this study in terms of biofilm formation was 5 
that S. mutans appeared to enhance S. aureus growth. There are multiple reasons why this 6 
might have occurred but it is tempting to speculate that S. mutans’ capacity to adhere to 7 
hard surfaces using sucrose dependent and independent mechanisms (Cvitkovitch et al. 8 
2003; Koga et al. 1986) could have conditioned the surface for S. aureus colonisation. 9 
Streptococcus mutans produces several exopolysaccharides, which are predominantly 10 
glucans, through glucosyltransferases and fructosyltransferases. These polysaccharides will 11 
adsorb to surfaces, and facilitate adherence of bacteria to the surface (Koo et al. 2010; 12 
Kuramitsu et al. 2007). The initial colonisation of surfaces by S. mutans may promote 13 
aggregation by species that may have not been able to colonise surfaces on their own. In 14 
addition to glucans, S. mutans synthesises Autoinducer-2 (AI-2), a furarone borate diester 15 
which has been proposed to act as a universal quorum sensing signal molecule (Shemesh et 16 
al. 2010). AI-2 synthesis and detection is widespread in bacteria (Gamma-, Beta-, 17 
Epsilonproteobacteria, Firmicutes, Archaea, Eukarya, Alphaproteobacteria, Actinobacteria 18 
and Cyanobacteria) with the exception of Vibrio species (Sun et al. 2004). AI-2 has been 19 
found to contribute to interaction between bacterial species and contribute to cell-cell 20 
aggregation. It was described that dual biofilms formed by Streptococcus oralis and 21 
Actinomyces naeslundii were dependent upon production of AI-2 as biofilms formed by a S. 22 
oralis mutant lacking AI-2 production were 10-fold lower in biomass for each species 23 
(Rickard et al. 2006). Even when AI-2 is not produced, it can be detected by other species, P. 24 
aeruginosa does not synthesise AI-2 but upregulation of virulence gene promoters has been 25 
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reported in the presence of AI2.synthesized enzymatically and in co-culture with a AI-2 1 
producer Streptococcus strain (Duan et al. 2003).  2 
In contrast, dual species biofilms of P. aeruginosa with an oral species had no effect on the 3 
quantity of P. aeruginosa cells recovered. The reason for this could be the already high 4 
capacity of P. aeruginosa to adhere and form biofilms on the PVC surface (Triandafillu et al. 5 
2003). However, compared with single species biofilms, increased numbers of P. aeruginosa 6 
occurred in the mixed species biofilms. Although not statistically significant, it is possible 7 
that the added presence of S. aureus in these mixed species biofilms was responsible for this 8 
synergistic effect. Dual species biofilms of P. aeruginosa and S. aureus were not examined in 9 
these studies and this represents an area for future investigations to establish this effect. 10 
Interaction between S. aureus and P. aeruginosa have, however, previously been found to 11 
be mutually beneficial for biofilm formation as well as increasing resistance to antibiotic 12 
treatment within in vitro wound models (DeLeon et al. 2014). Atomic force microscopy of P. 13 
aeruginosa and S. aureus (isolated from ETT biofilms) in vitro biofilms (4 h, 24 h, 48 h and 5 14 
d) on PVC discs revealed progressive accumulation of bacterial EPS. Importantly these 15 
biofilms demonstrated increased resistance to two antimicrobials (ceftazidime and 16 
hexetidine) (Gorman et al. 2001). However, in a cystic fibrosis model it was reported that 17 
although these two species initially appear to co-exist, P. aeruginosa drives the S. aureus 18 
expression profile from aerobic respiration to fermentation, affecting viability in thelonger 19 
term, but equally increasing S. aureus lactate production which P. aeruginosa consumes. The 20 
authors proposed that eventually the combination results in lysis of S. aureus which further 21 
benefits P. aeruginosa through provision of an additional iron source (Filkins et al. 2015). 22 
Staphylococcus aureus and P. aeruginosa are frequently pathogens in the same infections, 23 
as seen in VAP, chronic wounds and cystic fibrosis (Fazli et al. 2009; Sands et al. 2016a; 24 
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Trivedi et al. 2014; Zemanick et al. 2015), and their interactions are thus clearly important 1 
and worthy for future research.  2 
Another significant finding was the inhibition of C. albicans in dual species biofilms with P. 3 
aeruginosa (Figure 4.7). An earlier in vitro study using clinical isolates from sputum, found 4 
complete inhibition of C. albicans by P. aeruginosa and it was suggested that pyrrolnitrin (a 5 
Pseudomonas metabolite with antifungal effects) was responsible for this effect (Kerr 1994). 6 
It has also been reported that P. aeruginosa can selectively kill hyphae of C. albicans with 7 
blastopores remaining viable (Hogan and Kolter 2002). It appears that C. albicans hyphae 8 
stimulate the release of phenazines by P. aeruginosa, which in turn uses C. albicans hyphae 9 
as a growth substrate (Harriott and Noverr, 2011). Phenazines are heterocyclic, redox-active 10 
compounds that can be highly toxic to competing microorganisms and are also a terminal 11 
signalling factor in the quorum sensing network of P. aeruginosa (Dietrich et al. 2006). 12 
Additionally, the cell-cell signalling molecule, 3-oxo C12 homoserine lactone, has been found 13 
to inhibit C. albicans filamentation (Hogan et al. 2004). This inhibition has also been observed 14 
using SEM (Thein et al. 2006). In the current study there was little or no recovery of C. 15 
albicans from ETT sections also colonised with P. aeruginosa. Initially for C. albicans 16 
enumeration, the dual species biofilm cells were plated on to SDA as this is the routine agar 17 
for yeast, however P. aeruginosa grows also well and swarms on this agar. It was thought 18 
that P. aeruginosa may have been overgrowing the C. albicans on SDA, however, changing 19 
the agar to the more selective CHROMagar® Candida did not yield significantly higher 20 
candidal counts. Additionally, the apparent inhibitory effect on C. albicans biofilm cells was 21 
also seen in mixed species biofilms (Figure 4.3) indicating the presence of the other species 22 
offered little or no protection to C. albicans from P. aeruginosa. The relationship between 23 
these two microorganisms in vivo conflicts with in vitro findings. In a mouse lung infection 24 
model short term Candida colonisation lowered P. aeruginosa load as well as severity of lung 25 
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injury, importantly, the administration of antifungal treatment resulted in the opposite 1 
(Ader et al. 2011). Another murine model study reported that C. albicans colonisation 2 
triggers the recruitment of white blood cells which results in secretion of interleukins (IL-17 3 
and IL-22) and the production of antimicrobial peptides and which has a protective effect 4 
against P. aeruginosa infection (Mear et al. 2014). Interestingly, P. aeruginosa infection 5 
followed by C. albicans colonisation resulted in increased mortality in a burned mice model 6 
(Neely et al. 1986). In an acute lung injury murine model It was reported that P. aeruginosa 7 
type III secretion system diminishes the host response by cell damage and decreased 8 
production secretion of IL-17 (Faure et al. 2014). In contrast to findings in in vitro models, 9 
pre-existing colonisation by C. albicans has been suggested to be a risk factor for VAP caused 10 
by P. aeruginosa with poorer clinical outcomes including higher mortality and longer hospital 11 
stay in two studies including 803 and 639 patients (Azoulay et al. 2006; Delisle et al. 2011; 12 
Delisle et al. 2008). 13 
Candida albicans and Staphylococcus aureus are commonly co-isolated in a range of 14 
infections including denture stomatitis, angular cheilitis and infective endocarditis (Baena-15 
Monroy et al. 2005; Peters et al. 2012a; Shirtliff et al. 2009). Although in this study C albicans 16 
cause no significant increase on biofilm production or gene expression of S. aureus, C. 17 
albicans hyphae have been shown to aid S. aureus invasion to mucosal tissue and induce 18 
amplified virulence during coinfection (Schlecht et al. 2015). Additionally, enhanced 19 
tolerance to vancomycin has been observed in S. aureus when cultured with C. albicans 20 
mediated by polysaccharides secreted into the environment (Kong et al. 2016). 21 
An interesting finding from these in vitro biofilm experiments was that P. gingivalis, an 22 
obligated anaerobic bacterium, could survive in the aerobic biofilm model in both the mixed 23 
and dual species biofilms. Previous studies have observed that when P. gingivalis and P. 24 
nigrescens were combined with the bridging bacterium Fusobacterium nucleatum, the black 25 
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pigmented anaerobes survived the aerated conditions (Bradshaw et al. 1998). This effect 1 
occurred both with biofilms and planktonic cultures, and the authors proposed that 2 
metabolically organised aggregates facilitated persistence of the anaerobes (Bradshaw et al. 3 
1998). More recently, it was found that P. gingivalis could thrive in the presence of low 4 
concentrations of oxygen (6%) which was explained by the presence of encoding 5 
components of aerobic respiration in the P. gingivalis genome. The finding implicated this 6 
species with the potential ability to use formate and lactate for nutrition, which are 7 
secondary metabolic products of other bacteria including Streptococcus species and S. 8 
aureus (Filkins et al. 2015; Lewis et al. 2009).   9 
Survival of anaerobic bacteria in the presence of high concentrations of oxygen is obviously 10 
evident in the oral cavity and chronic wounds. Interestingly, in Chapter 2 and 3 of this thesis 11 
P. gingivalis was detected using molecular methods in ETT biofilms of mechanically 12 
ventilated patients, and although the species was not cultured, its potential presence raises 13 
the question of what effect it could have in the ETT biofilm microbiota or indeed the lower 14 
airways. However, in the dual species biofilm combinations, there was no significant changes 15 
in the number of S. aureus or P. aeruginosa biofilm cells recovered. This could possibly relate 16 
to the inconsistent P. gingivalis growth in these biofilms. 17 
A limitation to this study is the high level of variation in microbial growth between 18 
experiments which is evident in the standard variation values (Figures 4.3 to 4.8).It has to be 19 
noted that for the dual species biofilms, a monospecies biofilm (S. mutans, C. albicans or P. 20 
gingivalis) was created prior to inoculation with one of the respiratory pathogens. This 21 
would eliminate initial competition by the respiratory pathogen for attachment to the ETT. 22 
However, the rationale for this approach was that in vivo Streptococcus species would be 23 
present in the patient’s dental plaque prior to potential colonisation by respiratory 24 
pathogens (Dewhirst et al. 2010; Sands et al. 2016a). 25 
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Gene expression studies showed similar results to in vitro culture analyses, with enhanced 1 
expression of the S. aureus biofilm genes agrI, icaC, icaAb, icaRa, when S. aureus was present 2 
in combination with S. mutans and mixed species biofilms. Up regulation of P. aeruginosa 3 
biofilm genes (algD, mucA, mucB, cupA, 5033) was also observed and this was primarily in 4 
the mixed biofilms and in the case of alg D and cupA, the presence of a pre-existing C. 5 
albicans biofilm. Although the change in gene expression (<2 fold) was not extensive for all 6 
genes and in both respiratory pathogens, such changes may be sufficient to promote 7 
significant alterations in behaviour and biofilm development. Similar levels of upregulated 8 
gene expression from C. albicans combined with Streptococcus species was seen with 9 
biofilms grown in titanium surfaces, and resulted in significantly higher hyphal formation 10 
from Candida cells and virulence in an in vitro tissue model (Cavalcanti et al. 2016).  11 
The in vitro models used in this chapter where selected because of ease of reproducibility 12 
and with identical conditions and it allowed an adequate number of experiments to be 13 
performed for each microbial species combination in a reasonable time frame and cost. An 14 
alternative option could have been to add a “substrate conditioning step” by incubating the 15 
materials with for example artificial saliva to mimic this biofilm forming step. Furthermore 16 
future studies should consider the use of clinical isolates instead of reference strains, both 17 
of this changes could improve the similarties to the in vivo situation. 18 
An alternative in vitro model could have been to manufacture an artificial mouth to lung 19 
model that allowed the insertion of an ETT, mechanical ventilation and microbial infection. 20 
Such model was considered but it would have made difficult to perform experiments and 21 
controls simultaneously for the number of combinations. 22 
One aim of this chapter, was to use PNA-FISH and CSLM to determine the spatial location of 23 
the different species within mixed and dual species biofilms grown in ETT sections. This could 24 
in turn, further inform on potential inter-species interaction. Whilst the probes were 25 
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validated for specificity and function against all tested strains in planktonic state, 1 
hybridisation of biofilm cells with the PNA probes proved difficult. This could have related 2 
to impaired access of the probes to biofilm embedded cells, possibly due to the presence of 3 
the biofilm matrix. Nevertheless, multi-layered well-structured biofilms could be detected 4 
with CSLM and SEM (Figures 4.11 and 4.13). 5 
There is limited evidence on the interaction between oral microorganism and systemic 6 
pathogens such as S. aureus and P. aeruginosa. Recently, Peters et al., revealed a physical 7 
interaction between S. aureus and C. albicans that was associated with altered gene 8 
expression by S. aureus and an enhanced ability of the bacterium to invade epithelial cells 9 
(Peters et al. 2010; Peters et al. 2012b; Schlecht et al. 2015). However, more research in this 10 
subject would enhance our knowledge of how these bacterial interactions affect the clinical 11 
outcomes and may offer light in the search for novel and effective antimicrobials.12 
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4.6 Conclusions: 1 
 Streptococcus mutans, P. gingivalis, C. albicans, P. aeruginosa and S. aureus formed 2 
biofilms on the PVC surfaces of ETT, with the most extensive single species biofilms 3 
formed by P. aeruginosa and P. gingivalis. 4 
 Staphylococcus aureus and S. mutans exhibited enhanced growth as part of mixed 5 
species biofilms. 6 
 Staphylococcus aureus colonised biofilms to a greater extent in the presence of pre-7 
existing S. mutans. 8 
 Pseudomonas aeruginosa inhibited C. albicans growth in dual species biofilms. 9 
 Enhanced biofilm gene expression occurred with the respiratory pathogens S. 10 
aureus and P. aeruginosa as part of mixed species biofilms and in the presence of S. 11 
mutans for S. aureus, and C. albicans for P. aeruginosa.  12 
 13 
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5. Evaluation of strategies to combat 
biofilms associated with ventilator 
associated pneumonia  
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5.1 Introduction 
Ventilator-associated pneumonia (VAP) is a common nosocomial infection in mechanically 
ventilated patients. VAP is associated with high patient morbidity and mortality, significant 
cost to healthcare providers and the need for high levels of antibiotic use (Chastre and Fagon 
2002; Melsen et al. 2013). Consequently, preventive measures that reduce VAP incidence 
are essential. There are a number of strategies that can be used to reduce the risk of VAP 
occurrence and some of these are outlined below. 
Aspiration of oropharyngeal secretions has been identified as an important source of 
pathogens involved in the development of VAP (Brennan et al. 2004; Rodrigues et al. 2009; 
Rumbak 2005). Not only can aspiration lead to direct contamination of the lungs but it can 
also be the source of microorganisms for biofilm development within the endotracheal tube 
(ETT). 
Dental plaque is an ‘archetypal biofilm’ and during critical illness, it can rapidly become 
colonised by potential respiratory pathogens. In these cases, dental plaque acts as a 
reservoir of VAP pathogens that can translocate to the lungs following aspiration (Fourrier 
et al. 1998; Sachdev et al. 2013; Sands et al. 2016; Scannapieco et al. 1992). Clearly, reducing 
the microbial bio-load of dental plaque in mechanically ventilated patients is an approach 
that could lower the risk of VAP occurrence. Indeed, a number of interventions aimed at 
improving oral cleanliness with oral care protocols including use of antimicrobials, mainly 
chlorhexidine (CHX) have demonstrated a reduction in VAP or improved mortality rates in 
randomised clinical trials (Chan et al. 2007; Shi et al. 2013; Snyders et al. 2011). However, 
these studies did not evaluate the efficacy of the applied cleaning methods and there 
remains a paucity of research conducted in mechanically-ventilated patients on what the 
optimal methods for improving oral hygiene are (Wise and Williams 2013). Indeed the 
majority of observational studies in the general critical care population demonstrate an 
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increase in plaque scores over time, despite receipt of ‘routine’ oral care (Fourrier et al. 
1998; Sachdev et al. 2013; Scannapieco et al. 1992). 
It has long been established that the best approach for removal of dental plaque is by its 
mechanical disruption (Silness and Loe 1964). Brushing of teeth can be undertaken using a 
number of devices including manual brushes, powered brushes, swabs and interdental 
brushes.  The use of manual toothbrushes has been found to be superior than foam swabs 
(Pearson 1996), however this trial included healthy volunteers and not mechanically 
ventilated patients. Similarly in the general population powered toothbrushes have been 
shown to reduce more plaque and gingival inflammation than manual toothbrushes (Yaacob 
et al. 2014). This finding was also evident in mechanically- ventilated patients in a clinical 
trial (Needleman et al. 2011), however, this remains the only study evaluating powered 
toothbrushes in this patient group and the use of electric toothbrushes remains in ICUs 
remains low. 
Within critical care, oral care has historically been viewed as a comfort measure, rather than 
an infection control strategy. It has also been noted that nursing staff attitudes towards oral 
care delivery, varies on how well informed staff members are. More positive attitudes to 
oral care is evident with registered nurses compared to nursing assistants (Wardh et al. 
1997). Unfortunately, the problem of poor knowledge over the benefits of maintaining oral 
hygiene in the critically ill continues to be an issue. Some nursing staff continue to 
acknowledge a feeling of disgust and anxiety towards delivering mouth care and admit to 
deviating from oral care protocols (Johnson 2013). It is therefore not surprising that 
considerable variability exists in oral hygiene practices amongst critical care nurses (Dale et 
al. 2013; Rello et al. 2007). Currently, the most common methods of delivering oral care in 
the critically ill are through the use of foam brushes or toothbrushes, and with or without 
antiseptic solutions (Binkley et al. 2004; Rello et al. 2007). 
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Antimicrobial mouthwashes are frequently used as coadjuvants in the delivery of oral care, 
primarily to assist in the prevention of caries and periodontal disease, where their 
antimicrobial effectiveness has been established (Bonez et al. 2013; Hendry et al. 2009; 
Hooper et al. 2011; Malic et al. 2013; Masadeh et al. 2013). A number of randomised clinical 
trials have provided evidence of a reduced VAP incidence when CHX is incorporated as part 
of oral care (Garcia et al. 2009; Grap et al. 2011; Koeman et al. 2006). However, CHX use in 
critical care has not been found to reduce patient mortality rates or length of hospital stay. 
This finding has been determined by recent meta-analyses including a Cochrane review 
(Hoshijima et al. 2013; Hua et al. 2016). However there has been some limited evidence of 
the efficacy of antimicrobial mouthwashes in mechanically-ventilated patients, where CHX 
is the principle agent used. Other antibacterial mouthwashes available include essential oils, 
cetyl pyridinium chloride, tricolsan, octeneidine, delmopinol, polyvinylpyrrolidone, 
hyaluronic acid and Citroxx® (Tartaglia et al. 2016). The most widely used of these are CHX 
(Corsodyl®), “essential oils” (Listerine®) and cetyl pyridinium chloride (Colgate® Plax, Oral 
BTM Antiplaque). 
CHX gluconate is a water-soluble, cationic biguanide that binds to the negatively charged 
bacterial cell wall, and by doing so alters the bacterial cell osmotic equilibrium. CHX has 
bactericidal and bacteriostatic effects and has been shown to prevent spore formation in 
Clostridium difficile and Bacillus subtilis high (Jones et al. 1995; Nerandzic and Donskey 2015; 
Tartaglia et al. 2016). As an antiseptic, CHX is commonly used in hospitals to disinfect skin, 
wounds and surfaces (Weinstein et al. 2008). As a mouthwash, CHX is used in the 
management of periodontal disease, and as a 0.12-0.2% solution in perioperative 
prophylaxis prior to dental surgical procedures (Jose et al. 2015). CHX has been shown to 
reduce bacterial load and prevent plaque re-accumulation on clean oral surfaces (Bonez et 
al. 2013; Lucchese et al. 2012).  
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One highly used essential oil mouthwash is Listerine® (Johnson & Johnson Ltd), based on 
essential oils (eucalyptol, menthol, methyl salicylate and thymol). Listerine® Total Care Zero, 
unlike other Listerine® formulations it has no alcohol content. Alcohol in mouthwashes has 
been a cause of concern, with reported side effects including dental erosion (Pontefract et 
al. 2001), links to oropharyngeal cancer (Ahrens et al. 2014), and alcohol poisoning 
(Kolikonda et al. 2014). Additionally, a mouthwash with alcohol may be unsuitable for 
hospital use as it may lead to multiple drug interactions and promote dryness of the oral 
mucosa (Werner and Seymour 2009). 
In recent years a number of other mouthwashes based on plant extracts, and polyphenolic 
plant derivatives have been shown to have antimicrobial activity against oral bacteria and 
yeast (Hooper et al. 2011; Malic et al. 2013). Such natural products may offer the added 
advantage of improved safety profiles and better acceptance from patients. Citroxx® is 
based on a blend of soluble bioflavonoids derived from orange pith, with small amounts of 
malic and citric acids. Two Citroxx® formulations, referred to as BD and MDC (Oraldent) exist. 
BD is present in Oralclens® mouthrinse and toothpaste, and MDC is a surface disinfectant in 
Citroxx BioTM; both formulations are alcohol free (OralDent 2008). 
Multiple studies have shown that the ETT develops a biofilm in its lumen during use (De 
Souza et al. 2014; Inglis et al. 1989; Perkins et al. 2010). This biofilm has been shown to be 
an independent risk factor in the occurrence of VAP (Danin et al. 2015; Wilson et al. 2012). 
Previous studies have reported that oropharyngeal secretions accumulate above the inflated 
cuff of ETTs and then leak passed the cuff (Chapter 1, section 1.3.5.1). After this leakage 
occurs and aided by the forces of mechanical ventilation, microorganisms can then 
contaminate the lumen of the ETT where they grow as a biofilm (Chapter 2, Section 2.1.1). 
ETT biofilm has been detected after only a few hours of intubation (Adair et al. 1999; Inglis 
et al. 1989). This biofilm will be protected from the host’s immune system and any 
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administered systemic antibiotics (Bauer et al. 2002). The biofilm threfore provides a refuge 
of microorganisms that have unrestricted direct access to the lungs. Inglis et al., (1989) found 
that by the forces of mechanical ventilation, ETT biofilm particles could be displaced up to 
45 cm away from the tip of the ETT. Therefore microorganisms from ETT biofilms can readily 
be expelled into the lower airways and potentially cause infection.  
Given that aspiration from the oral cavity occurs as outlined above, it is perhaps not 
surprising, that oral microbial species have been detected in ETT biofilms (Cairns et al. 2011; 
Perkins et al. 2010). As previously shown in this Thesis (Chapters 2 and 3), along with oral 
species, Staphylococcus aureus and Pseudomonas aeruginosa as well as other respiratory 
pathogens can also be isolated and detected in ETT biofilms. Since biofilm microorganisms 
display greater tolerance to antimicrobials than planktonic equivalents (Luppens et al. 2002), 
it would be likely that this property would remain evident when aggregates of ETT biofilm 
are displaced to the lower airway. 
Given the risk that the ETT biofilm presents for the mechanically ventilated patients, changes 
to the ETT have been proposed to eliminate or minimise the leakage of subglottic secretions 
past the cuff and to impede biofilm formation. Most of these changes have being in the 
design of the ETT, including the use of tapered cuffs, double cuffs and incorporation of ports 
for removal of pooling subglottic fluids (Doyle et al. 2011; Hwang et al. 2013; Muscedere et 
al. 2008) (Chapter 1, Section 1.3.5.1). 
Changes to the ETT biomaterial include incorporation of silver coatings on the inner surface 
of the ETT as an alternative to the standard polyvinyl chloride (PVC) or polyurethane (Berra 
et al. 2008; Kollef et al. 2008). Silver has been used as a prophylactic antimicrobial or as a 
treatment agent since the times of Hippocrates (ca 400 BC) and was possibly the most 
important antimicrobial agent prior to antibiotics (Alexander 2009). Silver coated medical 
devices have previously shown limited success in urinary catheters (Bologna et al. 1999). 
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Therefore some expectation that silver coated ETTs could reduce VAP might be anticipated. 
Clinical evaluation have found a reduction in VAP incidence, although no impact in improving 
patient mortality rates have been reported (Berra et al. 2008; Kollef et al. 2008). Despite 
large randomised control trials involving over 2000 patients, the results have not been 
sufficiently robust for use of silver coated ETTs to be widely adopted, as reported recently 
in a Cochrane review (Tokmaji et al. 2015). 
The PneuXTM (Formerly known as LoTrachTM) ETT is constructed from silicone and includes 
wire re-enforcement. The PneuXTM ETT exhibits several features designed to minimise 
aspiration of oropharyngeal secretions with minimal trauma to the surrounding structures. 
The tube features three subglottic ports, a soft tip, a low pressure and low volume cuff, and 
a ‘coated lumen’ to prevent microbial colonisation (Fletcher et al. 2008). This ETT has been 
designed to be used as in conjunction with a tracheal seal monitor to maintain a constant 
cuff pressure. In a retrospective study of 53 patients using the PneuXTM system for a mean 
duration of 5.3 days, there were no VAP episodes while the tube was in situ and there was 
only one incident of respiratory failure. This followed after a planned extubation and re-
intubation with a standard ETT where the patient subsequently developed VAP after 48 h. 
Based on an intention to treat basis, the incidence of VAP was calculated as 1.8% (Doyle et 
al. 2011) and this study therefore showed promising results for use of the PneuXTM system. 
However it remains unclear which of the design features contributed to this reported low 
VAP incidence. 
Future, alternative therapies for management of ETT biofilms include photodynamic 
exposure. Indeed, one in vitro study reported the reduction of P. aeruginosa and MRSA ETT 
biofilms after a single treatment with a methylene blue (MB) photosensitizer and exposure 
to 664nm non-thermal activating light (Biel et al. 2011). Recently a multicentre randomised 
clinical trial involving 70 patients studied the effect of nebulised eucalyptus on biofilm 
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formation on ETT surfaces and found lower levels of K. pneumoniae, however this effect was 
not seen in other species (Amini et al. 2016).  
This chapter has been partly published in: 
Marino P J, Hannigan A, Haywood S, Cole J M, Palmer N, Emanuel C, Kinsella T, Lewis M A O, 
Wise M P, Williams D W. Comparison of foam swabs and toothbrushes as oral hygiene 
interventions in mechanically ventilated patients: a randomised split mouth study. BMJ 
Open Respiratory Research. 2016; 3(1):e000150. 
5.2 Objectives 
The aims of this chapter were to evaluate different VAP prevention strategies that were 
aimed at reducing biofilm. These included an evaluation of oral hygiene approaches to 
mechanically disrupt dental plaque during mechanical ventilation, and in vitro studies 
assessing the relative efficacy of antimicrobial mouthwashes against ETT biofilms, as well as 
the ability of biofilms to develop on different ETT biomaterials. Specific this study aimed to: 
 Compare the efficacy of foam swabs and toothbrushes at removing dental plaque in 
mechanically ventilated patients with outcomes measured based on plaque 
accumulation and gingival inflammation indexes, as well as total bacterial load. 
 Compare biofilm growth on biomaterial sections of four different ETTs. 
 Determine the antimicrobial activity of Citroxx®, Listerine® Total Care Zero and CHX 
against planktonic and biofilm constructs of oral and respiratory pathogen 
microorganisms.
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5.3 Materials and Methods 
5.3.1 Comparison of oral hygiene delivery in mechanically ventilated patients using 
swabs and toothbrushes  
5.3.1.1 Study design 
This study employed a ‘split-mouth’ design in which two oral hygiene methods i.e. use of a 
foam swab or a ‘small-headed’ toothbrush (Figure 5.1) were used to clean the teeth on 
different sides of a patient’s mouth. The advantage of this split-mouth design over 
randomising individual patients was the reduction in inter-subject variability (Lesaffre et al. 
2009). The side to which the cleaning method was allocated was determined by computer-
generated randomisation. All researchers involved in this study (see Thesis 
acknowledgements) were blinded to the assigned hygiene method until the statistical 
analysis had been completed. Assistance in this study was received from Dr Matt Wise, Mrs 
Niki Palmer, Ms Jade Cole, Mr. Sean Haywood, Ms Tracey Kinsella and Dr Charlotte Emanuel 
who were responsible for taking patient consent, delivery of oral care and assessment of 
oral interventions. All laboratory aspects of this study and interpretation of the data was 
undertaken by the PhD candidate (Ms Paola Marino). Statistical advice was provided by 
Professor Ailish Hannigan (University of Limerick, Limerick, Ireland).
  
212 
 
 
 
Figure 5.1 Toothbrush and foam swab (Sage products, Illinois, USA) evaluated for 
delivery of oral care in the studied patients. 
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5.3.1.2 Patient recruitment 
Ethical approval was obtained from the Research Ethics Committee for Wales 
(09/MRE09/44); Trial registration: Clinical Trials.Gov NCT01154257 14th June 2010. Written 
informed consent was obtained in accordance with ethical approval (Appendix I). 
Mechanically-ventilated patients admitted to the adult intensive care unit (ICU) at the 
University Hospital of Wales, Cardiff, UK were eligible for the study. Patients were eligible if 
they were aged >18 years, were mechanically-ventilated with an ETT placed via the oral 
route, and had >20 teeth of broadly symmetrical (left and right) distribution. Patients that 
did not meet the inclusion criteria, or those who had thrombocytopenia (platelet count <30), 
uncontrolled coagulopathy, facial or oral trauma, or were expected to be ventilated for <24 
h, were excluded from the study. Patients were randomised using a computer-generated 
sequence, with the right side of the mouth allocated to either use of a toothbrush or foam 
swab. The intervention allocations were placed in sealed envelopes which were opened at 
patient recruitment. Recruitment of patients occurred between July 2010 and April 2011. 
5.3.1.3 Intervention 
Prior to oral hygiene intervention, Silness-Löe plaque (Table 5.1) and gingival indices (Table 
5.2) were recorded. Using this scoring system, scores ranged between 0 to 3, with 0 being 
equal to health and a score of 3 meaning gross plaque deposits or marked gingival 
inflammation (Silness and Loe 1964). These scores were recorded on the upper and lower 
first molars, first bicuspid and central incisors on each side of the mouth from the buccal 
surface. Plaque and gingival index scores were an average of the six teeth on each side. For 
patients with missing index teeth, the remaining teeth in closest proximity were scored. A 
decayed, missing and filled teeth (DMFT) index (Larmas 2010) was used as an indicator of 
the patient’s oral health on admission to critical care. 
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A qualified  dental hygienist (Ms Tracey Kinsella) trained to the ICU research nursing staff in 
the provision of oral hygiene.. Cleaning was performed solely by the research staff every 12 
h until extubation (if <7 days) or up to seven days after recruitment. The modified Bass 
technique (Poyato-Ferrera et al. 2003) for brushing was used with toothbrushes and foam 
swabs, that had been pre-moistened with sterile water. CHX was not used in the study, as it 
was not part of the routine oral care in the critical care unit. Each side of the mouth was 
cleaned for 1 min (30 s per quadrant) and compliance with the intervention recorded. 
Silness-Löe plaque and gingival indices were recorded daily and on each side of the mouth 
by a single, dentally trained operator (Mr Sean Haywood, 5th year dental student) who was 
also trained for the study by the dental hygienist and was blinded to treatment allocation . 
The scores were recorded at the start of the study (i.e. baseline), before randomisation and 
then each morning. 
Dental plaque was collected using sterile endodontic paper points (size ISO45; QEP, 
Peterborough, UK), with one paper point used per tooth from each side of the mouth to 
determine bacterial load. Plaque samples were obtained at the same time of day, and by the 
same individual (Mr Sean Haywood) prior to cleaning. Sampling commenced at the distal 
part of the buccal aspect of the tooth with 1 mm of paper point placed into the gingival 
sulcus. Using a slow and continuous motion the paper point was drawn towards the operator 
to recover the plaque. Paper points were immediately immersed in 1 ml of Reduced 
Transport Fluid (RTF) for analysis of viable microorganisms by culture (Syed and Loesche 
1972).  
Each of the described interventions had a written standad operating procedure wich was 
readily available to the individuals performing them, compliance to adherence to the 
protocols was also recorded.
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Table 5.1 Plaque index scoring used in this study. 
 
Score                                                                         Criteria 
0 No plaque 
1 A film of plaque adhering to the free gingival margin and adjacent area of the 
tooth. The plaque may be seen in situ only after application of disclosing solution 
or by using the probe on the tooth surface. 
2 Moderate accumulation of soft deposits within the gingival pocket, or the tooth 
and gingival margin, which can be seen with the naked eye. 
3 Abundance of soft matter within the gingival pocket and/or on the tooth and 
gingival margin. 
Adapted from (Silness and Loe 1964) 
 
 
Table 5.2 Gingival index assessment (severity of gingivitis) used in this study based on 
gingival colour, presence of oedema and bleeding. 
 
Score                                                      Criteria 
0 Normal 
1 Mild inflammation, slight colour change and oedema, no bleeding 
2 Moderate inflammation, redness, oedema, bleeds on probing 
3 Severe inflammation, marked redness and oedema, ulceration, 
spontaneous bleeding 
Adapted from (Silness and Loe 1964) 
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5.3.1.4 Processing of dental plaque samples 
Paper points were vortex mixed for 20 s and the resulting solution serial decimally diluted in 
phosphate buffered saline (PBS).  Fifty-μl volumes of the dilutions were then inoculated onto 
blood agar using a spiral plating (Don Whitley Scientific, Shipley, UK) (Lab M, Heywood, UK) 
system and incubated aerobically at 37°C for 48 h for bacterial counts. After incubation, 
colony-forming units (CFUs) were enumerated.  
5.3.1.5 Statistical analysis 
It was estimated that 20 patients would be required to detect a 0.63 shift in plaque scores 
with a power of 80% at the conventional 0.05 alpha level. Initially, it was intended to analyse 
plaque scores after 72 h of cleaning and it was estimated that recruiting 50 patients would 
give at least 20 patients allowing for drop out of extubated patients or patient death before 
72 h. However, as 24 h of cleaning should be sufficient to reduce plaque scores, it was 
subsequently decided, prior to patient recruitment to analyse data after a minimum of 24 h. 
The distribution of numeric data was tested for normality and presented as mean (standard 
deviation) for normally distributed data, and median (range) for non-normally distributed 
data. The overall change (baseline to end of follow-up) in plaque index, gingival index and 
bacterial counts was calculated for each patient and for each mechanical method. The null 
hypothesis of no change in outcomes over time was tested using the paired samples t-test 
for normally distributed differences, or a Wilcoxon-signed-rank test for skewed 
distributions. McNemar’s test was used for paired proportions. 
For normally distributed differences, repeated measures analysis of variance (AVOVA) was 
used to test for statistically significant differences in outcomes between methods within 
patients after adjusting for baseline DMFT, number of days follow-up and side of the mouth. 
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A 5% level of significance was used for all statistical tests. The statistical software package 
IBM SPSS for Windows Version 21 was used for analyses.  
5.3.2 Comparison of biofilm development of different endotracheal tube biomaterial 
surfaces 
Mixed species biofilms were aerobically cultured at 37C for 5 days and recovered using the 
same method described in Chapter 4, sections 4.3.1 and 4.3.2. The ETT (Figure 5.2) surfaces 
tested included the standard PVC Portex® (Smiths medical, Kent, UK), the silicone PneuXTM 
(Venner medical, Jersey, UK), an experimental PVC silver coated tube (Mallinckrodt, 
Covidien, MA, USA) and non-silver-coated PVC tube (Taperguard EvacTM, Mallinckrodt). The 
number of bacteria present in the developed biofilms was then assessed by quantitative 
microbial culture. Four replicates experiments for each surface were performed and were 
repeated on three separate occasions. Statistical analysis using the Wilcoxon Rank tests and 
were calculated using Graph Pad Prism®. 
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Figure 5.2 Endotracheal tube types from which a comparison of biofilm growth on tube sections was 
undertaken. Left: from top to bottom Evac®, silver coted and Portex®, Right: PneuX™. 
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5.3.3 Susceptibility of planktonically cultured microorganisms and biofilms to 1 
antimicrobial mouthwashes 2 
5.3.3.1 Microorganisms 3 
Streptococcus mutans DSM 20523T and Candida albicans ATTC 90028 were used in this study 4 
as representative oral species with known biofilm forming capacity. In addition, the 5 
respiratory pathogens Staphylococcus aureus NCIB 9518 and Pseudomonas aeruginosa ATTC 6 
5682 were also tested. 7 
Streptococcus mutans, C. albicans, P aeruginosa and S. aureus were all initially cultured 8 
overnight at 37˚C using the following respective agar media (from Lab M unless otherwise 9 
stated), Mitis Salivarius Bacitracin agar (MSB; Difco), Sabouraud Dextrose Agar (SDA), 10 
Pseudomonas agar (PsA) and Manitol Salt Agar (MSA). For minimum inhibitory 11 
concentrations (MIC) assays, static overnight culture in Brain Heart Infusion (BHI) liquid 12 
medium at 37°C was used for all test isolates. 13 
5.3.3.2 Planktonic cell susceptibility to antimicrobial mouthwashes 14 
Overnight cultures of each isolate in BHI were standardised to a turbidity equivalent to a 0.5 15 
McFarland standard (approximately 108 colony forming units/ ml). To achieve this, turbidity 16 
was measured at 600nm using a spectrophotometer (Geneflow, Linchfield, UK) and the 17 
culture adjusted to an optical density between 0.08 and 0.10. The standardised culture was 18 
then further diluted 100-fold in BHI to obtain approximately 106 cells /ml.  19 
Serial dilutions of Citroxx® BD (Oraldent, Kimbolton, UK), Listerine Total Care ZERO® 20 
(Johnson & Johnson, UK) and chlorhexidine (20% solution in water, Sigma, Poole, UK) (Table 21 
5.3) were prepared in BHI. Double strength BHI was initially prepared and to this an equal 22 
volume of antimicrobial was added  23 
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 2 
Table 5.3 Concentrations of mouthwashes used for planktonic and biofilm assays. 3 
Mouthwash Planktonic assay  Biofilm assay 
Citroxx® 0.008% to 2% 0.25 to 8% 
Listerine Total Care 
Zero® 
0.95% to 50% 3% to 100% 
Chlorhexidine 0.000195% to 0.2% 0.000195% to 
1.92% 
 4 
 5 
Table 5.4 Microbial species used for planktonic and biofilm assays. 6 
Single species biofilm preparations Dual species biofilm preparations 
Streptococcus mutans Streptococcus mutans and 
Staphylococcus aureus  
Candida albicans Streptococcus mutans and 
Pseudomonas aeruginosa 
Staphylococcus aureus Candida albicans and Staphylococcus 
aureus 
Pseudomonas aeruginosa Candida albicans and Pseudomonas 
aeruginosa 
 7 
  8 
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One hundred-µl volumes of microbial broth, prepared as describe above was loaded into the 1 
wells of a 96-well tissue culture plate (Starstedt, USA), and 100-µl of each diluted test 2 
mouthwash in BHI was added to the microbial suspensions. Un-inoculated BHI was used as 3 
a negative control, and a bacterial suspension with no mouthwash used as a positive growth 4 
control.  5 
Microtitre plates were incubated aerobically for 24 h at 37˚C, after which time the relative 6 
growth of each microbial species was determined by measuring the turbidity of each well by 7 
spectrophotometric absorbance at 600 nm (FLUOstar® Omega; BMG Labtech, Aylesbury, UK).  8 
Absorbance readings were then adjusted using wells containing un-inoculated BHI to 9 
provide a baseline. Each preparation was done in triplicate and on three separate occasions 10 
and the MIC was determined as the concentration that caused ≥80% reduction absorbance 11 
reading compared to the positive control. 12 
5.3.3.3 Biofilm susceptibility to antimicrobial mouthwashes 13 
Single and dual species biofilms (Table 5.4) were prepared by inoculating a 100-µl volume of 14 
microbial suspensions of approximately 106 CFU/ml (prepared as described above) in to the 15 
wells of 96-well tissue culture plates and these were incubated without shaking at 37°C for 16 
24 h. For dual species biofilm preparations, 100 µl of each species was used. After 24 h 17 
incubation, the growth medium was carefully aspirated with a sterile pipette. The biofilm 18 
was then gently washed by addition of an equal volume of phosphate buffered saline (PBS) 19 
to each well to remove planktonic cells. Biofilms were then re-suspended in serial dilutions 20 
of fresh medium containing test mouthwash or no mouthwash for a positive control by 21 
mechanical disruption using vigorous pipetting (for 10 s). The re-suspended biofilms were 22 
then transferred to the wells of a new 96-well plate. The turbidity of the re-suspended 23 
biofilm was immediately measured at an absorbance of 600 nm   for a baseline measure and 24 
repeated after a 24h incubation at 37°C. The antimicrobial effect of the diluted mouthwash 25 
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concentrations was evaluated as described in the planktonic assay with the difference that 1 
S. mutans dual cultures were incubated anaerobically at 37°C as P. aeruginosa growth was 2 
detected on MSB.   3 
Mean values were determined from triplicate experiments and the antibiofilm effect 4 
recorded as the lowest concentration of the antimicrobial agent that demonstrated a ≥80% 5 
reduction in absorbance compared with the positive control of untreated biofilm 6 
suspensions. All experiments were performed in triplicate and on three separate occasions. 7 
The minimum biofilm eradication concentration (MBEC) was defined as the lowest 8 
concentration of antimicrobial agent that showed ≥80% reduction in absorbance compared 9 
to the positive control.  10 
5.3.3.4 Assessment of microbial viability after antimicrobial exposure  11 
To evaluate whether the antimicrobial effect was bacteriostatic or bactericidal, a portion of 12 
culture from the test wells (including at the optically determined MIC) was plated on 13 
appropriate agars i.e. MSB for S. mutans, SAB for C. albicans, MSA for S. aureus and 14 
Pseudomonas agar (PsA) for P. aeruginosa. Inoculated plates were incubated for 48 h to 15 
assess viability of isolates, with the exception of S. mutans, which was incubated for 5 days, 16 
as the growth of this organism was slower on the selected agar. 17 
5.4 Results 18 
5.4.1 Comparison of oral hygiene delivery in mechanically ventilated patients using 19 
swabs and toothbrushes 20 
Informed consent for 28 patients was obtained by a consultant (Dr Matt Wise). After 21 
inspection by the dental professional (Mr Sean Haywood, Ms Tracey Kinsella or Dr Charlotte 22 
Emanuel), 6 consented patients could not enter the study as they had insufficient or 23 
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asymmetric teeth and one further patient died within 24 h, leaving 21 patients to complete 1 
investigations. Following a safety alert from the UK medicines and healthcare products 2 
regulatory agency (MHRA 2012)(not arising from this study), foam swabs were subsequently 3 
withdrawn from clinical use in Wales (but not elsewhere in the UK) and no further 4 
recruitment was allowed.  5 
The 21 patients comprised of 10 males and 11 females, aged between 23 and 70 years (mean 6 
age 49 years). Recorded patients’demographic characteristics on admission, diagnosis, and 7 
DMFT index (Table 5.5). The length of hospitalisation and intubation at time of recruitment 8 
was presented in Chapter 2 (Table 2.7). On average, days of hospitalisation prior to 9 
admission in intensive care were 3.4 (4.5 SD), and ventilator days prior to randomisation was 10 
an average 3.4 (3.2 SD) days. The majority of patients (16/21) were in receipt of antibiotic 11 
therapy at the start of the study. The median number of follow-up days was 4 days (range 2 12 
to 7 days) and mean DMFT score was 10.7 (SD 5.2, range 3 to 23). Compliance with the oral 13 
interventions was 100% and there were no reports of harm or unintended effects for any of 14 
the participants.  15 
Baseline scores together with changes in each outcome over time for plaque index, gingival 16 
index and bacterial counts for each treatment are presented in Table 5.6 and Figures 5.3 - 17 
5.5.  18 
There was a significant reduction in plaque index over time for use of toothbrushes (mean 19 
change=-1.26; 95% confidence interval=-1.57, -0.95; p=< 0.001) and foam swabs (mean 20 
change=-1.28; 95% confidence interval=-1.54, -1.01; p=< 0.001). There was also a significant 21 
reduction in gingival index over time using toothbrushes (mean change= -0.92; 95% 22 
confidence interval= -1.19, -0.64; p=<0.001) and foam swabs (mean change= -0.85; 95% 23 
confidence interval= -1.10, -0.61; p=<0.001). There was no significant difference in reduction 24 
of plaque index between the two interventions (p=0.24). Greater reduction in gingival index 25 
 224 
 
was observed for toothbrushes compared to foam swabs (Figure 5.6), although this was not 1 
statistically significant (p=0.12). The number of days of cleaning was a significant covariate 2 
in the analysis of change in gingival index (p=0.003) and plaque index (p=0.05). There was 3 
some evidence of an interaction between treatment and baseline DMFT score for both 4 
change in gingival index (p=0.07) and plaque index (p=0.06), suggesting that the impact of 5 
toothbrushes and foam swabs may be highest in those with poorest oral health.  6 
An overall analysis of patients’ oral health status was compared to results from the 2009 7 
Adult Oral Health survey (Health and social care information centre 2011) undertaken by the 8 
National Health Service (NHS) Information Centre for health and social care (Table 5.7). 9 
Based on this previous survey, it was apparent that the patient cohort examined in this study 10 
had a similar number of teeth present and less obvious caries than the general population. 11 
However, periodontal health was worse, impacting on overall oral health (Table 5.7). The 12 
2009 survey reported that 10% of the population had excellent oral health, but if similar 13 
parameters of excellence were applied to the participants in this current study, only one 14 
patient (4%) met these criteria. For patients that were not randomised on the same day of 15 
hospital admission, it was possible that their periodontal health had progressively 16 
deteriorated due to inability to perform their normal oral hygiene routine or reliance on 17 
healthcare workers to perform oral hygiene tasks.  18 
No significant change in bacterial counts occurred with toothbrushes or foam swabs (Table 19 
5.6). Ten patients had high baseline bacterial counts (≥106 colony forming units), with 7 and 20 
4 patients showing a reduction in these counts when toothbrushes and 21 
foam swabs were respectively used.  22 
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Table 5.5 Characteristics of the 21 mechanically ventilated patients participating in the study 
assessing oral care delivery. 
 Patient Sex Age Diagnosis DMFT 
P01 M 53 Sepsis 7 
P02 F 61 Urosepsis 21 
P03 M 70 Pneumonia/ Pneumocystis 
Pneumonia (PCP) 
14 
P05 M 43 Substance overdose/ 
Aspiration pneumonia 
7 
P06 F 55 Respiratory Failure 14 
P07 F 37 Aneurysm 3 
P08 F 26 Ventricular fibrillation arrest 
postpartum 
7 
P09 F 64 Respiratory failure 12 
P10 F 68 Head injury 17 
P11 F 55 Urinary sepsis 10 
P13 M 52 Respiratory/renal failure 15 
P14 M 29 Head injury 6 
P16 F 64 Type 2 respiratory failure 13 
P17 M 55 Respiratory failure 11 
P19 M 45 Sepsis and respiratory failure 17 
P20 F 23 Alcoholic liver disease and 
pneumonia 
4 
P21 M 32 Cardiac arrest 10 
P24 F 44 Sepsis 4 
P25 F 49 Cardiogenic shock 4 
P27 M 39 Type 1 respiratory failure 9 
P28 M 52 Septic shock 9 
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Table 5.6 Baseline scores and change in outcomes (plaque index, gingival index and bacterial 
counts) by mechanical method (n=21 patients). 
Outcome Method 
 Toothbrush 
 
Foam Swab 
Mean baseline plaque index 
(SD) 
2.1 (0.49) 2.1 (0.42) 
Mean baseline gingival index 
(SD) 
2.1 (0.57) 2.0 (0.53) 
Median baseline bacterial 
count (min, max) 
4.6 x 105 
(2.4 x 103, 2.5 x 1010) 
5.9 x 105 
(4.0 x 102, 3.1 x 1010) 
Mean change in plaque index 
(SD) 
-1.26 (0.68)a -1.28 (0.59)a 
Mean change in gingival index 
(SD) 
-0.92 (0.61)a -0.85 (0.54)a 
Median change in bacterial 
counts (CFUs/sampleb min) 
max) 
-3.7 x104 
(-2.5 x 1010, 8.7 x 107) 
-9 x 104 
(-3.1 x 1010, 3.0 x 107) 
 
aSignificantly different from baseline (P=<0.001); bEach sample consisted of plaque 
obtained from 6 teeth resuspended in 1 ml of transport medium. 
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Figure 5.3 Changes in plaque and gingival index patients 1 to 8. 
 Changes in Sinless and Löe (1964) plaque and gingival indices over a 7-day period 
using oral hygiene intervention either with a toothbrush (solid line) or foam swab 
(broken line). 
 4    i  9  17. 
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Figure 5.5 Changes in plaque and gingival index patients 19 to 28. 
Changes in Silness and Löe (1964) plaque and gingival indices over a 7-day period 
using oral hygiene intervention either with a toothbrush (solid line) or foam swab 
(broken line). 
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Table 5.7 Comparison of oral health parameters of this study's patients and the general 
population  
 
 
 
 
 
 
  
Parameter  ADH Surveya Study 
Overall number of teeth 25.7 24.4 
Healthy periodontal tissuesb 17% 10% 
Obvious tooth caries 31% 23% 
Excellent oral healthc 10% 4% 
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Figure 5.6 Boxplots of change in gingival index (from baseline) for each study day. 
Asterisks represent extreme outliers > 3 IQR; circles represent outliers > 1.5 IQR. 
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5.4.2 Comparison of biofilm development of different endotracheal tube biomaterial 
surfaces 
Figure 5.7 presents the relative number of colonising microorganisms on the PneuX™ and 
Portex®, Evac® and silver coted ETTs. In terms of total microbial counts, there was no 
significant difference for the tested ETTs (p=>0.05). It was evident from this data that 
numbers of C. albicans were consistently low on all of the surfaces, whilst similar levels of S. 
aureus, P. aeruginosa, S. mutans and P. gingivalis were encountered on all ETT types. It 
would appear that all the ETTs tested were equivalent in terms of in vitro biofilm generation.  
5.4.3 Susceptibility of planktonically cultured microorganisms and biofilms to 
antimicrobial mouthwashes 
The susceptibility of planktonic, single species and dual species biofilms to three 
antimicrobial mouthwash preparations, Citroxx®, Listerine® and CHX was determined. 
A summary of the results are presented in Table 5.8 (average results per tested 
concentration in Appendix II). All microorganisms tested as planktonic cultures were 
susceptible to all the antimicrobial mouthwashes, except for P. aeruginosa which was 
resistant to 50% (v/v) Listerine.  
In all experiments, the MBEC was higher for single species biofilms than the MIC for 
planktonic cultures. Increased tolerance of biofilm cells was determined to vary between 2 
and >1200 fold depending on species. The exception to this was for S. aureus where equal 
susceptibility of planktonic and single species biofilm preparations to 2% Citroxx® BD was 
evident. Additionally, a number of dual biofilm preparations had higher resistance than the 
single species biofilms to the mouthwashes. For example, in the case of susceptibility to 
Citroxx® BD, the dual species biofilm combination of S. aureus/S. mutans and S. aureus /C. 
albicans exhibited MBEC of 8% (v/v) and 4% (v/v) respectively, compared with 2% (v/v) for 
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single species biofilms. In addition, some biofilms were not affected by exposure to the 
antimicrobial mouthwashes (Table 5.8). Pseudomonas aeruginosa biofilms exhibited 
resistance to Listerine®, CHX and, when cultured in combination with C. albicans, resistance 
to Citroxx® was also apparent. 
Subsequent culture of mouthwash treated biofilms on to appropriate agars was used to 
assess whether viable cells still persisted at the MIC/MBEC of the mouthwashes (Table 5.8). 
For the majority of preparations exposed to CHX (10/12) and Citroxx® (8/12) viable 
microorganisms could be detected post treatment. Listerine® treatment also showed the 
persistence of viable cells (6/12), albeit at a reduced incidence. In dual species biofilms of P. 
aeruginosa or S. aureus with an oral species (i.e. C. albicans or S. mutans) only the respiratory 
pathogens retained viability at the apparent MBEC. 
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Figure 5.7 Total microbial counts per for four different endotracheal tubes PneuXTM, Evac, Silver coated and Portex (Right). Recovered 
counts per species, figures show average counts for 4 replicates (Left). Error bars show standard deviation. 
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Table 5.8 Summary table of minimum inhibition concentrations (MIC) for Listerine®, 
Citroxx® and Chlorhexidine (CHX). Growth from culture at the MIC are indicated as Yes or 
No; F represents number of fold change resistance of biofilms compared to planktonic. 
 
 
Listerine®  F Citroxx® F CHX F 
S. aureus planktonic 12.5% 
No 
 2% 
Yes 
 0.0004% 
Yes 
 
S. aureus single biofilm >50%% 
Yes 
6 2% 
No 
0 0.008% 
Yes 
 
20 
S. aureus (with S. mutans) 50% 
No 
4 8% 
No 
4 0.008% 
Yes 
20 
S. aureus (with C. albicans) >50% 
Yes 
>8 4% 
No 
2 0.03% 
Yes 
75 
P. aeruginosa planktonic >50% 
Yes 
 2% 
Yes 
 0.004% 
Yes 
 
P. aeruginosa single biofilm >50% 
Yes 
 8% 
Yes 
4 >1.92% 
Yes 
>480 
P. aeruginosa (with S. mutans) >50% 
Yes 
 8% 
Yes 
4 >1.92% 
Yes 
>480 
 
P. aeruginosa (with C. albicans) >50% 
Yes 
 >8% 
Yes 
>4 >1.92% 
Yes 
>480 
S. mutans planktonic 12.5% 
No 
 4% 
No 
 0.0002% 
Yes 
 
S. mutans single biofilm 25% 
No 
2 >8% 
Yes 
>2 >0.24% 
 
>1200 
S. mutans (with S. aureus) No  No  No  
S. mutans (with P. aeruginosa) No  No  No  
C. albicans planktonic 25% 
No 
 4% 
Yes 
 0.002% 
No 
 
C. albicans single biofilm 50% 
No 
2 >8% 
Yes 
>2 1.92% 
No 
960 
C. albicans (with S. aureus) No  No  Yes  
C. albicans ( with P. aeruginosa) No  No  No  
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5.5 Discussion 
The oral cavity has been shown to become colonised with respiratory pathogens associated 
with VAP in patients who are mechanically ventilated (Chapters 2 and 3). The co-existence 
of oral microorganisms and respiratory pathogens may also lead to symbiotic effects such 
as enhanced biofilm production and gene expression (Chapter 4) which could lead to more 
difficult to eradicate biofilms. 
A logical approach aimed at preventing VAP would therefore be to reduce the bacterial load 
within the oral cavity of mechanically ventilated patients either through mechanical 
(toothbrushing) and/or chemical interventions (antimicrobial mouthwashes).  
In addition, ETT biofilms have also been shown to be a source of respiratory pathogens 
alongside typical oral microorganisms. As this can also serve as a reservoir of infection 
approaches that limit such biofilm development (e.g. modification to the design of the ETT 
or its material) could also have benefit in reducing the risk of VAP. The primary aim of the 
research presented in this chapter was to evaluate different strategies that could potentially 
reduce the microbial load of both the oral cavity and biofilms in ETT lumens. 
In health, the oral microflora is not traditionally considered a source of infection for the 
lower airways. This is despite recent research showing that the microbiome of lower airways 
include oral microorganisms (Beck et al. 2015; Cui et al. 2014). In health, the oral microbiome 
does not normally include respiratory pathogens such as P. aeruginosa and S. aureus 
(Dewhirst et al. 2010; Paster et al. 2001). In healthy adults oropharynx P. aeruginosa 
prevalence is estimated between 0 to 6.6% (Lister et al., 2009, Morrison and Wenzel, 1984) 
and S. aureus between 3% to 46% (Eick et al. 2016; Ohara-Nemoto et al. 2008). However, in 
critically ill patients the occurrence of these pathogens in the mouth is much more prevalent 
and during mechanical ventilation a rapid change in the dental plaque microbial community 
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to include respiratory pathogens culture based studies have reported respiratory pathogens 
prevalence of 26% to 65% (Fourrier et al. 1998; Sachdev et al. 2013), however culture 
independent studies (Sands et al. 2016) and the work presented in Chapters 2 and 3 have 
found that up to 100% of mechanically ventilated patients are colonised. Molecular analysis 
of the oral microbiota and that of the lower airways of VAP patients show that genetically 
identical organisms are present at both sites, supporting the concept that potentially 
pathogenic bacteria colonising the oral cavity are also involved in pulmonary infection 
(Bahrani-Mougeot et al. 2007; Heo et al. 2008). Additionally, in Chapter 2, microbial species 
from ETT biofilms and non-directed bronchial lavages (NBLs) from mechanically ventilated 
patients had identical genetic profiles (electrophoretic karyotypes and RAPD fingerprints) to 
dental plaque microorganisms. These findings strongly link the mouth as a source of VAP 
causing pathogens. 
Importantly, improvement in oral hygiene during mechanically ventilation has been 
identified as a VAP prevention strategy. Indeed, this approach is a component of current 
VAP prevention guidelines in the UK, Europe and USA (Masterton et al. 2008; Rello et al. 
2010b; Speck et al. 2016). Importantly, most studies designed to improve oral care in 
mechanically ventilated patients tend to involve antiseptic or antibiotic strategies (Cutler 
and Sluman 2014; Hoshijima et al. 2013; Koeman et al. 2006). Frequently, CHX treatment is 
used unlike typical approaches employed in dentistry to prevent plaque mediated-disease 
such as dental caries and gingivitis. In dentistry most effort is directed to the mechanical 
removal of dental plaque by toothbrushing and flossing (Claydon 2008). The reason for this 
discrepancy in practice may be due to critical care healthcare professionals being more 
familiar with employing pharmacological interventions (Wise et al. 2008). 
Almost all studies demonstrate that plaque scores increase in critically ill patients even when 
oral care programmes are in place (Fourrier et al. 1998; Sachdev et al. 2013; Scannapieco et 
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al. 1992). It should also be highlighted that there is considerable variability amongst critical 
care nurses on how they deliver oral care, with some opting for antiseptic solutions or gels, 
and when teeth are brushed, some use a foam swab in preference to a toothbrush (Feider 
et al. 2010; Grap et al. 2003; Rello et al. 2007). As such it is important to determine optimal 
oral care approaches to improve oral hygiene in mechanically ventilated patients (Wise and 
Williams 2013).  
In this current research, an evaluation of two approaches to deliver oral care in mechanically 
ventilated patients was undertaken. These approaches were the use of a small headed 
toothbrush or a foam swab to brush patients’ teeth. The study was a split-mouth design 
which was used as it reduces inter-individual variability. The results demonstrated that both 
plaque and gingival scores improved following these interventions and there was no 
significant difference between the approaches in improving oral cleanliness. Similar findings 
were reported in a recent study of 48 critically ill patients which compared toothbrushing 
against use of a gauze swab. Included with both interventions was administration of CHX at 
12 h and 24 h intervals. The study showed a similar reduction in visible plaque and gingival 
bleeding with all interventions (Oliveira et al. 2014). This is in contrast with other studies 
where the use of a toothbrush for mechanical disruption of plaque has been found to be 
most effective (Addems et al. 1992; Pearson and Hutton 2002).  
In this present investigation, the foam swab used had a coarse ridging (Figure 5.1), which 
may have assisted plaque removal, the head was of a similar size to that of the toothbrush 
used and both devices were applied using the same technique, which may account for the 
similarity in the results. Importantly, there was invariably some restricted access to dental 
surfaces given the presence of the ETT. A limitation to this study was its relatively short 
follow up period (2 to 7 days). However it would be expected that the changes in the level 
of dental plaque accumulation would be most noticeable in the first 48 h, and it was possible 
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that any improvement in plaque reduction would reach a plateau where no further 
significant improvement could be achieved. Nevertheless, lower levels of dental plaque 
would be expected when a strict protocol was followed. A similar dynamic was expected 
with gingival inflammation scores although the initial response was anticipated to be lagged 
compared with plaque scores, given that gingival responses to the new conditions would 
take time. A previous study compared use of an electric toothbrush with a foam swab in 46 
individually randomised patients, with cleaning undertaken four times a day for 2 min in 
combination with 20 ml of 0.2% CHX (Needleman et al. 2011). This previous study found that 
a powered toothbrush was significantly better at reducing plaque compared with the foam 
swab. However, it was reported that the foam swabs also reduced plaque scores significantly 
from initial baseline scores. Powered toothbrushes have the advantage of a much smaller 
head than a manual brush and direct visualisation of brushing is not necessary, as the 
rotating head has only to be held on the tooth surface. In mechanically ventilated patients, 
a powered toothbrush may have an advantage over a manual toothbrush for these reasons 
and could be an area for future work.  
No reduction in the number of bacteria that were isolated from plaque was seen with either 
method. This might reflect difficulties in plaque collection, or arise from the fact that plaque 
quantity is not just a reflection of bacterial number but also of extracellular polymeric 
substances (EPS) that are be present. For example, there could be instances where plaque 
indices differ not because of significant changes in bacterial number but due to removal of 
large quantities of EPS. This result is in contrast to the study of Needleman, where CHX was 
used in combination with a toothbrush or foam swab and led to significant reductions in the 
number of bacteria recovered from plaque.  
It is important to clarify that this study focused on the efficacy of two oral hygiene practices 
rather than their effect on VAP incidence, ICU length of stay or mortality rates. 
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Toothbrushing has been used in a number of critical care studies as a means to reduce VAP, 
with mixed findings arising (Lorente et al. 2012; Munro et al. 2009; Pobo et al. 2009; Yao et 
al. 2011). Unfortunately, within these studies, compliance with the intervention was 
typically variable (Ames 2011) and none of the studies documented whether there was a 
reduction in dental plaque (which serves as the reservoir for respiratory pathogens). In this 
study, both foam swabs and toothbrushes were able to reduce plaque scores in 
mechanically-ventilated patients and were not significantly different in this regard. 
However, considerably more research is required to define the optimal method for 
mechanically removing plaque; a powered toothbrush, a manual brush with a smaller head, 
or increased frequency of cleaning may prove more effective and larger sample size will 
make findings more robust.  
Since mechanical disruption appears to yield similar results regardless of the method used, 
other prevention strategies should be considered, including antimicrobial intervention. In a 
recent Cochrane review, the use of CHX and other oral mouthrinses to deliver oral care in 
the critically ill were analysed. The study concluded that there was evidence for a reduction 
in risk VAP from 25% to 19%, with a number of needed to treat of 17 (Hua et al. 2016). 
In order to assess efficacy of oral mouthwashes against mixed species biofilms comprising 
of oral species and respiratory pathogens, an in vitro study was performed. The in vitro 
model is simple compared to the clinical scenario, however it allows control for 
environmental factors and avoids confounding variables such as the use of antibiotics and 
age and co-morbidities. The simplicity of the in vitro model also makes the study financially 
and logistically affordable. The results from these experiments showed high variability in 
microbial susceptibility to the test agents, depending on the microbial species/combination. 
Generally, CHX was the most effective mouthwash as it retained activity, below its 
therapeutic dose (0.12% -0.2%) and significantly inhibited all planktonic cultures and S. 
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aureus biofilms. However, P. aeruginosa, and C. albicans biofilms were resistant to CHX even 
at 1.92%, and S. mutans showed an increased resistance of >1200 fold compared to the 
planktonic growth. Pseudomonas aeruginosa biofilm resistance to CHX has previously been 
reported (Bonez et al. 2013). Elevated resistance (8-fold higher) of C. albicans biofilms on 
denture acrylic discs compared with planktonic cultures has also been found (Lamfon et al. 
2004). Previously, S. mutans has been shown to be susceptible to CHX and there are no 
reports of resistance. However, most studies have been performed on isolates in planktonic 
state using disc diffusion assays and not against biofilms (Grönroos et al. 1995; Järvinen et 
al. 1993), although other Streptococcus species biofilms have however been shown to be 
susceptible to low CHX concentrations (Malic et al. 2013). CHX is less effective in vitro than 
other antiseptics, but in vivo the agent binds to clean tooth surfaces and is released over 
time, a property called substantivity. This property serves to slow plaque accumulation on 
‘clean’ tooth surfaces (García-Caballero et al. 2013; Singh et al. 2011). It follows that CHX is 
considered to be most effective when the plaque has previously been disrupted (Shen et al. 
2010).  
The antimicrobial effectiveness of Citroxx® BC was initially encouraging, as all planktonic 
cultures and most biofilms (8/10) were susceptible to this agent, with MICs of between 2% 
and 8% (maximum concentration tested). However, the commercial preparation of Citroxx® 
BC is a 1% formulation, which was less effective at inhibiting planktonic and biofilms 
microorganisms. However, <1% Citroxx® concentrations have previously been reported to 
be effective against Candida and Streptococcus species in both planktonic and biofilm 
growth forms (Hooper et al. 2011; Malic et al. 2013). Listerine® Total Care Zero was the least 
effective mouthwash tested, with resistance shown by 5/8 of the biofilm preparations, as 
well as P. aeruginosa in planktonic state. In a clinical study involving 398 mechanically-
ventilated patients, Listerine use led to no improvement in dental plaque colonisation by 
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respiratory pathogens, nor resulted in a reduced VAP incidence (Berry 2013). Despite these 
findings, the use of essential oils and plant extract-based agents should not be completely 
disregarded, as synergistic activity has been demonstrated between CHX and essential oils 
including 1,8-cineole against S. aureus, methicillin-resistant S. aureus (MRSA), Escherichia 
coli and C. albicans. Furthermore, combinations of CHX and Citroxx® BC have also been 
reported to have enhanced antimicrobial effects against biofilms of MRSA and P. aeruginosa 
(Hendry et al. 2009), and Candida and Streptococcus species (Malic et al. 2013). 
In all dual species biofilms involving either S. aureus or P. aeruginosa combined with C. 
albicans or S. mutans, only S. aureus and P. aeruginosa were found to retain viability at the 
MIC concentration. One obvious reason for this finding would be the inherent difference in 
susceptibility between the combined species. Indeed, the previously determined MICs were 
lower for the species that had been eradicated. For example, the MBEC values of Listerine® 
were 25% and 50% for S. mutans and C. albicans single species biofilms, respectively. For S. 
aureus single species biofilms, the MIC was >50%. Another possible explanation was that 
one microorganism may have outcompeted the other in the biofilm prior to antimicrobial 
treatment as was observed in Chapter 4. It was found that P. aeruginosa inhibited the 
growth of C. albicans in dual biofilm preparations, this inhibition has previously attributed 
to the release of phenazines by P. aeruginosa (Hogan et al. 2004; Kerr 1994). Additionally, 
P. aeruginosa tends to grows rapidly in vitro which could have impacted in S. mutans growth 
(LaBauve and Wargo 2012).  
An improved understanding of how antimicrobials interact with mechanical methods is 
required. In a recent meta-analysis, Klompas et al., (2014) suggested that CHX could be 
ineffective or possibly harmful in general critical care units, as it may promote occurrence of 
multi-resistant species. Additionally, allergic reactions to CHX mouthwash, including 
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anaphylactic reactions appear to be more frequently reported (Pemberton and Gibson 
2012). 
The last prevention strategy studied in this Chapter was modification of the ETTs 
biomaterial. For this study, four different ETTs were evaluated including a silicone ETT with 
a ‘coated lumen’ referred to as PneuX™, an experimental silver coated ETT, a standard PVC 
Evac® ETT, and the Portex® ETT. Experiments consisted of developing in vitro biofilms on ETT 
sections over 5 days using oral microbial species (S. mutans, C. albicans and P. gingivalis) 
and known VAP pathogens (S. aureus and P. aeruginosa). 
Results showed comparable levels (in terms of total microbial counts) of biofilm formation 
for all the microbial species for the tested ETTs. When analysed by species type, all tested 
ETT surfaces had lower numbers of C. albicans on the ETT surface compared with bacteria.  
These findings would appear to suggest that the actual biomaterial surface of these ETTs, 
including the PneuX™ and silver coated surfaces, has a limited effect in preventing biofilm 
development. In the case of the PneuX™ ETT, observed in vivo biofilm reduction most likely 
reflect reduced subglottic leakage below the cuff, and the ability to obtain subglottic 
drainage above the cuff. One interesting observation for the PneuX™ tube was the apparent 
presence of ‘ridges’ on the inner luminal surface, which arose from the inner supporting wire 
of the PneuX™ tube. As part of future studies, it would be interesting to examine where 
microbial colonisation is occurring preferentially within these. There are no other in vitro 
studies available for the PneuX™ ETT. 
The silver coating of the ‘experimental’ ETT tested did not appeared to have an impact on 
biofilm growth, this was an unexpected finding as in vitro studies including animal models 
with rabbits and dogs had reported less bacterial colonisation on silver coated ETTs (Olson 
et al. 2002; Rello et al. 2010a). Rello et al., (2010) reported a significant (>90%; p<0.05) 
reduction in microbial attachment for (12/21) isolates including P. aeruginosa, in the 
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colonisation of tracheal and lung tissue of rabbits when a silver coated ETT was compared 
to an uncoated control. Additionally, clinical trials have reported lower colonisation and a 
lower incidence of VAP when silver coated ETTs were used (Berra et al. 2008; Kollef et al. 
2008; Tokmaji et al. 2015). It is possible that as the tubes used in this experiments were from 
a different manufacturer, the performance was not the same as the commercially available 
tubes. In addition it is conceivable that the silver coating could have dissipated over the 5 
day study period used in these experiments. 
5.6 Conclusions 
 The oral health of patients admitted to the adult ICU was generally poor. Dental 
plaque and gingival inflammation indices were reduced when either a toothbrush or 
foam swabs were used in a strict oral care program. No differences were found in 
terms of bacterial load. 
 Planktonic cultures were susceptible to antimicrobial mouthwashes although varied 
levels of susceptibility were seen for single and dual biofilms, with higher levels of 
resistance seen in biofilms compared to planktonic cultures. 
 Microbial growth in biofilms was similar for four ETT surfaces, including a coated 
silicone ETT and an experimental silver coated ETT. 
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6. General Discussion 
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6.1. General discussion 1 
The impact of poor oral health on the general wellbeing of a person has been acknowledged 2 
for a number of conditions (Linden et al. 2013), and it is no longer considered only in relation 3 
to dental caries and periodontal disease. Indeed, poor oral health has now been linked with 4 
cardiovascular disease (Niederman and Weyant 2012), diabetes (Winning et al. 2017), low 5 
birth weight babies (Saini et al. 2011), rheumatoid arthritis (de Pablo et al. 2009) and renal 6 
disease (Sharma et al. 2016a). Of specific focus to this thesis, is that poor oral hygiene has 7 
also been implicated with higher incidence of respiratory infections, including community-8 
acquired pneumonia (CAP), health care-associated pneumonia (HCAP), hospital-acquired 9 
pneumonia (HAP) and ventilator-associated pneumonia (VAP) (Azarpazhooh and Leake 10 
2006; Fourrier et al. 1998; Scannapieco et al. 1992). 11 
Ventilator associated pneumonia (VAP) is the most common nosocomial infection in 12 
intensive care units (UCI), and defined as a pneumonia that occurs 48h after the start of 13 
mechanical ventilation. The condition affects between 8 and 28% of mechanically ventilated 14 
patients (Chastre and Fagon 2002) whose hospital stay is subsequently extended to an 15 
average of an extra 5 to 7 days (Safdar et al. 2005). Additionally, VAP has an attributable 16 
overall mortality rate estimated at 13% (Melsen et al. 2013) and results in increased 17 
treatment costs of up to £22.000 per case (Wagh and Acharya 2009). Clearly, VAP is a highly 18 
significant clinical problem and investigation into contributory factors are undoubtedly 19 
warranted.  20 
One of the associated factors for VAP, is respiratory pathogen colonisation of dental plaque 21 
in mechanically ventilated patients, which has been estimated to occur in 40% to 65% of 22 
patients (Fourrier et al. 1998; Sachdev et al. 2013; Scannapieco et al. 1992). The movement 23 
of these pathogens from the mouth to the lower airways is likely assisted by the placement 24 
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of an endotracheal tube (ETT), which will impede normal host defence mechanisms in the 1 
trachea (ciliary movement and cough reflexes). Oropharyngeal secretions ultimately pool 2 
above the inflated ETT cuff and following micro leakage via channels formed in the cuff, 3 
microorganisms in these secretions can then colonise the lower airways, promoting VAP 4 
(Dave et al. 2010; Hamilton and Grap 2012). Furthermore, not only can these 5 
microorganisms directly colonise the lungs, but soon after commencement of mechanical 6 
ventilation, biofilms consisting of both respiratory pathogens and oral microorganisms can 7 
be detected within the ETT lumen (Cairns et al. 2011; Perkins et al. 2010; Vandecandelaere 8 
et al. 2012). As these biofilm have unrestricted and direct access to the lower airways they 9 
serve as likely reservoirs of infectious agents. Since the ETT lumen is not accessible to either 10 
administered antibiotic therapies or host defence factors, eradication of these biofilms is 11 
extremely problematic and currently not achievable without ETT replacement. Furthermore, 12 
the replacement of ETT is considered an independent risk factor for VAP incidence (de 13 
Lassence et al. 2002; Torres et al. 1995). 14 
It is important to mention that throughout this research project key microorganisms that 15 
were representative of both the normal oral microflora (Streptococcus mutans, 16 
Porphyromonas gingivalis and Candida albicans) and respiratory pathogens associated with 17 
VAP (i.e. Staphylococcus aureus and Pseudomonas aeruginosa) were selected as target 18 
species for the analysis of clinical samples and in vitro experiments.  19 
Staphylococcus aureus and P. aeruginosa were selected as respiratory pathogens because 20 
they are deemed responsible for approximately 50% of VAPs (Chastre and Fagon 2002) and 21 
are not microorganisms that are normally considered inhabitants of the oral microflora in 22 
health. Indeed oral carriage in health has been estimated as < 7% for P. aeruginosa (Morrison 23 
and Wenzel 1984; Rivas Caldas et al. 2015) and between 3 to 50% for S. aureus, although 24 
when present, has been considered to be a transient coloniser rather than a permanent 25 
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resident (Eick et al. 2016; Ohara-Nemoto et al. 2008). Streptococcus mutans was as a typical 1 
oral microorganism given the high prevalence of the Streptococcus genus in dental plaque 2 
(Dewhirst et al. 2010). Streptococcus mutans itself has an incidence (72% to 95%) in the 3 
mouth and can be detected at levels of 106 colony forming units (CFU)/ml of saliva (Emilson 4 
and Thorselius 1988; Sharma et al. 2016b). Streptococcus mutans is also an adept biofilm 5 
former and readily attaches to the hard enamel surfaces of teeth (Lynch et al. 2013). 6 
Porphyromonas gingivalis was selected as a representative oral microorganism given its high 7 
incidence in subgingival plaque. Additionally, given the fact that critically ill patients were 8 
likely to have poor oral hygiene, it was anticipated that they would exhibit higher levels of 9 
gingivitis which is associated (50-79% of cases) with P. gingivalis (Ertugrul et al. 2013; Griffen 10 
et al. 1998; Ito et al. 2014). Furthermore, this anaerobic bacterium had previously been 11 
found in ETT biofilms (Cairns et al. 2011). The last oral species targeted was C. albicans, 12 
which, although far from being exclusive to the oral cavity, often colonises the oral mucosa 13 
with a prevalence estimated between 50 % to75% (Javed et al. 2013; Mayer et al. 2013) and 14 
it is also able to form biofilms in biomaterials including ETTs (Vandecandelaere et al., 2012). 15 
One of the underlying hypotheses of this thesis was that oral microorganisms would play a 16 
contributory role in the development of the ETT biofilm and facilitate colonisation by 17 
respiratory pathogens. To investigate this hypothesis it was firstly important to demonstrate 18 
the presence of typical oral microorganisms within ETT biofilms and in non-directed 19 
bronchial lavages (NBLs). These investigations were undertaken using traditional culture 20 
methods (Chapter 2) and contemporary molecular approaches (Chapter 3). 21 
Initially, this research used culture and species-specific PCR to detect the key target 22 
microorganisms mentioned earlier. Often microorganisms are difficult or not possible to 23 
cultivate from the oral cavity with the currently available media and culture conditions, and 24 
it is considered that approximately half of the species are not yet cultivable (Dewhirst et al. 25 
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2010). PCR-based methods offer the advantage of rapid high sensitivity in detecting species 1 
without the need for culture, and current technologies like next generation sequencing 2 
(NGS) can also inform on the relative abundance of individual species and characterise whole 3 
microbiomes in a cost effective manner (Didelot et al. 2012). 4 
The results of this research showed that oral species and respiratory pathogens were 5 
simultaneously present in the dental plaque, NBLs and ETT biofilms of the mechanically 6 
ventilated patients. Demonstrating the same species simultaneously at these sites within a 7 
given patient would imply a likely common origin of these microorganisms i.e. the oral cavity. 8 
However, this view would be reinforced if the organisms were shown to the same strain 9 
types. As a consequence, typing of isolates was undertaken by random amplification of 10 
polymorphic DNA (RAPD) and pulse field gel electrophoresis (PFGE) (Chapter 2). These 11 
results did indeed demonstrate that in many cases the isolated species from dental plaque 12 
were of the same genetic fingerprint as those recovered from NBLs and ETT biofilms within 13 
a given patient. These findings were similar to those reported by Heo et al., who studied 14 
dental plaque and bronchoalveolar lavage fluid from a hundred mechanically ventilated 15 
patients and found identical strains of S. aureus, P. aeruginosa, Escherichia coli and C. 16 
albicans by means of PGFE and multilocus sequence typing (Heo et al. 2008; Heo et al. 2011). 17 
Importantly, no previous studies have undertaken equivalent typing studies for isolates from 18 
the ETT biofilm.  19 
One limitation of the approach used in Chapter 2 was that only a few species were targeted. 20 
To address this, in Chapter 3, next generation sequencing (NGS) was used to characterise 21 
the microbiomes of dental plaque, NBL and ETT biofilm communities from mechanically 22 
ventilated patients. NGS theoretically allows all bacterial species in a sample to be detected 23 
as it is not reliant on culture or microbial viability (Didelot et al., 2012). There are of course 24 
limitations associated with NGS, some of which relate to potential bias in regards to DNA 25 
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extraction and PCR (Brooks et al. 2015) and others relate to the platform used and the 1 
downstream analysis that can lead to an overestimation of Operational Taxonomic Units 2 
(OTU) (Quince et al. 2011). NGS typically targets the 16S rRNA gene of bacteria and as these 3 
genes are normally in high abundance within the bacterial genome, the approach is generally 4 
more efficient than species-specific PCR (Poretsky et al. 2014). However, molecular methods 5 
do not normally distinguish between live and dead microorganisms, and without culture, 6 
phenotypic characteristics such as antibiotic resistance and virulence are arguably more 7 
difficult to ascertain. From these experiments it was found that the diversity in the 8 
microbiomes of dental plaque, ETTs and NBLs were similar. However, the NBL microbial 9 
communities were less similar to dental plaque compared with the ETT biofilm. 10 
Nevertheless, as previously reported by culture and species-specific PCR, typical oral species 11 
and respiratory pathogens were found at all sites. It is conceivable that in the lower airway, 12 
the lack of a hard surface for microbial attachment (or indeed other environmental 13 
differences from the other sites), was instrumental in the loss of some species leading to the 14 
observed differences in NBL microbiomes. Importantly, all of the 12 patients whose samples 15 
were studied by NGS had respiratory pathogens in their dental plaque including 16 
Streptococcus pneumoniae, Haemophilus influenza, S. aureus and P. aeruginosa. These 17 
species were amongst the top 20 most abundant in the dental plaque, and represent species 18 
that do not normally reside in the plaque of healthy individuals (Dewhirst et al. 2010; Paster 19 
et al. 2006). Whist the microbiome of ETTs, NBLs and dental plaque were similar, the most 20 
diverse sample was dental plaque which supports the notion of dental plaque being a 21 
reservoir for the other sites. Previous studies have used NGS methods to describe dental 22 
plaque, ETT biofilms and bronchial lavages (BAL) (Beck et al. 2015; Sands et al. 2016a; 23 
Vandecandelaere et al. 2012; Yang et al. 2015), but none have studied all three sites 24 
simultaneously. The results were similar to other studies which have shown respiratory 25 
 250 
 
pathogens were frequently and abundantly found in dental plaque (Sands et al. 2016a) and, 1 
that ETT biofilms were dominated by oral species like Prevotella and Peptostreptococcus 2 
(Vandecandelaere et al. 2012). The lung, is a site that has previously been considered a 3 
sterile one, however NGS technologies have shown that in the healthy adult, the microbiome 4 
of the lung is largely similar to the oropharynx. This was been shown in previous analyses of 5 
oral rinses and BALs in healthy subjects, where oral species including Streptococcus, 6 
Fusobacterium and Neisseria were found in relative high abundance (Beck et al. 2015). 7 
Moreover, a study that analysed oral washes, nasal swabs, gastric aspirates and BALs from 8 
28 healthy subjects using pyrosequencing concluded that the lung microbial community was 9 
different from that of the mouth, nose and stomach. However, bacterial communities of 10 
lungs and mouth overlapped with lower concentrations found in the lungs. Interestingly in 11 
this study, the nasal microbiome was distinct to that of the mouth and lung suggesting little 12 
contribution to the lung microbiome in health (Bassis et al. 2015). In VAP patients, the 13 
Streptococcus genus has previously been reported to be the most abundant from BAL 14 
samples, although species level identification was not undertaken (Yang et al. 2015). Kelly et 15 
al. (2016) demonstrated that intubated patients had an abnormal BAL microbiome at the 16 
time of intubation, which progressed to a characteristic pattern of lower diversity in clinical 17 
VAP cases. The same study also found in pneumonia patients where positive cultures were 18 
available they correlated to the most dominant species found through NGS but when 19 
cultures were negative the most predominant bacteria were those not usually thought to 20 
cause pneumonia (Enterococcus faecalis) and not normally cultured (Ureaplasma parum) 21 
(Kelly et al. 2016). 22 
A limitation to the work presented here was that the fungal microbiome or ‘mycobiome’ 23 
was not studied by NGS. A recent investigation of 202 patients divided in 6 sub-study groups 24 
(healthy, extra pulmonary infection, mechanically ventilated, mechanically ventilated 25 
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without pneumonia but on antibiotic therapy, mechanically ventilated with pneumonia and 1 
candidaemia) reported that in the critically ill, the mycobiome became rapidly predominated 2 
by Candida species. Interestingly, the critical illness and not antibiotic therapy was identified 3 
as the risk factor for Candida colonisation. Candidaemia was not associated with pulmonary 4 
colonisation and no association with bacteria was found in the pneumonia cases (Krause et 5 
al. 2016). This is in contrast to previous reports of Candida colonisation as a risk factor for 6 
Pseudomonas pneumonia (Azoulay et al. 2006; Roux et al. 2009). 7 
A further limitation to this part of the study was the relatively small number of 8 
samples/patients analysed by NGS. It was not possible to recruit more patients to the study, 9 
as the patients were part of a clinical trial (Chapter 5) comparing toothbrushes and foam 10 
swabs as methods of oral hygiene, and after a separate clinical incident (not associated with 11 
this study) the Wales Government banned the use of foam swabs (Jewell et al. 2012). There 12 
were also some difficulties in extracting bacterial DNA from some NBLs and ETTs, which also 13 
served to limit the number of samples analysed. Another potential issue related to the 14 
technique used to obtain NBLs. This involved inserting a catheter into the ETT until resistance 15 
was felt by the operator. Once the catheter had reached the lower airway, a saline solution 16 
was then used as an irrigation fluid and immediately aspirated. This method could 17 
potentially lead to cross contamination from the ETT, as the operator is effectively blinded 18 
and the saline solution could contact the ETT. An alternative to minimise potential cross 19 
contamination would have been to use a bronchoscopic technique, such as a protected 20 
brush specimen, however this technique is considered more invasive and offers little clinical 21 
advantage over NLBs (Flanagan et al. 2000). Therefore, alternative approaches to the NBL 22 
may not have been appropriate for patients where VAP was not suspected. NBLs were also 23 
already part of the ICU’s protocols for surveillance of VAP, and it is likely that a change of 24 
protocol would have not been ethically acceptable. 25 
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The primary aim of the research was to associate the microbiomes of dental plaque, ETT 1 
biofilms and the lower airways, and not to assess incidence of VAP to these microbiomes. 2 
VAP incidence was not recorded for all of the studied patients, partly due to the complexities 3 
of its diagnosis but also due to this information lacking from medical notes. Whilst this 4 
information could have been beneficial, it is likely that due to the relatively small patient 5 
cohort with wide variety of age and underlying medical conditions, a significant difference 6 
between VAP and non VAP patients would not have been achievable. 7 
Whilst these results provide clear association between the studied sites in terms of microbial 8 
translocation, the actual impact of the oral microorganisms on respiratory pathogens has 9 
previously received limited attention. 10 
Based on the findings from Chapters 2 and 3, it was evident that oral microbial species and 11 
respiratory pathogens co-existed in the dental plaque, the ETT biofilm and the lower airways. 12 
It was likely therefore that the oral cavity was a primary source of these species; however 13 
this finding on its own does not explain the potential interactions that may occur between 14 
these groups of microorganisms. The effect of oral bacteria on respiratory pathogens was 15 
the focus of the research presented in Chapter 4. In order to assess potential interactions, 16 
in vitro biofilms were generated and synergistic influences of the oral species (S. mutans, P. 17 
gingivalis and C. albicans) on biofilm formation and gene expression by targeted respiratory 18 
pathogens (S. aureus and P. aeruginosa) was assessed. The results showed that in dual 19 
biofilms, S. mutans increased biofilm formation by S. aureus. This increased biofilm 20 
development correlated with enhanced gene expression of genes associated with quorum 21 
sensing (agrI; Shopsin et al. 2003) and polysaccharide intercellular adhesin (PIA) production, 22 
(icaC, icaAb, icaBA, and icaRa genes; Malic, 2008). Pseudomonas aeruginosa was found to 23 
inhibit the growth of C. albicans in dual species biofilms, and this has previously been 24 
reported (Harriott and Noverr 2011; Hogan et al. 2004). In the presence of C. albicans, P. 25 
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aeruginosa releases toxic phenazines (Dietrich et al. 2006) which are considered cidal to 1 
Candida hyphae, thereby generating a growth substrate for P. aeruginosa (Harriott and 2 
Noverr 2011). The results showed that C. albicans presence led to upregulation of the algD 3 
and cupA genes of P. aeruginosa which encode for alginate production and adhesion to inert 4 
surfaces (Edwards and Saunders 2001; Mah et al. 2003). Importantly, gene expression and 5 
biofilm formation were enhanced for both respiratory pathogens as part of mixed species 6 
biofilms when all reference strains were included. 7 
A limitation to the in vitro biofilm model was its simplicity compared with the in vivo 8 
situation. In these experiments, ETT sections were immersed in broth, whilst in vivo, the ETT 9 
lumen would be relatively dry with higher oxygen concentrations. Furthermore, biomaterials 10 
and hard surfaces are normally covered by a complex conditioning layer formed from the 11 
absorption of water, protein, lipids extracellular matrix molecules, complement, fibronectin 12 
and inorganic salts, as a precursor of biofilm formation (Chapter 1 Section 1.2.1.1).  13 
Biofilms are associated with ‘difficult to treat’ and often recurrent infections due to their 14 
higher resistance to antibiotics (Luppens et al. 2002) and physical resilience (Normark and 15 
Normark 2002). It was therefore important to assess expression of biofilm related genes to 16 
further understand the infection process. Expression of a number of biofilm associated 17 
genes was therefore measured (Tables 4.4, 4.5). An alternative would have been to study 18 
genes associated with ‘true’ virulence factors including those involved in the invasion of host 19 
tissues or endotoxins linked with pneumonia. It has been reported that expression of type 3 20 
secretion system, exotoxin secretion and elastase production were associated with 21 
increased lung injury in a Pseudomonas pneumonia murine model (Le Berre et al. 2011). 22 
Recently, the S. aureus serine protease-like (spl) operon which carries six genes (slpA to splF) 23 
has been associated with invasion of the host in a rabbit pneumonia model (Paharik et al. 24 
2016). The research revealed more widespread lung damage in rabbits infected with the slp 25 
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mutant strain (Paharik et al. 2016). The same study also found that splA induced shedding 1 
of the mucin 16 glycoprotein from lung epithelial cells. Since mucin 16 is present at multiple 2 
body sites, including the airways, this function could facilitate infection (Paharik et al. 2016). 3 
Another study found that S. aureus strains exhibiting higher in vitro expression of agr, saeRS, 4 
sarA, hla, and Panton-Valentine leucocidin (pvl) genes were responsible for more severe 5 
cases of pneumonia, and higher bacterial counts in a rat pneumonia model (Montgomery et 6 
al. 2008). 7 
For this in vitro studies reference strains were used, however an alternative option would 8 
have been to use the clinical isolates found in the clinical samples of intensive care patients 9 
(Chapter 2). It is possible that the use of clinical isolates would give a better representation 10 
of bacterial interactions between respiratory pathogens and oral microorganisms. This was 11 
not however possible as part of this thesis to overlap timings during the experimental phase 12 
of this doctoral studies. 13 
As the research described in Chapters 2-4 had demonstrated both an involvement and 14 
influence of oral microorganisms on biofilms associated with VAP, it was a natural 15 
progression to consider potential interventions and strategies to disrupt and prevent these 16 
biofilms. These studies were undertaken in Chapter 5, which focused on evaluating two oral 17 
hygiene methods in mechanically ventilated patients, the effectiveness of mouthwash 18 
preparations for inhibiting in vitro biofilms and assessing different ETT surfaces in terms of 19 
biofilm formation. 20 
It was noted that poor oral health indices were evident in the majority of patients recruited 21 
to the clinical study. Only 4% of patients were classed as having excellent oral health (Table 22 
5.7) at the start of the study. The aim of this study was to determine the best method (of 23 
the two studied) for delivering oral hygiene in the mechanically ventilated patient. The 24 
normal practice in the ICU was to brush teeth using foam swabs with saline. It was presumed 25 
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that toothbrushes should be more efficient, which had been reported in a previous study 1 
comparing foam swabs and toothbrushes on healthy volunteers (Pearson and Hutton 2002). 2 
An alternative would have been to use an electric toothbrush as there is evidence of their 3 
superiority compared to manual toothbrushes in healthy individuals (Yaacob et al. 2014) and 4 
they are possibly easier to use.  5 
Importantly, dental plaque accumulation and gingival inflammation improved when either 6 
toothbrush or foam swab cleaning was implemented. The study showed that both methods 7 
were equally effective in improving oral cleanliness, although no significant changes were 8 
seen in the bacterial load. The study demonstrated that well trained and motivated staff 9 
could provide satisfactory oral care in mechanically ventilated patients with either of these 10 
mechanical cleansing devices. In this study, no antimicrobials were used as adjuvants, as no 11 
such agents were part of the ITU protocols at the time of the study, and it was thought that 12 
the use of a mouthwash could interfere with dental plaque accumulation and create a 13 
potential bias on the evaluation of the effects of mechanical cleaning. For future studies, it 14 
may be of value to record baseline scores of the basic periodontal exam (BPE) (Matthews 15 
2014). Despite its limitations in the diagnosis of periodontal disease, the BPE may offer a 16 
better indication of the periodontal condition pre- hospital admission. For example, the 17 
presence of dental calculus and deep periodontal pockets are unlikely to develop in just a 18 
few days of hospital stay and would not be expected to change despite an excellent 19 
toothbrushing technique or use of antimicrobials. A limitation of any toothbrushing 20 
technique, even in healthy adults is the presence of interproximal spaces that no toothbrush 21 
can effectively reach. It is because of such locations that daily use of dental floss or 22 
interproximal brushes is recommended to maintain good oral health (Claydon 2008). The 23 
problem of plaque removal from interproximal spaces has not been addressed in the 24 
mechanically ventilated patient. Routine oral care protocols do not address the problem, 25 
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probably as interproximal cleaning demands dexterity and good access to all sites in the 1 
mouth, which is a challenge in a heavily sedated patient with an ETT. Also, according to the 2 
oral health foundation, less than a quarter of people floss regularly 3 
(http://www.nationalsmilemonth.org/facts-figures/), and it is therefore not surprising that 4 
the practice is not at the forefront of most people’s minds. However, in the hospitalised 5 
patient, when dental plaque becomes colonised by respiratory pathogens this is likely to 6 
include the interproximal spaces, as well as other oral sites i.e. cheeks, tongue, lip, palate 7 
and subgingival spaces (Paster et al. 2006). It is possible that these sites act as ‘protected 8 
niches’ for respiratory pathogen colonisation allowing them to persist despite toothbrushing 9 
and mechanical and chemical intervention. Therefore, complete plaque removal in the 10 
mechanically ventilated patient (as well as heathy adults) is not practically possible and only 11 
a decrease in bacterial load can be expected. It remains to be established if oral hygiene 12 
intervention in mechanically ventilated patients can effectively achieve this goal. A study in 13 
elderly patients, found that the prevalence of pathogens including S. pneumoniae, S. aureus, 14 
and P. aeruginosa was not significantly different when the patients had received 15 
professional assistance with their oral care (Abe et al. 2001). Needleman et al., (2011) 16 
demonstrated improved dental plaque control and lower total bacterial counts in 46 17 
mechanically ventilated patients when a powered toothbrush was used in comparison to a 18 
sponge toothette. This previous study also found no significant differences in the prevalence 19 
of respiratory pathogens in the dental plaque, although the incidence of respiratory 20 
pathogens was relatively low, making it difficult to assess if a more effective toothbrushing 21 
technique would lead to reduced colonisation. The study reported a decrease (from day 1 22 
to 5) in S. aureus in the powered toothbrush group (26.1%-11%) that was not observed in 23 
the control group (33.3%-30%). The difference was not however statistically significant 24 
(p=0.3) (Needleman et al. 2011). This is in contrast to other studies that have reported an 25 
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increase in respiratory pathogens with increasing time of mechanical ventilation (Fourrier et 1 
al. 1998; Sands et al. 2016b). Additionally, Needleman’s study used only culture-based 2 
methods to determine the presence of the respiratory pathogens, which is likely to have 3 
limited sensitivity. For example, as described in this thesis, S. aureus was detected in dental 4 
plaque by culture in 6/21 patients, but using species-specific PCR, the incidence increased to 5 
13/21 (Chapter 2). Similarly, of the patients studied by NGS, 11 out of 12 plaque samples 6 
had S. aureus sequences detected (Chapter 3).  7 
The impact of toothbrushing on the reduction of VAP incidence has not been determined. 8 
There are only five studies (Lorente et al. 2012; Munro et al. 2009; Pobo et al. 2009; Roca 9 
Biosca et al. 2011; Yao et al. 2011) that have evaluated effects of toothbrushing on VAP 10 
incidence. Only one study, involving 53 patients, reported a reduction in VAP following 11 
toothbrushing (17% powered toothbrush group, 71% control group; p=<0.05). This study did 12 
not include antimicrobials and also reported reduced plaque accumulation (Yao et al. 2011). 13 
Most often, other studies include chlorhexidine in both control and toothbrushing groups. 14 
In Chapter 5, the efficacy of three antibacterial mouthwashes (Citroxx®, Listerine® Total Care 15 
Zero, and chlorhexidine) was tested against planktonic cultures and in vitro single and dual 16 
species biofilms developed by P. aeruginosa, S. aureus, C. albicans and S. mutans. It has been 17 
reported previously that biofilm cells are more resistant to treatment with mouthwashes 18 
than microorganisms in the planktonic state, with a degree of variability depending on the 19 
active ingredients (Hooper et al. 2011; Malic et al. 2013; Masadeh et al. 2013). Importantly, 20 
some bacterial species are more susceptible than others. It has been shown that whilst most 21 
Streptococcus species are susceptible to most available mouthwashes (Malhotra et al. 2011), 22 
P. aeruginosa and meticillin resistant S. aureus (MRSA) biofilms are reported as resistant to 23 
variety of mouthwashes, including CHX (Masadeh et al. 2013; Smith et al. 2013). This raises 24 
the concern that the use of antiseptic mouthwashes may favour the colonisation and 25 
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persistence of multidrug resistant species. Additionally there is a recent report that indicated 1 
that exposure to CHX resulted in Klebsiella pneumoniae developing resistance not just to 2 
CHX, but also to the colistin, which is considered a ‘last resort’ antibiotic (Wand et al. 2016). 3 
Despite these experiments not using a mouthwash preparation, it raises concerns over the 4 
potential promotion of antibiotic resistance. 5 
It was decided that although in vitro studies have the limitation of simplicity compared to 6 
the clinical scenario, they avoid confounding factors such as different patient medical 7 
histories, and the additional use of antibiotics. Furthermore, the cost and logistics of 8 
undertaking further in vivo studies in the PhD were inhibitory. It would have been interesting 9 
to repeat these experiments with clinical isolates from mechanically ventilated patients to 10 
assess their innate antimicrobial resistance.  11 
Importantly the results showed that biofilms were more resistant than planktonic cultures, 12 
and some dual species biofilms exhibited higher resistance than single species. These 13 
findings are in agreement with previous reports showing dual species biofilms having higher 14 
resistance, possibly due to clustering of the different species (Kara et al. 2007; Sanchez-15 
Vizuete et al. 2015). Other authors have reported inefficacy of CHX, essential oils, 16 
cetylpyridinium chloride and isopropylmethylphenol mouthwashes in penetrating and 17 
disrupting S. mutans biofilms (Wakamatsu et al. 2014). The most effective agent was 18 
deemed to be chlorhexidine (CHX), although P. aeruginosa biofilms were resistant to CHX 19 
even at the highest concentration used (1.92%). Chlorhexidine is more frequently used at 20 
0.12% or 0.2% formulations, although some investigations in mechanically ventilated 21 
patients have assessed 2% CHX solution and gels, and generally report a VAP reduction 22 
(Koeman et al. 2006; Tantipong et al. 2008). A recent Cochrane review reported that from 23 
18 randomised clinical trials (RCTs), use of CHX led to a reduced VAP incidence from 25% to 24 
19%, and no differences were found with CHX doses of 0.12%, 0.2% or 2%. However, no 25 
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difference was found in either mortality or hospital stay (Hua et al. 2016). Evaluation of other 1 
antimicrobial solutions in mechanically ventilated is very limited. A study evaluating 2 
Listerine® and sodium bicarbonate reported no reduction in VAP incidence (Berry 2013) 3 
Another RCT multicentre study on the effects of povidone-iodine also reported no 4 
improvement on VAP outcomes and a possible increased risk of acute respiratory distress 5 
syndrome (Seguin et al. 2014). 6 
Finally, an evaluation of four different ETT materials including a silicone ETT with a ‘coated 7 
lumen’ (PneuX™), an experimental silver coated ETT and two standard PVC ETTs (Evac® and 8 
Portex®) for their ability to inhibit microbial colonisation was undertaken. The results 9 
showed that all test surfaces equally supported biofilm growth, and based on this 10 
mechanism were unlikely to provide clinical benefit. However, as previously mentioned, the 11 
model system used was considerably more simplistic than that encountered in vivo. The 12 
PneuX™ ETT also offers multiple mechanisms to inhibit biofilm development in its lumen and 13 
these were not assessed in this study.  14 
6.2. Future work 15 
The relationship between dental plaque, ETT biofilms and VAP is complicated and needs 16 
further research and a number of projects could arise from the current work. 17 
Further phenotypic characteristics could be assessed from the isolates obtained from 18 
mechanically ventilated patients, including antibiotic resistance and the presence of genes 19 
previously described as being associated with resistance and virulence.  20 
Since the microbiome of the dental plaque, ETT biofilm and NBLs appears to be similar and 21 
frequently shared the same species and strains, it is possible that sampling dental plaque 22 
may be a useful practice in the surveillance for VAP. Analysing dental plaque may be an 23 
alternative and less invasive approach than NBLs for detection of important respiratory 24 
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pathogens. Taking dental plaque samples would arguably be less demanding for medical 1 
staff as they could be taken by a single nurse, be better tolerated by the patient and could 2 
also be helpful in establishing likely antibiotic sensitivity. 3 
Further studies of the oral/respiratory microbiome in mechanically ventilated patients 4 
should aim to recruit more patients for more robust results and evaluate the possibility of 5 
including the fungal microbiome in analyses for a more comprehensive study. For such a 6 
study, it would also be beneficial to develop improved DNA extraction techniques for NBLs 7 
and ETT biofilms. 8 
To develop effective preventative strategies in this field, robust in vitro models, potentially 9 
displaying the complexities of the ventilator-mouth-trachea-lung interfaces are needed. The 10 
incorporation of a pre-conditioning layer to the ETTs in vitro biofilms and the use of a more 11 
diverse list of oral/respiratory microorganisms may offer further insight into bacterial 12 
interactions between oral species and respiratory pathogens. In this PhD study, a selection 13 
of biofilm–related genes were studied, and other genes related to virulence factor could be 14 
explored in future research. 15 
Much variation is reported in the literature in terms of oral care protocols, and the frequency 16 
and use of antimicrobials (Hua et al. 2016), which makes policy making difficult, therefore 17 
ideally a large multicentre RCT that evaluates oral cleanliness, colonisation of respiratory 18 
pathogens and VAP incidence with and without the use of antimicrobials is required. 19 
Additionally the PneuXTM ETT has showed promising results from in vitro research and in a 20 
retrospective study in preventing leakage of oropharyngeal secretions that pool above the 21 
ETT cuff (Fletcher et al. 2008; Young et al. 2006); an RCT study of this ETT is needed to 22 
demonstrate its impact on VAP prevalence.  23 
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6.3. Conclusions 1 
Patients admitted to ICU have a poor oral hygiene status, and microbiological culture and 2 
molecular studies including next generation sequencing have revealed that the dental 3 
plaque of these patients becomes colonised by respiratory pathogens. Importantly, the 4 
same species were also found in the lower airways and ETT biofilms of these patients. 5 
Molecular genotyping showed that identical genetic profiles from isolates from dental 6 
plaque, ETTs and NBLs often occurred, and NGS showed that the microbiomes of these three 7 
sites were similar, thereby supporting the hypothesis that the microorganisms translocate 8 
from the mouth to the lower airway and ETT. Additionally, it was shown that oral 9 
microorganisms can enhance biofilm production and gene expression by targeted 10 
respiratory pathogens indicating a potential synergistic relationship.  11 
Evaluation of oral hygiene methods, antimicrobial mouthwashes and different ETT 12 
biomaterials highlighted the challenges involved when attempting to control biofilms in 13 
mechanically ventilated patients. Of significance in these investigations was that mechanical 14 
toothbrushing had significant effect on improving oral hygiene indices. Given the in vitro 15 
research presented in this thesis which shows how oral microorganisms facilitate in vitro 16 
biofilms and gene expression by respiratory pathogens, such oral care interventions could 17 
be highly valuable in management and prevention of VAP. Nevertheless more research 18 
aimed at reducing respiratory pathogens colonisation of the dental plaque and preventing 19 
biofilm formation in the ETT lumen are needed, as this creates a risk of developing VAP.  20 
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Appendix II: Phenotypic tests  
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Table 1 Phenotypic test results for isolates. Table shows patient, site of origin and result for 
catalase, coagulase and oxidase tests as appropriate; + ( positive), - (negative). 
Patient Site Isolate Catalase Coagulase Oxidase 
P01 Plaque Staphylococcus haemolyticus + -   
P03 Plaque Pseudomonas aeruginosa     + 
  NBL Pseudomonas aeruginosa     + 
  ETT Pseudomonas aeruginosa     + 
P05 Plaque Staphylococcus epidermis + -   
    Echerichia coli + -   
  NBL Echerichia coli + -   
P06 Plaque Staphylococcus aureus + +   
  NBL Staphylococcus aureus + +   
  ETT Staphylococcus aureus + +   
P07 NBL Streptococcus intermedius -     
  ETT Streptococcus intermedius -     
    Streptococcus gordonii -     
  Plaque Staphylococcus aureus + +   
P08   Echerichia coli + -   
  NBL Staphylococcus aureus + +   
P09 Plaque Staphylococcus haemolyticus + -   
  ETT Staphylococcus haemolyticus + -   
P10 Plaque Enterococcus fecalis -     
  NBL Staphylococcus aureus + +   
  ETT Staphylococcus aureus + +   
P14 Plaque Staphylococcus aureus + +   
P16 Plaque Staphylococcus haemolyticus + -   
  NBL Staphylococcus aureus + +   
P19 Plaque Staphylococcus aureus + +   
  ETT Echerichia coli + -   
P20 Plaque Staphylococcus aureus + +   
P21 Plaque Streptococcus mutans -     
    Staphylococcus aureus + +   
  NBL Staphylococcus aureus + +   
  ETT Staphylococcus aureus + +   
P24 Plaque Pseudomonas aeruginosa     + 
  NBL Pseudomonas aeruginosa     + 
P25 Plaque Streptococcus intermedius -     
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Table 1 
  
(continuation) 
     
Patient Site Isolate Catalase Coagulase Oxidase 
P27 Plaque Staphylococcus epidermis + -   
    Enterococcus faecium -     
  NBL Staphylococcus epidermis + -   
  ETT Staphylococcus epidermis + -   
    Enterococcus faecium -     
P28 Plaque Staphylococcus aureus + +   
    Klebsiella pneumoniae + -   
  NBL Klebsiella pneumoniae + -   
    Staphylococcus aureus + +   
  ETT Staphylococcus aureus + +   
    Staphylococcus Lugdunensis + -   
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a)   
 
b)  
Figure 1  a) Coagulase test on suspected S.aureus isolates:  #1 negative control, #2 positive 
control, #3 to # 6: test isolates. b) Oxidase test on suspected Pseudomonas aeruginosa 
isolates 
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Figure 2  a) Oxacillin strip test for identifying Methicillin Resistant Staphylococcus aureus. 
MSSA (methicillin sensitive S. aureus). b)  cefoxcitlin discs showing sensitivity for P19 isolate 
and resistance for P28 isolates from dental plaque (p), NBL, and endotracheal tube (T).
a
)) 
b 
MRSA strain 
MSSA strain 
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 Table 2.  Meticillin susceptibility tests results on Staphyloccocus aureus clinical isolates from 
plaque, non-directed bronchial lavages (NBL) and endotracheal tube biofikms (ETT) using an 
oxacillin strip and a cefoxitine disc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
S indicates sensitive, R indicates resistant
Patient Site Cefoxitine Oxacillin 
P06 Plaque S S 
  NBL S S 
  ETT S S 
P08 Plaque S S 
  NBL S S 
P10 Plaque R R 
  ETT S S 
P14 Plaque S S 
  ETT S S 
P19 Plaque S S 
P20 Plaque S S 
P21 Plaque S S 
  NBL S S 
  ETT S S 
P28 Plaque R R 
  NBL R R 
 ETT R R 
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Appendix III: Microbial susceptibility to 
mouthwash preparations 
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Table 1. Absorbance readings for Citroxx® assays for S. aureus (SA) in planktonic cultures, 
single biofilm and dual combinations with S. mutans (SM) and C. albicans (CA). 
Average from 3 sets of triplicate experiments shown with standard deviation (SD), 
highlighted text shows MIC/MCBI for 80% reduction.  
 
 
 
 
 
 
 
 
 
 
% SA 
Plank 
SD Single SD SA/SM SD SA/CA SD 
0 0.80 0.09 1.41 0.07 0.51 0.16 1.36 0.20 
0.25 0.70 0.10 1.18 0.25 0.36 0.16 1.31 0.23 
0.5 0.58 0.19 0.85 0.29 0.73 0.23 1.15 0.37 
1 0.43 0.31 0.55 0.44 0.55 0.47 1.14 0.32 
2 0.08 0.07 0.08 0.03 0.40 0.38 0.67 0.63 
3 0.05 0.03 0.11 0.06 0.46 0.40 0.53 0.59 
4 0.03 0.04 0.42 0.36 0.24 0.14 0.10 0.06 
8 
  
0.12 0.10 0.09 0.05 0.14 0.22 
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Table 2. Absorbance readings for Citroxx® assays for P. aeruginosa (PA) in planktonic 
cultures, single biofilm and dual combinations with S. mutans (SM) and C. albicans (CA). 
Average from 3 sets of triplicate experiments with standard deviation (SD), highlighted text 
shows MIC/MCBI for 80% reduction.  
 
 
Plank SD PA 
single 
SD PA/SM SD PA/CA SD 
0 1.46 0.77 1.08 0.34 1.75 0.71 1.52 0.37 
0.25 1.65 0.91 1.52 0.31 1.65 0.55 1.59 0.32 
0.5 1.81 1.05 1.49 0.29 1.79 0.57 1.61 0.36 
1 0.86 1.20 1.47 0.29 1.72 0.43 1.62 0.15 
2 0.05 0.05 0.75 0.74 1.44 0.63 1.85 0.18 
3 0.03 0.04 0.97 0.70 1.45 0.65 1.19 0.67 
4 0.02 0.04 0.65 0.71 0.76 1.22 0.85 0.65 
8 
  
0.15 0.31 0.30 2.45 0.30 0.23 
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Table 3. Absorbance readings for Citroxx® assays for C. albicans (CA) and S. mutans (SM) 
planktonic and single species biofilms. Average from 3 sets of triplicate experiments shown 
with standard deviation (SD), highlighted text shows MIC/MCBI for 80% reduction.    
 
 
CA 
Plank 
SD CA single SD SM 
Plank SD SM Single SD 
0 1.14 0.79 1.36 0.17 0.94 0.94 0.29 0.11 
0.25 1.15 0.70 1.30 0.13 0.98 0.84 0.39 0.25 
0.5 1.09 0.67 1.30 0.11 0.89 0.82 0.25 0.30 
1 0.94 0.55 1.28 0.12 0.68 0.73 0.09 0.06 
2 0.74 0.42 1.28 0.11 0.45 0.60 0.29 0.23 
3 0.59 0.40 1.32 0.08 0.41 0.53 0.23 0.18 
4 0.08 0.06 0.94 0.52 0.04 0.04 0.19 0.16 
8 
  
0.53 0.56 
  
0.10 0.12 
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Table 4. Absorbance readings for Listerine assays for S. aureus (SA) in planktonic cultures, 
single biofilm and dual combinations with S. mutans (SM) and C. albicans (CA). Average from 
3 sets of triplicate experiments shown with standard deviation (SD), highlighted text shows 
MIC/MCBI for 80% reduction.  
 
% SA 
Plank 
SD Single  
Biofilm 
SD SA/SM SD SM/CA SD 
0 0.96 0.09 1.22 0.28 0.68 0.42 1.53 0.16 
3.12 1.12 0.16 1.30 0.15 1.15 0.40 1.44 0.18 
6.25 0.76 0.13 1.20 0.21 1.34 0.32 1.54 0.16 
12.5 0.03 0.02 1.15 0.28 0.87 0.60 1.31 0.25 
25 0.03 0.02 1.29 0.30 0.84 0.79 1.46 0.36 
50 0.08 0.08 1.16 0.68 0.04 0.04 0.38 0.69 
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Table 5 Absorbance readings for Listerine assays for P. aeruginosa (PA) in planktonic 
cultures, single biofilm and dual combinations with S. mutans (SM) and C. albicans (CA).  
Average from 3 sets of triplicate experiments shown with standard deviation (SD), 
highlighted text shows MIC/MCBI for 80% reduction. Average from 3 sets of triplicate 
experiments shown with standard deviation (SD), highlighted text shows MIC/MCBI for 80% 
reduction.  
 
% PA 
Plank 
SD PA 
single 
SD PA/SM SD PA/CA 
 
0 1.80 0.32 1.57 0.34 1.69 0.26 1.60 0.49 
3.12 1.86 0.16 1.57 0.36 1.79 0.21 1.58 0.35 
6.25 1.53 0.11 1.68 0.22 1.70 0.23 1.60 0.35 
12.5 1.20 0.37 1.79 0.35 1.87 0.24 1.56 0.34 
25 0.99 0.19 1.69 0.40 1.92 0.34 1.69 0.52 
50 0.42 0.38 1.47 0.36 1.53 0.30 1.50 0.36 
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Table 6. Absorbance readings for Listerine assays for C. albicans (CA) and S. mutans (SM) 
planktonic and single species biofilms. Average from 3 sets of triplicate experiments shown 
with standard deviation (SD), highlighted text shows MIC/MCBI for 80% reduction.    
  % C. 
albicans 
Plankto
nic 
SD Single 
Biofilm 
SD S. 
mutans 
Plank 
SD Single 
Biofilm 
SD 
0.00 0.62 0.27 1.20 0.32 0.42 0.10 0.27 0.11 
3.13 0.67 0.13 1.45 0.22 0.36 0.22 0.26 0.25 
6.25 0.15 0.09 1.27 0.14 0.10 0.05 0.31 0.44 
12.50 0.13 0.08 1.33 0.09 0.07 0.05 0.11 0.14 
25.00 0.06 0.03 1.34 0.07 0.08 0.05 0.02 0.02 
50.00 0.05 0.02 0.15 0.31 0.04 0.05 0.02 0.03 
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Table 7. Absorbance readings for Chlorhexidine assays for S. aureus (SA) in planktonic 
cultures, single biofilm and dual combinations with S. mutans (SM) and C. albicans (CA). 
Average from 3 sets of triplicate experiments shown with standard deviation (SD), 
highlighted text shows MIC/MCBI for 80% reduction. 
 
 
SA 
plank 
SD SA 
single 
SD SA/SM SD SA/CA 
 
0 0.811 0.116 1.096 0.427 0.535 0.307 1.302 0.240 
0.0002 0.368 0.380 1.181 0.100 0.718 0.323 1.281 0.225 
0.0005 0.014 0.014 0.879 0.538 0.317 0.275 1.271 0.218 
0.0009 0.006 0.007 1.073 0.191 0.263 0.261 1.260 0.210 
0.002 0.007 0.005 1.053 0.461 0.403 0.410 1.184 0.224 
0.004 0.002 0.002 0.513 0.637 0.118 0.150 1.152 0.263 
0.008 0.004 0.003 0.036 0.033 0.037 0.033 0.488 0.656 
0.015 
  
0.027 0.027 0.054 0.043 0.652 0.587 
0.03 
  
0.032 0.028 0.101 0.166 0.018 0.029 
0.06 
  
0.042 0.022 0.093 0.108 0.004 0.004 
0.12 
  
0.089 0.045 0.062 0.087 0.026 0.036 
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Table 8. Absorbance readings for Chlorhexidine assays for P. aeruginosa (PA) in planktonic 
cultures, single biofilm and dual combinations with S. mutans (SM) and C. albicans (CA). 
Average from 3 sets of triplicate experiments shown with standard deviation (SD), 
highlighted text shows MIC/MCBI for 80% reduction.  
  
% Plank SD PA bio 
 
PA/SM SD PA/CA SD 
0 2.13 0.23 1.85 0.62 1.55 0.33 1.75 0.37 
0.002 1.85 0.44 2.12 0.59 1.86 0.24 2.10 0.33 
0.004 0.23 0.59 1.97 0.57 1.81 0.17 1.91 2.10 
0.008 0.15 0.35 1.90 0.46 1.94 0.17 2.02 0.31 
0.015 0.01 0.01 1.88 0.27 1.91 0.42 2.16 0.31 
0.03 
  
1.77 0.55 1.70 0.42 1.89 0.35 
0.06 
  
1.75 0.22 1.86 0.25 2.03 0.32 
0.12 
  
1.98 0.42 1.92 0.37 1.78 0.65 
0.24 
  
1.76 0.32 1.25 0.95 1.19 0.96 
0.48 
  
1.68 0.64 1.23 0.82 1.72 0.97 
0.96 
  
0.55 0.79 1.04 0.49 1.26 1.03 
1.92 
  
0.18 0.41 2.13 0.24 0.85 0.85 
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Table 9. Absorbance readings for Chlorhexidine assays for C. albicans (CA) in planktonic 
cultures.  Average from 3 sets of triplicate experiments shown with standard deviation (SD), 
highlighted text shows MIC/MCBI for 80% reduction.  
 
     % CA 
Plank 
SD  CA Single SD 
0.000 0.767 0.096 1.236 0.401 
0.001 0.551 0.368 1.025 0.037 
0.002 0.004 0.006 1.354 0.124 
0.004 0.006 0.004 1.329 0.346 
0.008 0.006 0.005 0.619 0.611 
0.015 0.013 0.012 0.718 0.624 
0.030 
  
1.240 0.603 
0.060 
  
0.821 0.695 
0.120 
  
0.743 0.731 
0.240 
  
0.706 0.836 
0.480 
  
0.451 0.617 
0.960 
  
0.280 0.357 
1.920 
  
0.188 0.173 
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Table 10. Absorbance readings for Chlorhexidine assays for S. mutans (CA) in planktonic 
cultures.  Average from 3 sets of triplicate experiments shown with standard deviation (SD), 
highlighted text shows MIC/MCBI for 80% reduction.  
 
 
S. mutans  
Planktonic 
SD Single 
Biofilm 
SD 
0 0.43 0.22 0.31 0.21 
0.0001 0.35 0.51 
  
0.0002 0.04 0.04 0.28 0.06 
0.0005 0.04 0.04 0.46 0.23 
0.0009 0.04 0.04 0.45 0.36 
0.002 0.05 0.04 0.27 0.17 
0.004 
  
0.19 0.17 
0.008 
  
0.14 0.16 
0.015 
  
0.15 0.18 
0.03 
  
0.18 0.22 
0.06 
  
0.22 0.25 
0.12 
  
0.20 0.23 
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